Processing 00000000.tx.1: Caveolae, Plasma Membrane Microdomains for -Secretase-mediated Processing of the Amyloid Precursor Protein* Tsuneya Ikezu, Bruce D. 

Phrase: "Caveolae,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "Plasma Membrane Microdomains for -Secretase-mediated Processing of the Amyloid Precursor Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0887868:Membrane Microdomains [Cell Component]

Phrase: "* Tsuneya Ikezu,"

Phrase: "Bruce D."
Processing 00000000.tx.2: Trapp, Kenneth S. 

Phrase: "Trapp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0913340:trapp [Amino Acid, Peptide, or Protein]
  1000   C1166859:trapp [Cell Component]

Phrase: "Kenneth S."
Processing 00000000.tx.3: Song, Amnon Schlegel, Michael P. 

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "Amnon Schlegel,"

Phrase: "Michael P."
Processing 00000000.tx.4: Lisanti, and Takashi Okamoto** From the Department of Neurosciences, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195and the Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461  ABSTRACT Top Abstract Introduction Procedures Results Discussion References Caveolae are plasma membrane invaginations where key signaling elements are concentrated. 

Phrase: "Lisanti,"

Phrase: "and"

Phrase: "Takashi Okamoto"

Phrase: "*"

Phrase: "*"

Phrase: "From the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Neurosciences,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027910:Neurosciences [Biomedical Occupation or Discipline]
   966 E C1552241:Neuroscience [Professional or Occupational Group]
   966 E C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "The Lerner Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Cleveland Clinic Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44195and"

Phrase: "the Department of Molecular Pharmacology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Albert Einstein College of Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0013227:Medicine, NOS [Pharmacologic Substance]
   804   C0025118:Medicine [Biomedical Occupation or Discipline]
   804   C0557806:College [Manufactured Object]

Phrase: "Bronx,"

Phrase: "New York 10461  ABSTRACT Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "are"

Phrase: "plasma membrane invaginations where key signaling elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0013879:Elements [Element, Ion, or Isotope]
   762 E C1705248:Element [Conceptual Entity]

Phrase: "are"

Phrase: "concentrated."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]
Processing 00000000.tx.5: In this report, both biochemical and histochemical analyses demonstrate that the amyloid precursor protein (APP), a source of A amyloid peptide, is enriched within caveolae. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "both biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "histochemical analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the amyloid precursor protein (APP),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "a source of A amyloid peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "is"

Phrase: "enriched within caveolae."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C0359583:enriched [Food]
Processing 00000000.tx.6: Caveolin-1, a principal component of caveolae, is physically associated with APP, and the cytoplasmic domain of APP directly participates in this binding. 

Phrase: "Caveolin-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a principal component of caveolae,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1882460:Principal Component [Quantitative Concept]
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "physically"

Phrase: "associated with APP,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   835   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "the cytoplasmic domain of APP directly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1511625:Cytoplasmic Domain [Cell Component]
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "participates in this binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
Processing 00000000.tx.7: The characteristic C-terminal fragment that results from APP processing by -secretase, an as yet unidentified enzyme that cleaves APP within the A amyloid sequence, was also localized within these caveolae-enriched fractions. 

Phrase: "The characteristic C-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that results from APP processing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "by -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "an as yet unidentified enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205427:Unidentified [Qualitative Concept]

Phrase: "that"

Phrase: "cleaves"

Phrase: "APP within the"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "A amyloid sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "localized within these caveolae-enriched fractions."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0230653:Caveolae [Cell Component]
   753   C0359583:enriched [Food]
   753   C0392752:Localized [Spatial Concept]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.8: Further analysis by cell surface biotinylation revealed that this cleavage event occurs at the cell surface. 

Phrase: "Further analysis by cell surface biotinylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "this cleavage event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "occurs at the cell surface."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1709305:Occur [Activity]
   760   C1948049:Cell [Spatial Concept]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.9: Importantly, -secretase processing was significantly promoted by recombinant overexpression of caveolin in intact cells, resulting in increased secretion of the soluble extracellular domain of APP. 

Phrase: "Importantly, -"

Phrase: "secretase processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "significantly"

Phrase: "promoted by recombinant overexpression of caveolin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514559:Overexpression [Genetic Function]
   753   C1514798:recombinant [Organism]
   719   C0033414:Promote [Activity]

Phrase: "in intact cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "resulting in increased secretion of the soluble extracellular domain of APP."
Meta Candidates (Total=29; Excluded=3; Pruned=0; Remaining=26)
   766   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   766   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   750   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0332294:Resulting in [Functional Concept]
   750   C1517050:Extracellular Domain [Spatial Concept]
   749   C0162808:Protein Domain [Spatial Concept]
   749   C1159339:Protein Secretion [Cell Function]
   749   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   749   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   749   C1514562:Protein Domain [Amino Acid Sequence]
   735   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0011560:Amyloid [Pathologic Function]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0036536:secretion [Biologic Function]
   735   C0036537:Secretion [Body Substance]
   735   C0205217:Increased [Quantitative Concept]
   735   C0442805:Increased [Functional Concept]
   735   C0521119:Extracellular [Cell Component]
   735   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0678226:resulting [Functional Concept]
   735   C1709634:Precursor [Idea or Concept]
   735   C1749467:soluble [Cell Component]
   735   C1880389:Domain [Functional Concept]
   735   C1883221:Domain [Conceptual Entity]
   735   C1948047:Soluble [Qualitative Concept]
   735   C3541951:Domain [Intellectual Product]
   702 E C1274040:Result [Functional Concept]
   702 E C1546471:Result [Idea or Concept]
   702 E C2825142:Result [Finding]
Processing 00000000.tx.10: Conversely, caveolin depletion using antisense oligonucletotides prevented this cleavage event. 

Phrase: "Conversely,"

Phrase: "caveolin depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisense oligonucletotides"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "this cleavage event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]
Processing 00000000.tx.11: Our current results indicate that caveolae and caveolins may play a pivotal role in the -secretase-mediated proteolysis of APP in vivo.  

Phrase: "Our current results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "and"

Phrase: "caveolins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0887901:Caveolins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a pivotal role in the -secretase-mediated proteolysis of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.12: INTRODUCTION Top Abstract Introduction Procedures Results Discussion References Senile plaques and paired helical filaments are the hallmarks of the brain pathology of Alzheimer's disease (1). 

Phrase: "INTRODUCTION Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "paired helical filaments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "are"

Phrase: "the hallmarks of the brain pathology of Alzheimer's disease"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: The principal component of the senile plaque is the A amyloid peptide, which is composed of 39-43 amino acid residues. 

Phrase: "The principal component of the senile plaque"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1882460:Principal Component [Quantitative Concept]
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "the A amyloid peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "composed of 39-43 amino acid residues."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.14: The A amyloid peptide is derived from a full-length precursor protein, termed APP1 (amyloid precursor protein) (2). 

Phrase: "The"

Phrase: "A amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "derived from a full-length precursor protein,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "termed APP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418230:APP1 [Gene or Genome]
   861   C1421542:APP1 [Gene or Genome]

Phrase: "(amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Alternate splicing of the APP gene generates at least 10distinct isoforms; 

Phrase: "Alternate splicing of the APP gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002345:Alternate Splicing [Genetic Function]
   767   C0017365:gene splicing [Gene or Genome]
   767   C0017387:Gene Splicing [Molecular Biology Research Technique]
   767   C0376437:Protein Splicing [Genetic Function]
   744   C0035687:Splicing [Genetic Function]
   744   C2610186:splicing [Genetic Function]

Phrase: "generates at least 10distinct isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.16: APP695 is the brain-specific isoform. 

Phrase: "APP695"

Phrase: "is"

Phrase: "the brain-specific isoform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.17: The A amyloid peptide is generated by the processing of APP with - and -secretases (3). 

Phrase: "The"

Phrase: "A amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "generated by the processing of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0033666:protein processing [Molecular Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C1709694:Processing [Activity]
   744   C3146294:Generated [Activity]

Phrase: "with -"

Phrase: "and -"

Phrase: "secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: Alternatively, APP is processed by -secretase, which cleaves APP within the A sequence, thereby precluding the formation of A (4). 

Phrase: "Alternatively,"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "processed by -secretase,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "cleaves"

Phrase: "APP within the"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "A sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "thereby"

Phrase: "precluding"

Phrase: "the formation of A (4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: ")."
Processing 00000000.tx.19: The identities of these secretases remain unknown. 

Phrase: "The identities of these secretases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0424215:identities [Mental Process]
   726 E C2003939:Identity [Finding]

Phrase: "remain"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.20: In some inherited forms of Alzheimer's disease, point mutations have been identified within the coding sequence of the APP gene (5). 

Phrase: "In some inherited forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "identified within the coding sequence of the APP gene"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   772   C0079941:Protein Coding Sequence [Gene or Genome]
           Coding Sequence
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0002518:Protein Sequence [Amino Acid Sequence]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0009219:Coding [Occupational Activity]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0205396:Identified [Qualitative Concept]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1519249:Sequence [Functional Concept]
   738   C1550043:Identified [Finding]
   738   C1551388:Identified [Functional Concept]
   738   C1709634:Precursor [Idea or Concept]
   704 E C0805701:Code [Intellectual Product]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: These mutations co-segregate with the disease phenotype and cause Alzheimer's disease. 

Phrase: "These mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "co-segregate with the disease phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0012634:Disease [Disease or Syndrome]
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "cause Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.22: Understanding the molecular function and processing of APP is therefore critical to unraveling the molecular basis of Alzheimer's disease. 

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the molecular function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1148560:molecular function [Molecular Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0033666:protein processing [Molecular Function]
   760   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "therefore critical to unraveling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "the molecular basis of Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1853126:MOLECULAR BASIS [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.23: One approach to elucidate the function of APP is to identify APP-interacting proteins. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the function of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "APP-interacting proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.24: At least five distinct classes of molecules have been identified as APP binding partners as follows: Go (6), Fe65 (7), X11 protein (8), Fe65-like protein (9), and APP-BP1 (10). 

Phrase: "At least five distinct classes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456387:Class [Intellectual Product]
   812   C1705943:Class [Classification]

Phrase: "of molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified as APP binding partners"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033618:Protein Binding [Molecular Function]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205396:Identified [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0682323:partners [Family Group]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "X11 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "Fe65-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "like protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "APP-BP1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1414078:BP1 [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.25: The APP domain that interacts with Go has been localized to residues His657-Lys676 within the cytoplasmic domain of APP695. 

Phrase: "The APP domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0162808:Protein Domain [Spatial Concept]
   861   C1514562:Protein Domain [Amino Acid Sequence]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "that"

Phrase: "interacts with"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "localized to residues His657-Lys676"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392752:Localized [Spatial Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "within the cytoplasmic domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Domain [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of APP695."
Processing 00000000.tx.26: Go is a brain-specific member of heterotrimeric GTP-binding protein (G-protein) family. 

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "is"

Phrase: "a brain-specific member of heterotrimeric GTP-binding protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "(G-protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "family."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.27: The in vivo interaction between APP695 and Go results in apoptotic cell death (11) and inhibition of cAMP response element trans-activation (12). 

Phrase: "The in vivo interaction between APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "results in apoptotic cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "inhibition of cAMP response element trans-activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1510574:Response Inhibition [Mental Process]
   774   C3463820:Response Inhibition [Activity]
           Inhibition
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.28: In contrast, functional consequences of interactions between APP and other binding partners have not yet been described. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "functional consequences of interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "between APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "other binding partners"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0243122:binding [Functional Concept]
   861   C0682323:partners [Family Group]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.29: However, it is likely that these APP-interacting protein molecules directly participate in APP-mediated cell signaling events. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "these APP-interacting protein molecules directly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0567416:molecules [Substance]
   712 E C1521991:Molecular [Qualitative Concept]

Phrase: "participate in APP-mediated cell signaling events."
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0037083:Cell Signaling [Cell Function]
           Signaling
   762   C0018956:precursor cell [Cell]
   762   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cell [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0441471:Events [Event]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1709634:Precursor [Idea or Concept]
   742   C1948049:Cell [Spatial Concept]
   742   C3537152:signaling [Biologic Function]
   742   C3541888:Events [Classification]
   708 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.30: A recent report described APP enrichment within caveolae-like domains in neurons (13). 

Phrase: "A recent report described APP enrichment within caveolae-"

Phrase: "like domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1880389:Domain [Functional Concept]
   966   C1883221:Domain [Conceptual Entity]
   966   C3541951:Domain [Intellectual Product]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: Caveolae are plasmalemmal microdomains where multiple signaling molecules are concentrated. 

Phrase: "Caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "are"

Phrase: "plasmalemmal microdomains where multiple signaling molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   810   C1519315:Signaling Molecule [Biologically Active Substance]
   799   C0567416:molecules [Substance]
   716 E C1521991:Molecular [Qualitative Concept]

Phrase: "are"

Phrase: "concentrated."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]
Processing 00000000.tx.32: Growth factor-mediated and G-protein-mediated signaling cascades have been shown to be initiated within these microdomains (14-16). 

Phrase: "Growth factor-mediated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086597:mediated [Social Behavior]
   827   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   734   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "G-protein-mediated signaling cascades"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   823   C2611812:signaling cascade [Cell Function]
   771   C1707310:Cascade [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "initiated within these microdomains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: "(14-16"

Phrase: ")."
Processing 00000000.tx.33: A major protein component of caveolae is caveolin. 

Phrase: "A major protein component of caveolae"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1179435:Component of protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein Component
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "caveolin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.34: Molecular cloning has recently identified a caveolin gene family. 

Phrase: "Molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a caveolin gene family."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.35: Three distinct caveolin genes have been identified, cav-1, -2,and -3 (17-19). 

Phrase: "Three distinct caveolin genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "cav-1, -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and -"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(17-19"

Phrase: ")."
Processing 00000000.tx.36: In addition, two isoforms of caveolin-1 (Cav-1 and Cav-1) are derived from a single transcript from alternate translation initiation sites. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "two isoforms of caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(Cav-1"

Phrase: "and"

Phrase: "Cav-1"

Phrase: ")"

Phrase: "are"

Phrase: "derived from a single transcript"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C3245521:derived [Idea or Concept]

Phrase: "from alternate translation initiation sites."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C1519613:Translation Initiation [Genetic Function]
   812   C0040712:Translation [Intellectual Product]
   812   C0205145:Sites [Spatial Concept]
   812   C0589507:Initiation [Mental Process]
   812   C0597295:translation [Molecular Function]
   812   C1158830:Initiation [Genetic Function]
   812   C1519614:Translation [Genetic Function]
   812   C1704686:Initiation [Functional Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.37: Caveolins-1 and -2are most abundantly expressed in adipocytes, endothelial cells, and fibroblastic cell types, whereas the expression of caveolin-3 is muscle-specific. 

Phrase: "Caveolins-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
       E   caveolin
   983   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:Caveolins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "2are most abundantly"

Phrase: "expressed in adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0206131:Adipocytes [Cell]

Phrase: "endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "fibroblastic cell types,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0449475:Cell types [Intellectual Product]
   867 E C0007634:Cell Type [Cell]
           Cell
   865   C0016030:fibroblast cell [Cell]
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "the expression of caveolin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "muscle-specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]
Processing 00000000.tx.38: Caveolin proteins form homo-oligomers that bind cholesterol and glycosphingolipids. 

Phrase: "Caveolin proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887901:Caveolin Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "glycosphingolipids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017978:Glycosphingolipids [Lipid,Pharmacologic Substance]
Processing 00000000.tx.39: These protein-protein and protein-lipid interactions are thought to be essential for caveolae formation (20). 

Phrase: "These protein-protein"

Phrase: "and"

Phrase: "protein-lipid interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0872079:protein interaction [Molecular Function]
   793   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "essential for caveolae formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.40: Evidence is accumulating that caveolins can sequester molecules involved in G-protein-coupled signaling within caveolae. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "accumulating"

Phrase: "that caveolins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0887901:Caveolins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "sequester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "involved in G-protein-coupled signaling"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   783 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   783   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0037083:Signaling [Cell Function]
   753   C0439267:g% [Quantitative Concept]
   753   C1314939:Involved [Functional Concept]
   753   C1948027:Coupled [Functional Concept]
   753   C3537152:signaling [Biologic Function]
   719 E C0010222:couple [Family Group]

Phrase: "within caveolae."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]
Processing 00000000.tx.41: Heterotrimeric G-proteins are concentrated within caveolae and interact directly with caveolin via the G subunit (21). 

Phrase: "Heterotrimeric G-proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752348:Heterotrimeric G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C1325335:heterotrimeric G-protein [Cell Component]
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "are"

Phrase: "concentrated within caveolae"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C1880165:Concentrated [Biomedical or Dental Material]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "interact"

Phrase: "directly with caveolin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1947931:Directly [Qualitative Concept]

Phrase: "via the G subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.42: In addition, several G-protein-coupled receptors are sequestered within caveolae in a ligand-independent (endothelin receptor) (22) and ligand-dependent fashion (muscarinic acetylcholine, -adrenergic, and bradykinin receptor) (23-26). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several G-protein-coupled receptors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   937   C0682972:G-Protein-Coupled Receptors [Amino Acid, Peptide, or Protein,Receptor]
   853   C0597357:protein receptors [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   840   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439267:g% [Quantitative Concept]
   804   C1948027:Coupled [Functional Concept]
   771 E C0010222:couple [Family Group]

Phrase: "are"

Phrase: "sequestered within caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C0333312:Sequestered [Functional Concept]

Phrase: "in a ligand-independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085862:Independent [Idea or Concept]
   861   C1299583:Independent [Finding]

Phrase: "(endothelin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059285:Endothelin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "ligand-dependent fashion"

Phrase: "(muscarinic acetylcholine, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0026815:muscarinic [Pharmacologic Substance]

Phrase: "adrenergic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599756:adrenergic [Functional Concept]

Phrase: "and"

Phrase: "bradykinin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0107053:Bradykinin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "(23-26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.43: The molecular mechanism that underlies the recognition of signaling molecules by caveolin has recently been elucidated (27). 

Phrase: "The molecular mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "underlies"

Phrase: "the recognition of signaling molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0524637:Recognition [Mental Process]
   756   C0599844:molecular recognition [Molecular Function]

Phrase: "by caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "elucidated"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.44: Like other scaffolding proteins involved in signal transduction, caveolin contains a modular protein domain, termed the caveolin scaffolding domain. 

Phrase: "Like other scaffolding proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179132:Scaffolding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in signal transduction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0037083:Signal Transduction [Cell Function]
   770   C1160185:transduction [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a modular protein domain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162808:Protein Domain [Spatial Concept]
   901   C1514562:Protein Domain [Amino Acid Sequence]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "the caveolin scaffolding domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.45: The caveolin scaffolding domain, in turn, recognizes a specific consensus motif within its interacting partners (28). 

Phrase: "The caveolin scaffolding domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "recognizes"

Phrase: "a specific consensus motif within its interacting partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514562:Motif [Amino Acid Sequence]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.46: As APP can function as a Go-coupled "receptor" (29) and contains a caveolin binding motif within its cytoplasmic domain, caveolin could provide a means for sequestering APP with caveolae membrane domains. 

Phrase: "As APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "function as a"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "coupled ""receptor"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a caveolin binding motif within its cytoplasmic domain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514562:Motif [Amino Acid Sequence]

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a means for sequestering APP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]

Phrase: "with caveolae membrane domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.47: As APP is expressed in many non-neuronal cell types where caveolin-1 is abundantly expressed, we initiated this study to determine whether APP localizes within caveolae and if caveolin plays a role in this sequestration event. 

Phrase: "As APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "expressed in many non-neuronal cell types where caveolin-1"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   782   C0027836:Non-neuronal cell [Cell]
   760   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   760   C0449475:Cell types [Intellectual Product]
   760   C1332669:CAVEOLIN 1 [Gene or Genome]
   741   C0441729:Type 1 [Classification]
   739   C0007634:Cell [Cell]
       E   Cell Type
   739   C0332307:Types [Qualitative Concept]
   739   C0521390:Neuronal [Immunologic Factor]
   739   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1269647:Cell [Cell]
   739   C1518422:Non [Functional Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   706 E C1547052:*Type [Quantitative Concept]
   705   C0682689:neuron type [Cell]

Phrase: "is"

Phrase: "abundantly"

Phrase: "expressed"

Phrase: ","

Phrase: "we"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "this study to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "determine"

Phrase: "whether"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "localizes within caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C0392752:localize [Spatial Concept]

Phrase: "and"

Phrase: "if"

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in this sequestration event."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.48: Here, we show that (i) endogenous APP co-fractionates with caveolin-1 in three distinct cell lines (COS-7, HEK293, and MDCK); 

Phrase: "Here,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "(i) endogenous APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "co-fractionates with caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   806   C1332669:CAVEOLIN 1 [Gene or Genome]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in three distinct cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "(COS-7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454802:Cos [Geographic Area]

Phrase: "HEK293,"

Phrase: "and"

Phrase: "MDCK"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.49: (ii) recombinantly expressed APP co-immunoprecipitates with caveolin-1 when expressed in COS-7 cells; 

Phrase: "(ii"

Phrase: ")"

Phrase: "recombinantly expressed APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "co-immunoprecipitates with caveolin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   806   C1332669:CAVEOLIN 1 [Gene or Genome]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "when"

Phrase: "expressed in COS-7 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.50: (iii) a GST fusion protein encoding the cytoplasmic domain of APP interacts directly with purified recombinant caveolin-1 protein. 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "a GST fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the cytoplasmic domain of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1511625:Cytoplasmic Domain [Cell Component]
   774   C0162808:Protein Domain [Spatial Concept]
   774   C1514562:Protein Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "interacts"

Phrase: "directly with purified recombinant caveolin-1 protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   778   C1332669:CAVEOLIN 1 [Gene or Genome]
   774   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1514798:recombinant [Organism]
   748   C1947931:Directly [Qualitative Concept]
   748   C1998793:Purified [Functional Concept]
Processing 00000000.tx.51: These three independent lines of evidence support the hypothesis that APP physically associates with caveolin. 

Phrase: "These three independent lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205132:lines [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that APP physically"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "associates with caveolin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0750490:Associate [Idea or Concept]
   790   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.52: Functionally, we show that the -secretase cleavage product of APP is enriched within caveolae and that this cleavage event occurs at the cell surface. 

Phrase: "Functionally,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the -secretase cleavage product of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0597304:Protein Cleavage [Molecular Function]
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "enriched within caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C0359583:enriched [Food]

Phrase: "and"

Phrase: "that"

Phrase: "this cleavage event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "occurs at the cell surface."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1709305:Occur [Activity]
   760   C1948049:Cell [Spatial Concept]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.53: Specifically, we find that recombinant overexpression of caveolin-1 promoted -secretase-mediated proteolysis of APP. 

Phrase: "Specifically,"

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that recombinant overexpression of caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "promoted -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "secretase-mediated proteolysis of APP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]
Processing 00000000.tx.54: The production of the -secretase cleavage product of APP was abrogated by caveolin-1-based antisense oligonucleotides that effectively block caveolin-1 expression. 

Phrase: "The production of the -secretase cleavage product of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "abrogated by caveolin-1-based antisense oligonucleotides"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   778   C1332669:CAVEOLIN 1 [Gene or Genome]
   748   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that effectively"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "caveolin-1 expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332669:CAVEOLIN 1 [Gene or Genome]
Processing 00000000.tx.55: These in vivo functional data clearly indicate that caveolae and caveolin proteins play a pivotal role in -secretase-mediated processing of APP on the plasma membrane.  

Phrase: "These in vivo functional data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1511726:Data [Idea or Concept]
   804   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "and"

Phrase: "caveolin proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887901:Caveolin Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a pivotal role in -secretase-mediated processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0033666:protein processing [Molecular Function]
   738   C1709694:Processing [Activity]

Phrase: "on the plasma membrane."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.56: EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion References Materials-- The cDNAs for canine caveolin-1 were as we described previously (30). 

Phrase: "EXPERIMENTAL PROCEDURES Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The cDNAs for canine caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "as"

Phrase: "we"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.57: Ni-NTA-agarose for purification of polyhistidine-tagged proteins was from Qiagen. 

Phrase: "Ni-NTA-agarose for purification of polyhistidine-tagged proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0036681:Agarose [Carbohydrate]

Phrase: "was from Qiagen."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.58: Antibodies and their sources were as follows: anti-caveolin IgG polyclonal and monoclonal (2234) (gifts of Dr. John R.Glenney, Transduction Labs), anti-myc epitope IgG (monoclonal, 9E10; Santa Cruz Biotech), anti-HA epitope IgG (rat and mouse (12CA5) monoclonal, Boehringer Mannheim). 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "their sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449416:sources [Finding]
   966 E C1705919:Source [Idea or Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "anti-caveolin IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "polyclonal"

Phrase: "and"

Phrase: "monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "(2234"

Phrase: ")"

Phrase: "(gifts of Dr. John R.Glenney,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1136188:Gifts [Entity]

Phrase: "Transduction Labs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0587081:Labs [Finding]
   827 E C0022877:Lab [Manufactured Object,Organization]
   789 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "anti-myc epitope IgG (monoclonal, 9E10"

Phrase: "; Santa Cruz Biotech"

Phrase: ")"

Phrase: ","

Phrase: "anti-HA epitope IgG (rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   708   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "(12CA5"

Phrase: ")"

Phrase: "monoclonal, Boehringer Mannheim"

Phrase: ")."
Processing 00000000.tx.59: A variety of other reagents were purchased commercially as follows: fetal bovine serum (JRH Biosciences), purified myelin basic protein (Sigma), and pre-stained protein markers (Bio-Rad and NOVEX). 

Phrase: "A variety of other reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "were"

Phrase: "purchased"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0869011:purchased [Activity]

Phrase: "commercially"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(JRH Biosciences"

Phrase: ")"

Phrase: ","

Phrase: "purified myelin basic protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   923   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   875   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026969:Myelin [Tissue]
   812   C0026973:Myelin [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1527178:Basic [Functional Concept]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pre-stained"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]
   861   C2986582:Stained [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "protein markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "(Bio-Rad"

Phrase: "and"

Phrase: "NOVEX"

Phrase: ")."
Processing 00000000.tx.60: The anti-GST antibody was from Santa Cruz Biotechnology, and anti-myelin basic protein antibody was from Dako. 

Phrase: "The anti-GST antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Santa Cruz Biotechnology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]

Phrase: "and"

Phrase: "anti-myelin basic protein antibody"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0369713:Anti-myelin basic protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Myelin basic protein antibody
   911   C1276239:Anti-myelin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Myelin antibody
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   884   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   853   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0026969:Myelin [Tissue]
   804   C0026973:Myelin [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1527178:Basic [Functional Concept]
   733 E C0920750:basicity [Quantitative Concept]

Phrase: "was from Dako."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.61: Antibodies against APP are well characterized and include the following: (i) monoclonal antibody: 22C11 specific for the extracellular domain of APP (Boehringer Mannheim), 4G8 specific for A residues 18-24, and 6E10 specific for A residues 1-17 (Senetek) (31); 

Phrase: "Antibodies against APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "well characterized"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C1880022:Characterized [Activity]
   861   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(i) monoclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0221138:I not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C0370188:i Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: ":"

Phrase: "22C11"

Phrase: "specific for the extracellular domain of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "(Boehringer Mannheim"

Phrase: ")"

Phrase: ","

Phrase: "4G8"

Phrase: "specific for A residues 18-24,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "6E10"

Phrase: "specific for A residues 1-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "(Senetek"

Phrase: ")"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.62: and (ii) polyclonal antibody: A-(1-28) (Zymed), 1153specific for A-(1-28) (kindly provided by Richard Scott) (32), 369(kindly provided by Samuel E.Gandy) (33), AC-1 (kindly provided by Kazuaki Yoshikawa) (34), both specific for the cytoplasmic region, and CT-15 specific for the C-terminal 15amino acids (kindly provided by Sangram S.Sisodia) (35). 

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "A-(1-28"

Phrase: ")"

Phrase: "(Zymed"

Phrase: ")"

Phrase: ","

Phrase: "1153specific for A-(1-28"

Phrase: ")"

Phrase: "(kindly"

Phrase: "provided by Richard Scott"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: ")"

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "369"

Phrase: "(kindly"

Phrase: "provided by Samuel E.Gandy) (33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999230:Provided [Activity]

Phrase: ")"

Phrase: ","

Phrase: "AC-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "(kindly"

Phrase: "provided by Kazuaki Yoshikawa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999230:Provided [Activity]

Phrase: ")"

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "both specific for the cytoplasmic region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "CT-15 specific for the C-terminal 15amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "(kindly"

Phrase: "provided by Sangram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]

Phrase: "S."

Phrase: "Sisodia"

Phrase: ")"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.63: Cell Culture and cDNA Transfection-- COS-7, HEK293, and MDCK cells (all from ATCC) were grown in DMEM plus 10% fetal bovine serum supplemented with penicillin and streptomycin (complete DMEM). 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "cDNA Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "--"

Phrase: "COS-7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454802:Cos [Geographic Area]

Phrase: "HEK293,"

Phrase: "and"

Phrase: "MDCK cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0598829:MDCK Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "all from ATCC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444868:All [Quantitative Concept]
   790   C0598079:ATCC [Intellectual Product]
   790   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "grown in DMEM plus 10% fetal bovine serum"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0007452:Bovine [Mammal]
   744   C0015965:Fetal [Embryonic Structure]
   744   C0229671:Serum [Body Substance]
   744   C0332287:Plus [Qualitative Concept]
   744   C0521457:Fetal [Functional Concept]
   744   C1140701:bovine [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: "supplemented with penicillin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0030842:Penicillin [Antibiotic,Organic Chemical]
   790   C0220892:Penicillin [Antibiotic,Organic Chemical]
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(complete DMEM"

Phrase: ")."
Processing 00000000.tx.64: cDNA transfections were conducted as described previously (36). 

Phrase: "cDNA transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.65: Briefly, COS-7 cells were seeded at 1106 cells per 100-mm dish. 

Phrase: "Briefly,"

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded at 1106 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0036563:Seed [Plant]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737 E C1948049:Cell [Spatial Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "per 100-mm dish."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.66: Twenty-four hours later, DNA (6g) of interest was transfected with 30l of LipofectAMINE (Life Technologies, Inc.) in 5ml of DMEM. 

Phrase: "Twenty-four hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(6g"

Phrase: ")"

Phrase: "of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "was"

Phrase: "transfected with 30l of LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) in 5ml of DMEM."
Processing 00000000.tx.67: 24h post-transfection, the media were changed to complete DMEM. 

Phrase: "24h post-transfection,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456696:/24h [Temporal Concept]
   827   C1442770:24H [Temporal Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "DMEM."
Processing 00000000.tx.68: 48h post-transfection, media or cells were harvested and subjected to further analyses. 

Phrase: "48h post-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "subjected to further analyses."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C1517331:Further [Spatial Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737 E C0205108:far [Spatial Concept]
   737   C0681850:Subject [Group]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.69: cDNA Constructions-- For construction of the cDNA encoding HA-inserted APP, the APP695 cDNA in pCDNA-1 (37) was digested with XmaI and dephosphorylated with calf intestine alkaline phosphatase (New England Biolabs). 

Phrase: "cDNA Constructions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "For construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "of the cDNA encoding HA-inserted APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: "the APP695 cDNA in pCDNA-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(37"

Phrase: ")"

Phrase: "was"

Phrase: "digested with XmaI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "dephosphorylated with calf intestine alkaline phosphatase"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   820   C0134983:alkaline phosphatase intestine [Amino Acid, Peptide, or Protein,Enzyme]
   797 E C1412363:ALKALINE PHOSPHATASE, INTESTINAL [Gene or Genome]
   790   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   785 E C0312400:Alkaline phosphatase.intestinal [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0021853:Intestine [Body Part, Organ, or Organ Component]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0230445:Calf [Body Location or Region]
   753   C1149880:phosphatase [Molecular Function]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1708548:INTESTINE [Tissue]
   753   C1979842:Alkaline [Qualitative Concept]

Phrase: "(New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")."
Processing 00000000.tx.70: The oligonucleotides that encode HA sequence possessing XmaI restriction sites at both ends were phosphorylated, annealed, and ligated with the dephosphorylated APP cDNA. 

Phrase: "The oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "HA sequence possessing XmaI restriction sites at both ends"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   742   C0205145:Sites [Spatial Concept]
   742   C0443288:Restriction [Functional Concept]
   731   C1882940:Restriction Site [Nucleotide Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "phosphorylated"

Phrase: ","

Phrase: "annealed"

Phrase: ","

Phrase: "and"

Phrase: "ligated with the dephosphorylated APP cDNA."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.71: The orientation and sequence of the inserted fragment was confirmed by DNA sequencing. 

Phrase: "The orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0029266:Orientation [Mental Process]
  1000   C1704322:orientation [Spatial Concept]
  1000   C1704972:Orientation [Spatial Concept]
  1000   C3539923:Orientation [Intellectual Product]

Phrase: "and"

Phrase: "sequence of the inserted fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "confirmed by DNA sequencing."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.72: The HA peptide sequence was inserted between residues Pro307 and Gly308 of APP695. 

Phrase: "The HA peptide sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0920679:peptide sequence [Amino Acid Sequence]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "inserted between residues Pro307"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0441587:Inserted [Health Care Activity]
   737   C1709915:Residue [Conceptual Entity]
   737 E C1743766:Insert [Medical Device]
   737   C1882936:RESIDUE [Phenomenon or Process]
   737 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "Gly308 of APP695."
Processing 00000000.tx.73: For construction of the GST fusion protein cDNA encoding the cytoplasmic domain of APP (Lys649-Asn695), this domain was amplified as a fragment with additional restriction cleavage sites at both ends (EcoRI and BamHI sites). 

Phrase: "For construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "of the GST fusion protein cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the cytoplasmic domain of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1511625:Cytoplasmic Domain [Cell Component]
   774   C0162808:Protein Domain [Spatial Concept]
   774   C1514562:Protein Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "(Lys649-Asn695"

Phrase: ")"

Phrase: ","

Phrase: "this domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "amplified as a fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332255:fragment [Functional Concept]
   770   C1708096:Fragment [Qualitative Concept]

Phrase: "with additional restriction cleavage sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   858   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "at both ends"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0444930:ends [Spatial Concept]
   966 E C2746065:End [Temporal Concept]
   928 E C0205088:Terminal [Temporal Concept]
   928 E C1705314:Terminal [Manufactured Object]
   928 E C1705315:Terminal [Spatial Concept]

Phrase: "(EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "BamHI sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.74: After PCR, the amplified fragment was digested with EcoRI and BamHI and subcloned in frame into the vector pGEX4T-1 (Amersham Pharmacia Biotech). 

Phrase: "After PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "the amplified fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "digested with EcoRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "BamHI"

Phrase: "and"

Phrase: "subcloned in frame into the vector pGEX4T-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080089:Frame [Nucleotide Sequence]
   744   C0180979:Frame [Medical Device]
   744   C1705858:Frame [Manufactured Object]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.75: Detergent-free Purification of Caveolin-rich Membrane Domains-- Cultured cells were grown to confluence in 150-mm dishes and used to prepare caveolin-enriched membrane fractions, as described previously (38). 

Phrase: "Detergent-free Purification of Caveolin-rich Membrane Domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "--"

Phrase: "Cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "grown to confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "in 150-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "caveolin-enriched membrane fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.76: After two washes with ice-cold phosphate-buffered saline, cultured cells (two confluent 150-mm dishes) were scraped into 2ml of 500mM sodium carbonate, pH 11.0,and homogenized sequentially with a loose-fitting Dounce homogenizer (10strokes), a Polytron tissue grinder (three 10-s bursts; Kinematica GmbH, Brinkmann Instruments), and a sonicator (three 20-s bursts; Branson Sonifier 250,Branson Ultrasonic Corp.). 

Phrase: "After two washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "with ice-cold phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(two confluent 150-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0020498:DISH [Disease or Syndrome]

Phrase: ")"

Phrase: "were"

Phrase: "scraped into 2ml of 500mM sodium carbonate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]
   748   C0007026:Carbonate [Inorganic Chemical]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0184933:scraped [Therapeutic or Preventive Procedure]
   748   C0444082:scraped [Body Substance]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 11.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "homogenized"

Phrase: "sequentially with a loose-fitting Dounce homogenizer"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0036572:Fitting [Sign or Symptom]
   748   C0181200:homogenizer [Medical Device]
   748   C0205407:Loose [Qualitative Concept]
   748   C0441548:Fitting [Health Care Activity]
   714 E C0424576:Fit [Finding]
   714 E C2349186:Fit [Activity]

Phrase: "(10strokes"

Phrase: ")"

Phrase: ","

Phrase: "a Polytron tissue grinder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0493160:GRINDER, TISSUE [Medical Device]

Phrase: "(three 10-s bursts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439818:bursts [Qualitative Concept]
   779 E C1881705:BURST [Phenomenon or Process]

Phrase: "; Kinematica GmbH,"

Phrase: "Brinkmann Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a sonicator"

Phrase: "(three 20-s bursts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439818:bursts [Qualitative Concept]
   779 E C1881705:BURST [Phenomenon or Process]

Phrase: "; Branson Sonifier 250,"

Phrase: "Branson Ultrasonic Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.77: The homogenate was then adjusted to 45% sucrose by the addition of 2ml of 90% sucrose in MBS (25mM Mes, pH 6.5,0.15M NaCl) and placed at the bottom of an ultracentrifuge tube. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "adjusted to 45% sucrose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0456081:Adjusted [Functional Concept]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 2ml"

Phrase: "of 90% sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "in MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036082:Saline [Substance]

Phrase: "(25mM Mes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0265215:MES [Congenital Abnormality]
   861   C1417092:MES [Gene or Genome]

Phrase: "pH 6.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.15M NaCl)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "placed at the bottom of an ultracentrifuge tube."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0175730:Tube [Medical Device]
   744   C1511276:Bottom [Spatial Concept]
   744   C1547937:Tube NOS [Intellectual Product]
   744   C1552825:bottom [Idea or Concept]
   744   C1561954:tube [Conceptual Entity]
   744   C1704730:TUBE [Medical Device]
   711   C0442504:Place [Spatial Concept]
   711   C1704765:Place [Functional Concept]
   711   C1882509:Place [Activity]
   711   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.78: A 5-35% discontinuous sucrose gradient was formed above (4ml of 5% sucrose, 4ml of 35% sucrose; both in MBS containing 250mM sodium carbonate) and centrifuged at 39,000rpm for 16-20 h in an SW41 rotor (Beckman Instruments). 

Phrase: "A 5-35% discontinuous sucrose gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439182:% gradient [Quantitative Concept]
   804   C0812409:Gradient [Quantitative Concept]

Phrase: "was"

Phrase: "formed above"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0205431:Formed [Functional Concept]
   799 E C0348078:Form [Qualitative Concept]
   799 E C0376315:Form [Manufactured Object]
   799 E C1522492:Form [Functional Concept]

Phrase: "(4ml of 5% sucrose,"

Phrase: "4ml of 35% sucrose"

Phrase: ";"

Phrase: "both in MBS containing 250mM sodium carbonate"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]
   742   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0007026:Carbonate [Inorganic Chemical]
   742   C0036082:Saline [Substance]
   742   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0238767:Both [Spatial Concept]
   742   C0265215:MES [Congenital Abnormality]
   742   C0332256:Containing [Functional Concept]
   742   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1417092:MES [Gene or Genome]
   742   C1706086:Both [Qualitative Concept]
   742   C2700400:Containing [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "centrifuged at 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000rpm for 16-20 h"

Phrase: "in an SW41 rotor"

Phrase: "(Beckman Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")."
Processing 00000000.tx.79: A light-scattering band confined to the 5-35% sucrose interface contained caveolin but excluded most other cellular proteins. 

Phrase: "A light-scattering band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]
   734   C0596837:Light Scattering [Phenomenon or Process]

Phrase: "confined to the 5-35% sucrose interface contained caveolin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0332256:contained [Functional Concept]
   742   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   742   C1708533:Interface [Manufactured Object]
   742   C2698172:Interface [Intellectual Product]
   742   C2700400:Contained [Activity]

Phrase: "but"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "most other cellular proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.80: The caveolae-rich fractions were diluted 3-fold with MBS and centrifuged at 15,000rpm for 20min at 4C. 

Phrase: "The caveolae-rich fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "3-fold with MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "centrifuged at 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000rpm for 20min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.81: The pellets were used as "purified caveolae-enriched membranes." 

Phrase: "The pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as ""purified caveolae-enriched membranes."""
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0025255:Membranes [Tissue]
   794   C1167209:caveolar membrane [Cell Component]
   771 E C0596901:Membrane [Cell Component]
   771 E C1706182:Membrane [Manufactured Object]
   721 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.82: This protocol separated caveolin from the bulk of cellular membranes and cytosolic proteins. 

Phrase: "This protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "caveolin from the bulk of cellular membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cytosolic proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.83: This fractionation scheme is based on the specific buoyant density of caveolin-rich membrane domains and their resistance to solubilization by sodium carbonate. 

Phrase: "This fractionation scheme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]

Phrase: "is"

Phrase: "based on the specific buoyant density of caveolin-rich membrane domains"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   738   C0025255:Membrane [Tissue]
   738   C0178587:density [Quantitative Concept]
   738   C0205369:Specific [Qualitative Concept]
   738   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0596901:Membrane [Cell Component]
   738   C0699759:Rich [Qualitative Concept]
   738   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1527178:Based [Functional Concept]
   738   C1552740:specific [Intellectual Product]
   738   C1705938:Based [Idea or Concept]
   738   C1706182:Membrane [Manufactured Object]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704 E C1880279:Base [Biomedical or Dental Material]
   704   C1880389:Domain [Functional Concept]
   704   C1883221:Domain [Conceptual Entity]
   704   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "their resistance to solubilization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0332325:Resistant to [Functional Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]

Phrase: "by sodium carbonate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]
   861   C0007026:Carbonate [Inorganic Chemical]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.84: By using this scheme, endogenous MDCK (38) and COS-7 caveolin (39) are purified 2,000-fold relative to total cell lysates; 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this scheme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519193:Scheme [Intellectual Product]

Phrase: "endogenous MDCK (38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205227:Endogenous [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "COS-7 caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(39"

Phrase: ")"

Phrase: "are"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "2,000-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "relative to total cell lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.85: approximately 90-95% of caveolin is recovered in fractions 4and 5of these sucrose density gradients while excluding greater than 99.95% of total cellular proteins. 

Phrase: "approximately 90-95% of caveolin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332232:Approximately [Qualitative Concept]
   760   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "recovered in fractions 4and 5of"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0521108:recovered [Qualitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "these sucrose density gradients"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0812409:gradients [Quantitative Concept]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   793 E C0439182:% gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "while"

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "greater than 99.95% of total cellular proteins."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439093:Greater Than [Quantitative Concept]
   744   C0443228:greater [Quantitative Concept]
   744   C1704243:Greater [Quantitative Concept]
   711 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.86: By using this same fractionation scheme, cav-myc and cav-myc-H7 co-fractionated with endogenous caveolin, an indication that the myc and polyhistidine tags do not interfere with the correct targeting of caveolin (38). 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this same fractionation scheme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519193:Scheme [Intellectual Product]

Phrase: "cav-myc"

Phrase: "and"

Phrase: "cav-myc-H7"

Phrase: "co-fractionated with endogenous caveolin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205227:Endogenous [Functional Concept]
   760   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1979893:Fractionated [Qualitative Concept]

Phrase: "an indication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392360:indication [Idea or Concept]
  1000   C3146298:Indication [Functional Concept]

Phrase: "that"

Phrase: "the myc"

Phrase: "and"

Phrase: "polyhistidine tags"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1139855:tags [Medical Device]
   827 E C0037293:Tag [Neoplastic Process]
   827 E C0181496:Tag [Manufactured Object]
   827 E C1710492:TAG [Gene or Genome]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the correct targeting of caveolin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0521102:Interfere [Qualitative Concept]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1521840:Targeting [Functional Concept]
   748   C2349182:Correct [Qualitative Concept]
   714 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.87: Sodium carbonate extraction is routinely used to determine if proteins are firmly attached to membranes, and caveolin is not solubilized by sodium carbonate. 

Phrase: "Sodium carbonate extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]
   734   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "routinely"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "firmly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880776:Firmly [Qualitative Concept]

Phrase: "attached to membranes,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0025255:Membranes [Tissue]
   790   C0231441:Attached [Finding]
   756 E C0596901:Membrane [Cell Component]
   756 E C1314972:ATTACH [Intellectual Product]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "solubilized by sodium carbonate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]
   770   C0007026:Carbonate [Inorganic Chemical]
   770   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   770   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.88: By using this scheme, endogenous caveolin and cav-myc-H7 were not only recovered almost quantitatively in fractions 4and 5,while excluding most cellular proteins, but also were separated from the glycosylphosphatidylinositol-linked plasma membrane marker, carbonic anhydrase IV (38). 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this scheme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519193:Scheme [Intellectual Product]

Phrase: "endogenous caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cav-myc-H7"

Phrase: "were"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "almost quantitatively in fractions 4and 5,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "while"

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "most cellular proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "also"

Phrase: "were"

Phrase: "separated from the glycosylphosphatidylinositol-linked plasma membrane marker,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0007603:Plasma membrane [Cell Component]
   744   C0005516:Marker [Clinical Attribute]
   744   C0025255:Membrane [Tissue]
   744   C0032105:Plasma [Body Substance]
   744   C0061688:Glycosyl-Phosphatidylinositol [Carbohydrate,Lipid,Organophosphorus Compound]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0596901:Membrane [Cell Component]
   744   C0687118:Separated [Functional Concept]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C1706182:Membrane [Manufactured Object]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "carbonic anhydrase IV (38"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0950150:Carbonic Anhydrase IV [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1413045:CARBONIC ANHYDRASE IV [Gene or Genome]
   861   C0007028:Carbonic Anhydrase [Amino Acid, Peptide, or Protein,Enzyme]
   741   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.89: This is consistent with recent observations that glycosylphosphatidylinositol-linked proteins are not concentrated directly within caveolae but may reside in close proximity to the "neck regions" of caveolae within intact cells (40). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with recent observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that glycosylphosphatidylinositol-linked proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2936531:Glycosylphosphatidylinositol Linked Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0061688:Glycosyl-Phosphatidylinositol [Carbohydrate,Lipid,Organophosphorus Compound]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "directly within caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C1947931:Directly [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "reside in close proximity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0587267:Close [Functional Concept]
   770   C1514583:Proximity [Spatial Concept]
   770   C2982691:Reside [Activity]

Phrase: "to the ""neck regions"""
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0920882:Neck region [Body Location or Region]
   972 E C0556956:cervical regions [Body Location or Region]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "within intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.90: As an alternative approach to purify caveolae, a protocol developed by Smart et al. 

Phrase: "As an alternative approach to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "caveolae,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "a protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "developed by Smart et al."
Processing 00000000.tx.91: (41) was employed. 

Phrase: "(41"

Phrase: ")"

Phrase: "was"

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.92: A plasma membrane fraction was prepared from 10100-mm dishes of confluent tissue culture cells. 

Phrase: "A plasma membrane fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "was"

Phrase: "prepared from 10100-mm dishes of confluent tissue culture cells."
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   764   C1331092:tissue/cell culture [Laboratory Procedure]
   761 E C0040284:cell tissue culture [Laboratory Procedure]
           Tissue culture
   761   C0492792:DISH, TISSUE CULTURE [Medical Device]
   757   C0007585:cells culture [Laboratory Procedure]
   741   C2347576:Cells/dish [Quantitative Concept]
   739   C0007634:Cells [Cell]
   739   C0010453:Culture [Idea or Concept]
   739   C0040300:Tissue [Tissue]
   739   C0205200:Confluent [Qualitative Concept]
   739   C0220814:culture [Functional Concept]
   739   C0430400:Culture [Laboratory Procedure]
   739   C1547928:Tissue [Intellectual Product]
   739   C2242979:Culture [Laboratory Procedure]
   739   C3282337:Cells [Cell]
   706   C0020498:DISH [Disease or Syndrome]
   706 E C1269647:Cell [Cell]
   706   C1521827:Prepare [Functional Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.93: Each dish was washed twice with 5ml of buffer A (0.25M sucrose, 1mM EDTA, 20mM Tricine, pH 7.8). 

Phrase: "Each dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020498:DISH [Disease or Syndrome]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with 5ml of buffer A (0.25M sucrose,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   742   C1720725:Twice [Intellectual Product]
   742   C1948050:Twice [Quantitative Concept]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "20mM Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0077068:tricine [Organic Chemical]

Phrase: "pH 7.8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.94: Cells were collected by centrifugation at 1,400g for 5min (Sorval RT6000: 3000rpm) and resuspended in 1ml of buffer A and homogenized 15times with Teflon glass homogenizer. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected by centrifugation at 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "400g for 5min"

Phrase: "(Sorval RT6000"

Phrase: ":"

Phrase: "3000rpm"

Phrase: ")"

Phrase: "and"

Phrase: "resuspended in 1ml of buffer A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "homogenized 15times with Teflon glass homogenizer."
Processing 00000000.tx.95: Homogenized cells were centrifuged at 1,000g for 10min (Sorval RT6000: 2500rpm), and the supernatant was subjected to Percoll gradient centrifugation. 

Phrase: "Homogenized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "000g for 10min"

Phrase: "(Sorval RT6000"

Phrase: ":"

Phrase: "2500rpm"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "subjected to Percoll gradient centrifugation."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0430994:Percoll gradient centrifugation [Laboratory Procedure]
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.96: The sample was overlaid on top of 23ml of 30% Percoll solution in buffer A and centrifuged at 83,000g (30,000rpm) for 30 min in a Beckman Ti-60 rotor. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "overlaid on top of 23ml of 30% Percoll solution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0037633:Solution [Substance]
   742   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0525069:Solution [Biomedical or Dental Material]
   742   C1704458:Top [Spatial Concept]
   708   C0444456:Overlay [Spatial Concept]
   708   C1706359:Overlay [Medical Device]

Phrase: "in buffer A"

Phrase: "and"

Phrase: "centrifuged at 83,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g"

Phrase: "(30,"

Phrase: "000rpm"

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in a Beckman Ti-60 rotor."
Processing 00000000.tx.97: A plasma membrane fraction was collected, and the volume was adjusted to 2ml in buffer A.1.84ml of 50% Optiprep in buffer B (0.25M sucrose, 6mM EDTA, 120mM Tricine, pH 7.8) was added to 0.16ml of buffer A (23% Optiprep solution), which was mixed with the sonicated plasma membrane fraction. 

Phrase: "A plasma membrane fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "adjusted to 2ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: "in buffer A.1.84ml"

Phrase: "of 50% Optiprep"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642362:OptiPrep [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in buffer B (0.25M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "6mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "120mM Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0077068:tricine [Organic Chemical]

Phrase: "pH 7.8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "added to 0.16ml of buffer A (23% Optiprep solution"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0037633:Solution [Substance]
   739   C0450348:23 [Quantitative Concept]
   739   C0525069:Solution [Biomedical or Dental Material]
   739   C1524062:Added [Functional Concept]
   739   C3642362:OptiPrep [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   706 E C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "mixed with the sonicated plasma membrane fraction."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0007603:Plasma membrane [Cell Component]
   748   C0025255:Membrane [Tissue]
   748   C0032105:Plasma [Body Substance]
   748   C0205430:Mixed [Functional Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1264633:Fraction [Quantitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1554103:Fraction [Idea or Concept]
   748   C1706182:Membrane [Manufactured Object]
   748   C3160715:Mixed [Finding]
   714 E C1421951:MIX [Gene or Genome]
   714 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.98: The entire solution was placed at the bottom of a Beckman SW41 rotor tube and overlaid onto a linear 10-20% Optiprep gradient (prepared by diluting 50% Optiprep in buffer A and B) and centrifuged at 52,000g (18000rpm) for 90min using SW41 rotor (Beckman). 

Phrase: "The entire solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "placed at the bottom of a Beckman SW41 rotor tube"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0175730:Tube [Medical Device]
   739   C1511276:Bottom [Spatial Concept]
   739   C1547937:Tube NOS [Intellectual Product]
   739   C1552825:bottom [Idea or Concept]
   739   C1561954:tube [Conceptual Entity]
   739   C1704730:TUBE [Medical Device]
   706   C0442504:Place [Spatial Concept]
   706   C1704765:Place [Functional Concept]
   706   C1882509:Place [Activity]
   706   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "overlaid onto a linear 10-20% Optiprep gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0444456:Overlay [Spatial Concept]
   711   C1706359:Overlay [Medical Device]

Phrase: "("

Phrase: "prepared by diluting 50% Optiprep"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C3642362:OptiPrep [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726   C1521827:Prepare [Functional Concept]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "in buffer A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "centrifuged at 52,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g"

Phrase: "(18000rpm"

Phrase: ")"

Phrase: "for 90min"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SW41 rotor"

Phrase: "(Beckman"

Phrase: ")."
Processing 00000000.tx.99: The bottom fraction was collected (non-caveolae membrane). 

Phrase: "The bottom fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "(non-caveolae membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   859   C1167209:caveolar membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.100: The top 5ml of the gradient (fractions 1-6) was collected and mixed with 50% Optiprep in buffer B, which was then placed on the bottom of SW41 rotor tube and overlaid by 2ml of 5% Optiprep in buffer A.

Phrase: "The top 5ml of the gradient"

Phrase: "(fractions 1-6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "mixed with 50% Optiprep"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205430:Mixed [Functional Concept]
   770   C3160715:Mixed [Finding]
   770   C3642362:OptiPrep [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "in buffer B,"

Phrase: "which"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed on the bottom of SW41 rotor tube"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0175730:Tube [Medical Device]
   744   C1511276:Bottom [Spatial Concept]
   744   C1547937:Tube NOS [Intellectual Product]
   744   C1552825:bottom [Idea or Concept]
   744   C1561954:tube [Conceptual Entity]
   744   C1704730:TUBE [Medical Device]
   711   C0442504:Place [Spatial Concept]
   711   C1704765:Place [Functional Concept]
   711   C1882509:Place [Activity]
   711   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "overlaid by 2ml of 5% Optiprep"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0444456:Overlay [Spatial Concept]
   719   C1706359:Overlay [Medical Device]

Phrase: "in buffer A."
Processing 00000000.tx.101: The membrane fractions were centrifuged at 52,000g for 90 min. 

Phrase: "The membrane fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "centrifuged at 52,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 90 min."
Processing 00000000.tx.102: An opaque band located just above the 5% interface was designated the caveolae fraction (41). 

Phrase: "An opaque band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "located"

Phrase: "just above the 5% interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1708533:Interface [Manufactured Object]
   760   C2698172:Interface [Intellectual Product]

Phrase: "was"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "the caveolae fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.103: Immunoblotting of Gradient Fractions-- From the top of each gradient, 1-ml gradient fractions were collected to yield a total of 12fractions. 

Phrase: "Immunoblotting of Gradient Fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "From the top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "of each gradient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "1-ml gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "a total of 12fractions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.104: Caveolin migrates mainly in fractions 4and 5of these sucrose density gradients (38). 

Phrase: "Caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "migrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrate [Functional Concept]

Phrase: "mainly in fractions 4and 5of"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "these sucrose density gradients"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0812409:gradients [Quantitative Concept]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   793 E C0439182:% gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.105: Gradient fractions were separated by SDS-PAGE and transferred to Immobilon-PSQ sheets (Millipore). 

Phrase: "Gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "transferred to Immobilon-PSQ sheets"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   760   C0348011:transferred [Functional Concept]
   760   C0439643:Sheets [Spatial Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
   726 E C2349187:Sheet [Quantitative Concept]

Phrase: "(Millipore"

Phrase: ")."
Processing 00000000.tx.106: After transfer, sheets were stained with Ponceau S to visualize protein bands and subjected to immunoblotting. 

Phrase: "After transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "sheets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439643:Sheets [Spatial Concept]
   966 E C2349187:Sheet [Quantitative Concept]

Phrase: "were"

Phrase: "stained with Ponceau S to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0071720:Ponceau S stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ponceau S
   781   C0491958:STAIN, PONCEAU [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "visualize"

Phrase: "protein bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "subjected to immunoblotting."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]
Processing 00000000.tx.107: For immunoblotting using ECL, incubation conditions were as described by the manufacturer (Amersham Pharmacia Biotech), except we supplemented our blocking solution with both 1% bovine serum albumin, 3% nonfat dry milk, and 0.02% sodium azide. 

Phrase: "For immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ECL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "incubation conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "as"

Phrase: "described by the manufacturer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1705426:Manufacturer [Population Group]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "except we"

Phrase: "supplemented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]

Phrase: "our blocking solution with both 1% bovine serum albumin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0359180:Albumin solution [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0037633:Solution [Substance]
   742   C0525069:Solution [Biomedical or Dental Material]

Phrase: "3% nonfat dry milk,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C2825079:Milk [Food]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]

Phrase: "and"

Phrase: "0.02% sodium azide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0004492:azide [Chemical Viewed Structurally]
Processing 00000000.tx.108: Chemical Cross-linking Studies-- After transfection of cDNAs, cells were incubated with DMEM plus 10% Me2SO containing 48g/ml bis-[-(4-azidosalicylamindo)ethyl] disulfide (Pierce) for 10min at RT. 

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "-"

Phrase: "-"

Phrase: "After"

Phrase: "transfection of cDNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "with DMEM plus 10% Me2SO containing 48g/ml bis-[-(4-azidosalicylamindo"

Phrase: ")"

Phrase: "ethyl"

Phrase: "] disulfide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "(Pierce"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0522529:Conjugated [Spatial Concept]
   789 E C1160466:conjugation [Cell Function]

Phrase: ")"

Phrase: "for 10min at RT."
Processing 00000000.tx.109: Media were discarded, and cells were exposed to ultraviolet light (wavelength 365nm) (model LM20E, VWR Scientific) for 15min at 4C. 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "discarded"

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to ultraviolet light"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0041625:Ultraviolet Light [Natural Phenomenon or Process]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   791 E C0181651:ultraviolet lights [Medical Device]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C1306462:Light [Functional Concept]
   770   C1532472:Ultraviolet [Qualitative Concept]
   770   C1881376:Light [Qualitative Concept]

Phrase: "(wavelength 365nm"

Phrase: ")"

Phrase: "(model LM20E,"

Phrase: "VWR"

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")"

Phrase: "for 15min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.110: Cells were solubilized in a lysis buffer A (10mM Tris/HCl, pH 8.0,1mM EDTA, 1mM dithiothreitol, 60mM octylglycoside, 1% Triton X-100, 1mM aprotinin, 1mM phenylmethylsulfonyl fluoride) with sonication (three 20-s bursts, Branson Sonifier 250,Branson Ultrasonic Corp). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "solubilized in a lysis buffer A (10mM Tris/HCl,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0024348:Lysis [Pathologic Function]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0814229:TRI [Intellectual Product]
   742   C1536403:lysis [Cell Function]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "60mM octylglycoside,"

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "1mM aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1mM phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "with sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037680:Sonication [Research Activity]

Phrase: "(three 20-s bursts,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439818:bursts [Qualitative Concept]
   779 E C1881705:BURST [Phenomenon or Process]

Phrase: "Branson Sonifier 250,"

Phrase: "Branson Ultrasonic Corp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.111: After centrifugation at 15,000 rpm for 20min at 4C, supernatants were collected and subjected to immunoprecipitation/immunoblot analysis. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 15,000 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]

Phrase: "for 20min"

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation/immunoblot analysis."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.112: Cross-linking reagents were cleaved by boiling samples at 95C for 5min in the presence of 5% -mercaptoethanol, and the samples were subjected to SDS-PAGE. 

Phrase: "Cross-linking reagents"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0010360:Cross-Linking Reagents [Indicator, Reagent, or Diagnostic Aid]
   901   C0332220:Cross-linking [Functional Concept]
   884 E C0178576:Cross link [Natural Phenomenon or Process]
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   827   C2828360:Cross [Conceptual Entity]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]

Phrase: "were"

Phrase: "cleaved by boiling samples"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
   737   C0242301:Boil [Disease or Syndrome]
   737   C0370003:Sample [Substance]
   737   C1546559:Boil [Intellectual Product]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "at 95C"

Phrase: "for 5min"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5% -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.113: Immunoprecipitation of Caveolae-enriched Fractions-- Caveolae-enriched fractions were diluted with Mes-buffered saline (MBS) and solubilized in buffer A without Triton X-100. 

Phrase: "Immunoprecipitation of Caveolae-enriched Fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "--"

Phrase: "Caveolae-enriched fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "diluted with Mes-buffered saline (MBS)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0265215:MES [Congenital Abnormality]
   760   C1417092:MES [Gene or Genome]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "solubilized in buffer A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "without Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   901   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   827   C0242759:Triton [Geographic Area]
Processing 00000000.tx.114: After dialysis against buffer A without detergent, immunoprecipitation was conducted with anti-HA (Boehringer Mannheim) or anti-myc antibodies (Santa Cruz Biotechnology) overnight at 4C. 

Phrase: "After dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011945:Dialysis [Natural Phenomenon or Process]
  1000   C0011946:dialysis [Therapeutic or Preventive Procedure]
  1000   C0917873:dialysis [Therapeutic or Preventive Procedure]
  1000   C1059964:Dialysis [Eukaryote]

Phrase: "against buffer A"

Phrase: "without detergent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergent [Chemical Viewed Functionally]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "conducted with anti-HA (Boehringer Mannheim"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0004927:Conduct [Individual Behavior]

Phrase: ")"

Phrase: "or"

Phrase: "anti-myc antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.115: Fifty l of a ~50% slurry protein G-Sepharose (Amersham Pharmacia Biotech) was added and further incubated for 2h. 

Phrase: "Fifty l of a ~50% slurry protein G-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0439294:g l [Quantitative Concept]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated for 2h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292425:2H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.116: The beads were washed 3times with Tris-buffered saline (TBS, 10mM Tris/HCl, pH 8.0,0.15M NaCl), once with TE buffer (0.1M Tris/HCl, pH 6.8,1mM EDTA), and subjected to SDS-PAGE/immunoblotting. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3times with Tris-buffered saline"

Phrase: "(TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "10mM Tris/HCl,"

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.15M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "once with TE buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1705540:TE [Conceptual Entity]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]

Phrase: "(0.1M Tris/HCl,"

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "subjected to SDS-PAGE/immunoblotting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0020985:Immunoblotting [Laboratory Procedure]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.117: Affinity Purification of Caveolin-myc-H7 Expressed in Insect Cells Using Ni-NTA-Agarose-- The Sf21 cells overproducing His-tagged caveolin-1 (76) were collected and solubilized in buffer A.Ni-NTA-agarose (200 l) was then pre-equilibrated with TBS. 

Phrase: "Affinity Purification of Caveolin-myc-H7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008551:affinity purification [Laboratory Procedure]
   753   C0243114:purification [Functional Concept]
   753   C1998793:Purification [Functional Concept]

Phrase: "Expressed in Insect Cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0021585:Insect [Eukaryote]
   770   C0770740:INSECT [Pharmacologic Substance]
   770   C1546678:Insect [Intellectual Product]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ni-NTA-Agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]

Phrase: "-"

Phrase: "-"

Phrase: "The Sf21 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C3494246:Sf21 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overproducing"

Phrase: "His-tagged caveolin-1"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   896   C1413560:TAG-1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   827   C1708632:Tagged [Qualitative Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]

Phrase: "(76"

Phrase: ")"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "solubilized in buffer A.Ni-NTA-agarose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0028132:NTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0036681:Agarose [Carbohydrate]
   748   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "(200 l)"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "pre-equilibrated with TBS."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   770   C0332152:Pre [Temporal Concept]
   770   C0740175:Pre [Qualitative Concept]
   770   C1532188:Tbsp [Quantitative Concept]
   770   C2257086:PRE [Genetic Function]
Processing 00000000.tx.118: Solubilized caveolin-containing cell extracts were then added to the resin and incubated for 6 h at 4C on a rotating platform. 

Phrase: "Solubilized caveolin-containing cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0007592:Cell Extracts [Cell Component]
   771   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the resin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0035191:Resin [Biomedical or Dental Material]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for 6 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0444953:H 6 [Intellectual Product]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "on a rotating platform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710360:Platform [Research Device]
Processing 00000000.tx.119: After binding, the beads were allowed to gently settle by gravity (5min on ice) and washed extensively (four times, 5min each; twice with TBS and twice with TBS plus 30mM imidazole). 

Phrase: "After binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to gently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1638411:Gently [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]

Phrase: "settle by gravity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0282189:Gravity [Natural Phenomenon or Process]
   790   C1266099:SETTLE [Neoplastic Process]
   790   C2700494:Gravity [Quantitative Concept]

Phrase: "(5min on ice)"

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively"

Phrase: "(four times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "5min"

Phrase: "each"

Phrase: "; twice with TBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "twice with TBS plus 30mM imidazole"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   753   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]
   753   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   753   C0332287:Plus [Qualitative Concept]
   753   C0450396:30mm [Quantitative Concept]
   753   C1532188:Tbsp [Quantitative Concept]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.120: After washing, bound proteins were eluted with TBS containing 200mM imidazole, as per the manufacturer's instructions (Qiagen). 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with TBS containing 200mM imidazole,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   753   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]
   753   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   753   C0332256:Containing [Functional Concept]
   753   C1532188:Tbsp [Quantitative Concept]
   753   C2700400:Containing [Activity]

Phrase: "as"

Phrase: "per the manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(Qiagen"

Phrase: ")."
Processing 00000000.tx.121: Purification of GST-APP Cytoplasmic Region-- An overnight culture of Escherichia coli harboring plasmids encoding either GST-APP or GST alone was purified as described previously (42). 

Phrase: "Purification of GST-APP Cytoplasmic Region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597301:protein purification [Laboratory Procedure]
   744   C0243114:purification [Functional Concept]
   744   C1998793:Purification [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "An overnight culture of Escherichia coli harboring plasmids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0010453:Culture [Idea or Concept]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C2242979:Culture [Laboratory Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "either GST-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "GST"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.122: Interaction of Caveolin-myc-H7 with GST-APP Cytoplasmic Region Proteins-- The interaction of GST-APP fusion proteins with caveolin-1-myc-H7 was evaluated as described for the interaction of caveolin with baculovirus-expressed heterotrimeric G-protein subunits (21). 

Phrase: "Interaction of Caveolin-myc-H7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with GST-APP Cytoplasmic Region Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "-"

Phrase: "The interaction of GST-APP fusion proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0872079:Protein-Protein Interaction [Molecular Function]
           interaction protein
   742   C1704675:Interaction [Functional Concept]

Phrase: "with caveolin-1-myc-H7"

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "as"

Phrase: "described for the interaction of caveolin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1552738:described [Idea or Concept]
   753   C1704675:Interaction [Functional Concept]

Phrase: "with baculovirus-expressed heterotrimeric G-protein subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   890   C1333999:Heterotrimeric G Protein Subunit [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   766   C1711351:Subunit [Quantitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.123: Briefly, GST or purified GST-APP cytoplasmic fusion proteins bound to glutathione-agarose beads were extensively prewashed with phosphate-buffered saline and lysis buffer containing protease inhibitors. 

Phrase: "Briefly,"

Phrase: "GST"

Phrase: "or"

Phrase: "purified GST-APP cytoplasmic fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   864   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332466:Fusion [Functional Concept]
   793   C1293131:Fusion [Therapeutic or Preventive Procedure]
   779   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "bound to glutathione-agarose beads"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Agarose [Carbohydrate]
   760   C0332297:bound [Spatial Concept]
   760   C0991566:Beads [Biomedical or Dental Material]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "extensively"

Phrase: "prewashed with phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "lysis buffer containing protease inhibitors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   806 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   804   C1947941:Protease [Enzyme]
   771 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.124: These beads contained ~100 pmol of a given fusion protein per 100l of packed volume. 

Phrase: "These beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "~100 pmol of a given fusion protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439192:pmol [Quantitative Concept]

Phrase: "per 100l"

Phrase: "of packed volume."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.125: Approximately 100l of this material was incubated with 1g of caveolin-1-myc-H7 on a rotating platform overnight at 4C. 

Phrase: "Approximately 100l of this material"

Phrase: "was"

Phrase: "incubated with 1g of caveolin-1-myc-H7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   770   C1332669:CAVEOLIN 1 [Gene or Genome]
   744   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "on a rotating platform overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710360:Platform [Research Device]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.126: After binding, the beads were washed extensively (6-8 times) with buffer B (50mM HEPES/NaOH, pH 7.5,120mM NaCl, 1 mM EDTA, 0.5% CHAPS, and protease inhibitors). 

Phrase: "After binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively"

Phrase: "(6-8 times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: ")"

Phrase: "with buffer B (50mM HEPES/NaOH,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "120mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.5% CHAPS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   793 E C0950540:chap [Therapeutic or Preventive Procedure]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.127: Finally, bound proteins were eluted with 100l of elution buffer containing 50mM Tris, pH 8.0,1mM EDTA, 1% Triton X-100, 10mM reduced glutathione, and protease inhibitors. 

Phrase: "Finally,"

Phrase: "bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with 100l of elution buffer containing 50mM Tris,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   762   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0332256:Containing [Functional Concept]
   742   C0450400:50mm [Quantitative Concept]
   742   C0814229:TRI [Intellectual Product]
   742   C1441565:Elution [Laboratory Procedure]
   742   C2700400:Containing [Activity]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "10mM reduced glutathione,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034917:Reduced Glutathione [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "protease inhibitors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.128: The eluate was mixed 1:1 with 2 sample buffer and subjected to SDS-PAGE (10% acrylamide) and Western blot analysis with anti-caveolin polyclonal antibody (1:1000 dilution, Transduction Laboratories). 

Phrase: "The eluate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0301870:Eluate [Body Substance]
  1000   C1272724:Eluate [Substance]

Phrase: "was"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 with 2 sample buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0580272:1/2 [Intellectual Product]
   797   C1519043:1-2 [Research Activity]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "subjected to SDS-PAGE (10% acrylamide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   753   C1704732:Page [Intellectual Product]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Western blot analysis with anti-caveolin polyclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "Transduction Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.129: Horseradish peroxidase-conjugated secondary antibodies (1:10000 dilution, Bio-Rad) were used to visualize bound primary antibodies by ECL (Amersham Pharmacia Biotech). 

Phrase: "Horseradish peroxidase-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10000 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "Bio-Rad)"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "bound primary antibodies by ECL (Amersham Pharmacia Biotech"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.130: In place of caveolin-myc-H7, purified myelin basic protein (a negative control) and FE65 (a positive control) were also used for binding experiments. 

Phrase: "In place of caveolin-myc-H7,"

Phrase: "purified myelin basic protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   923   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   875   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026969:Myelin [Tissue]
   812   C0026973:Myelin [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1527178:Basic [Functional Concept]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "("

Phrase: "a negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "("

Phrase: "a positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "used for binding experiments."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0243122:binding [Functional Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.131: For detection of myelin basic protein, anti-myelin basic protein antibody was used. 

Phrase: "For detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of myelin basic protein,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   913   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527178:Basic [Functional Concept]
   755 E C0920750:basicity [Quantitative Concept]

Phrase: "anti-myelin basic protein antibody"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0369713:Anti-myelin basic protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Myelin basic protein antibody
   911   C1276239:Anti-myelin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Myelin antibody
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   884   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   853   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0026969:Myelin [Tissue]
   804   C0026973:Myelin [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1527178:Basic [Functional Concept]
   733 E C0920750:basicity [Quantitative Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.132: For the binding study of FE65 and APP, the gene of human FE65 PTB2 domain (484-612 amino acids) was first cloned (43) by PCR with a set of 5' and 3' primers (5' primer, ACGCGTCGACTCACAGGAAGGAGAGGAAACGCAC; 

Phrase: "For the binding study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "of FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "the gene of human FE65 PTB2 domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0314604:Human gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "(484-612 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "(43"

Phrase: ")"

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "with a set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "of 5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3' primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5' primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "ACGCGTCGACTCACAGGAAGGAGAGGAAACGCAC"

Phrase: ";"
Processing 00000000.tx.133: 3' primer, GCGGATCCTGTGAGGCACCTGCCAAGAAC) using human hippocampus cDNA library (CLONTECH) as a template. 

Phrase: "3' primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "GCGGATCCTGTGAGGCACCTGCCAAGAAC"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "human hippocampus cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   812   C0023621:Library [Manufactured Object,Organization]
   812   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(CLONTECH"

Phrase: ")"

Phrase: "as a template."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]
Processing 00000000.tx.134: PCR product was digested with BamHI-SalI and ligated into pCAL-n-EK vector (Stratagene) for generating a fusion protein cDNA which contains calmodulin binding peptide and FE65-PTB2 fusion domains. 

Phrase: "PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "digested with BamHI-SalI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "ligated into pCAL-n-EK vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0008415:EK [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "for generating"

Phrase: "a fusion protein cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "calmodulin binding peptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1149164:calmodulin binding [Molecular Function]
   827   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "FE65-PTB2 fusion domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.135: Expression of calmodulin binding peptide-FE65-PTB2 protein was induced by isopropyl-1-thio--D-galactopyranoside and was purified using calmodulin affinity resin (Stratagene) as described previously (44). 

Phrase: "Expression of calmodulin binding peptide-FE65-PTB2 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "induced by isopropyl-1-thio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205263:Induced [Functional Concept]
   760   C1412102:THIO [Gene or Genome]
   760   C2945717:isopropyl [Chemical Viewed Structurally]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "calmodulin affinity resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035191:Resin [Biomedical or Dental Material]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.136: The purified fusion protein (1 g) was used for binding analysis as described above. 

Phrase: "The purified fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(1 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "used for binding analysis"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0243122:binding [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "as described above."
Processing 00000000.tx.137: After transfer of eluted samples separated in SDS-PAGE, the membrane was blocked with 2% skim milk and 2% bovine serum albumin in PBS, 0.02% sodium azide overnight at 4C. 

Phrase: "After transfer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "of eluted samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "separated in SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "blocked with 2% skim milk"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   806   C0349375:Skim milk [Food]
   760   C0026131:Milk [Body Substance]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "2% bovine serum albumin in PBS,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "0.02% sodium azide overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   748   C0004492:azide [Chemical Viewed Structurally]
Processing 00000000.tx.138: The membrane was incubated with 5g/ml biotinylated calmodulin (Calbiochem) in washing buffer (50mM Tris/HCl, pH 7.5,150mM NaCl, 1mM CaCl2) for 30min at RT, washed 3times with the same washing buffer (10min each), incubated with 1/20,000 diluted streptavidin-horseradish peroxidase-conjugated (Pierce) for 30min at RT, and washed 3times with the same washing buffer. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with 5g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439526:/mL [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "biotinylated"

Phrase: "calmodulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "in washing buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50mM Tris/HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM CaCl2"

Phrase: ")"

Phrase: "for 30min at RT,"

Phrase: "washed 3times with the same washing buffer"

Phrase: "(10min"

Phrase: "each"

Phrase: ")"

Phrase: ","

Phrase: "incubated with 1/20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "000 diluted streptavidin-horseradish peroxidase-conjugated (Pierce)"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   827   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   799   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   799   C0330510:Horseradish [Food]
   799   C0522529:Conjugated [Spatial Concept]
   799   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   799   C1110641:Horseradish [Plant]
   799   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   766 E C0301869:Conjugate [Immunologic Factor]
   766   C1720119:Dilute [Functional Concept]
   766   C1948037:Dilute [Functional Concept]

Phrase: "for 30min at RT,"

Phrase: "and"

Phrase: "washed 3times with the same washing buffer."
Processing 00000000.tx.139: Finally bands were visualized by diaminobenzidine staining (Vector). 

Phrase: "Finally bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized by diaminobenzidine staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.140: Immunocytochemistry-- Transfected cells (50,000cells) were split onto 4-well chamber slides (Becton Dickinson). 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "--"

Phrase: "Transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(50,"

Phrase: "000cells"

Phrase: ")"

Phrase: "were"

Phrase: "split onto 4-well chamber slides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1534709:Split [Functional Concept]
   753   C1881714:SPLIT [Phenomenon or Process]

Phrase: "(Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.141: Twenty-four hours later, the cells were incubated for 15min at 8C with anti-HA rat monoclonal antibody (5g/ml, Boehringer Mannheim) and cholera toxin B subunit conjugated with peroxidase (1g/ml, Sigma) in complete DMEM (45). 

Phrase: "Twenty-four hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 8C"

Phrase: "with anti-HA rat monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "(5g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Boehringer Mannheim"

Phrase: ")"

Phrase: "and"

Phrase: "cholera toxin B subunit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   812   C0008354:Cholera [Disease or Syndrome]
   812   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "conjugated with peroxidase"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0522529:Conjugated [Spatial Concept]
   790   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in complete DMEM"

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.142: Cells were washed with PBS (45min) and fixed in PBS containing 4% paraformaldehyde. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with PBS (45min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1548982:Washed [Idea or Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   737 E C0441648:Wash [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "fixed in PBS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C2827483:Fixed [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4% paraformaldehyde."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.143: After washing with PBS (55min), nonspecific binding of antibodies was blocked with 3% normal goat serum (Life Technologies, Inc.) in PBS for 30min at RT. 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "with PBS (55min"

Phrase: ")"

Phrase: ","

Phrase: "nonspecific binding of antibodies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0312590:Nonspecific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0205370:Non-specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C0750540:Nonspecific [Idea or Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "blocked with 3% normal goat serum"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   753   C0018019:goat [Mammal]
   753   C0028778:Blocked [Pathologic Function]
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0332206:Blocked [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1265549:goat [Mammal]
   753   C1510458:Goat [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) in PBS"

Phrase: "for 30min at RT."
Processing 00000000.tx.144: Cells were then incubated with anti-cholera toxin rabbit antibody (Calbiochem) in PBS containing 3% normal goat serum for 1h at RT. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with anti-cholera toxin rabbit antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   778   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0008354:Cholera [Disease or Syndrome]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   748   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3% normal goat serum for 1h at RT."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0018019:goat [Mammal]
   744   C0205307:Normal [Qualitative Concept]
   744   C0229671:Serum [Body Substance]
   744   C0439166:% normal [Quantitative Concept]
   744   C1265549:goat [Mammal]
   744   C1510458:Goat [Mammal]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   744   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.145: The chamber slides were washed with PBS (45min) and incubated for 60min at RT with secondary antibodies (Texas Red-conjugated goat anti-rabbit IgG (preabsorbed with rat and mouse IgG), 1:300 dilution, Jackson ImmunoResearch, and biotin-conjugated goat anti-rat IgG, 1:300 dilution, Boehringer Mannheim) and washed in PBS and in 0.1M NaHCO3, pH 8.2(4for 5min). 

Phrase: "The chamber slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0444330:slides [Research Device]
   827 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "washed with PBS (45min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1548982:Washed [Idea or Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   737 E C0441648:Wash [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "incubated for 60min at RT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Texas Red-conjugated goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0034493:Rabbit [Mammal]

Phrase: "("

Phrase: "preabsorbed with rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "mouse IgG"

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "Jackson ImmunoResearch,"

Phrase: "and"

Phrase: "biotin-conjugated goat anti-rat IgG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0034693:Rat, NOS [Mammal]
   799   C0034721:Rat [Mammal]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "Boehringer Mannheim"

Phrase: ")"

Phrase: "and"

Phrase: "washed in PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and in 0.1M NaHCO3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]
   760   C0470296:1M [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "pH 8.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(4for 5min"

Phrase: ")."
Processing 00000000.tx.146: Cells were incubated with avidin-fluorescein isothiocyanate conjugate (1/300 dilution, Vector) in NaHCO3 buffer for 1h at RT. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with avidin-fluorescein isothiocyanate conjugate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C0060531:avidin, fluorescein isothiocyanate [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   783   C0627968:fluorescein-avidin [Amino Acid, Peptide, or Protein]
   753   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0124209:Isothiocyanate [Organic Chemical]
   753   C0206359:isothiocyanate [Organic Chemical]
   753   C0301869:Conjugate [Immunologic Factor]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1/300 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: "Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "in NaHCO3 buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 1h at RT."
Processing 00000000.tx.147: Slides were mounted with Vectashield (Vector) and analyzed with a Leica TCS NT confocal microscope. 

Phrase: "Slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "mounted with Vectashield"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed with a Leica TCS NT confocal microscope."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1626420:Confocal microscope [Medical Device]
   744   C0181839:Microscope [Medical Device]
   744   C0242387:TCS [Congenital Abnormality]
   744   C0332126:NT [Qualitative Concept]
   744   C0936012:Analyzed [Research Activity]
   744   C1449832:NT [Diagnostic Procedure]
   744   C1706379:Microscope [Medical Device]
Processing 00000000.tx.148: Immunoprecipitation of APPs-- Forty-eight hours post-transfection, 1ml of media was mixed with 1ml of 2 RIPA (150mM NaCl, 1.0% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 50mM Tris/HCl, pH 8.0) and incubated with 2g each of antibodies (anti-A-(1-28), 1153,CT-15, 6E10, 4G8, normal rabbit serum (NRG) or normal mouse serum (NMG)) overnight at 4C. 

Phrase: "Immunoprecipitation of APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "--"

Phrase: "Forty-eight hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "1ml of media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "mixed with 1ml of 2 RIPA (150mM NaCl,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0034584:RIPA [Laboratory Procedure]
   744   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0205430:Mixed [Functional Concept]
   744   C1959973:% NaCl [Quantitative Concept]
   744   C3160715:Mixed [Finding]
   711 E C1421951:MIX [Gene or Genome]
   711 E C1720722:Mix [Qualitative Concept]

Phrase: "1.0% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "0.5% deoxycholate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "0.1% SDS,"

Phrase: "50mM Tris/HCl,"

Phrase: "pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "incubated with 2g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "each of antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C1457900:Each [Quantitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "1153,"

Phrase: "CT-15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "6E10,"

Phrase: "4G8,"

Phrase: "normal rabbit serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0034493:Rabbit [Mammal]
   827   C0205307:Normal [Qualitative Concept]
   827   C0229671:Serum [Body Substance]
   827   C0439166:% normal [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "(NRG)"

Phrase: "or"

Phrase: "normal mouse serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0205307:Normal [Qualitative Concept]
   827   C0229671:Serum [Body Substance]
   827   C0439166:% normal [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "(NMG"

Phrase: ")"

Phrase: ")"

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.149: 50l of ~50% slurry protein G-Sepharose was added and incubated for 2h at 4C. 

Phrase: "50l of ~50% slurry protein G-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0036681:Sepharose [Carbohydrate]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for 2h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292425:2H [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.150: Beads were washed 3times with RIPA buffer and once with TE buffer. 

Phrase: "Beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3times with RIPA buffer"

Phrase: "and"

Phrase: "once with TE buffer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1705540:TE [Conceptual Entity]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]
Processing 00000000.tx.151: Final samples were incubated with 60l of 2sampling buffer containing -mercaptoethanol and boiled at 95C for 3min. 

Phrase: "Final samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated with 60l of 2sampling buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "boiled at 95C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "for 3min."
Processing 00000000.tx.152: Fifteen l of each sample was subjected to SDS-PAGE. 

Phrase: "Fifteen l of each sample"

Phrase: "was"

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.153: As a critical control, 2g of anti-A-(1-28) polyclonal antibody was preincubated with 20g of the A-(1-16) synthetic peptide (Bachem) overnight at 4C and used for immunoprecipitation. 

Phrase: "As a critical control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "2g of anti-A-"

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "preincubated with 20g of the A-(1-16"

Phrase: ")"

Phrase: "synthetic peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "(Bachem"

Phrase: ")"

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "used for immunoprecipitation."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.154: For immunoblotting, immunostained bands were visualized with ECL. 

Phrase: "For immunoblotting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "immunostained bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized with ECL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0234621:Visualized [Functional Concept]
   790   C1332684:ECL [Gene or Genome]
Processing 00000000.tx.155: In Fig. 

Phrase: "In Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 6C, we used ECL-Plus (Amersham Pharmacia Biotech). 

Phrase: "6C,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ECL-Plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332287:Plus [Qualitative Concept]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.157: Cell Surface Biotinylation-- Cells were washed twice with ice-cold PBS and incubated with PBS containing 0.5mg/ml sulfo-NHS-biotin (Pierce) for 30min at 4C (46), washed three times with ice-cold PBS, and placed in complete DMEM. 

Phrase: "Cell Surface Biotinylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0525026:Biotinylation [Laboratory Procedure]
   734   C0699040:Cell surface [Cell Component]

Phrase: "--"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720725:Twice [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "incubated with PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5mg/ml sulfo-NHS-biotin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0084682:sulfo-NHS-biotin [Organic Chemical]
   827   C0053654:NHS-biotin [Organic Chemical]
   799   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   799   C2700256:Biotin [Laboratory Procedure]

Phrase: "(Pierce"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0522529:Conjugated [Spatial Concept]
   789 E C1160466:conjugation [Cell Function]

Phrase: ")"

Phrase: "for 30min"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with ice-cold PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "placed in complete DMEM."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205197:Complete [Qualitative Concept]
   770   C0725685:COMPLEAT [Food]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.158: Four hours after incubation at 37C in a CO2 incubator, media were harvested and mixed with the same volume of 2 RIPA buffer, followed by incubation with Neutravidin beads (Pierce). 

Phrase: "Four hours after incubation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "at 37C"

Phrase: "in a CO2 incubator,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021178:Incubator [Manufactured Object]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "mixed with the same volume of 2 RIPA buffer,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   762   C0808397:Volume 2 [Quantitative Concept]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0034584:RIPA [Laboratory Procedure]
   742   C0205430:Mixed [Functional Concept]
   742   C0445247:Same [Qualitative Concept]
   742   C0449468:*Volume [Quantitative Concept]
   742   C1690016:% volume [Qualitative Concept]
   742   C1705102:Volume [Intellectual Product]
   742   C2700258:Volume [Laboratory Procedure]
   742   C3160715:Mixed [Finding]
   708 E C1421951:MIX [Gene or Genome]
   708 E C1720722:Mix [Qualitative Concept]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with Neutravidin beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "(Pierce"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0522529:Conjugated [Spatial Concept]
   789 E C1160466:conjugation [Cell Function]

Phrase: ")."
Processing 00000000.tx.159: After overnight incubation at 4C, the Neutravidin beads were washed three times with RIPA buffer and once with TE buffer. 

Phrase: "After overnight incubation"

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "the Neutravidin beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with RIPA buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "once with TE buffer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1705540:TE [Conceptual Entity]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]
Processing 00000000.tx.160: Final samples were mixed with sampling buffer containing -mercaptoethanol, boiled for 3min, and subjected to immunoblot analysis with 22C11. 

Phrase: "Final samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "mixed with sampling buffer"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0205430:Mixed [Functional Concept]
   770   C0441621:Sampling [Diagnostic Procedure]
   770   C0870078:Sampling [Idea or Concept]
   770   C3160715:Mixed [Finding]
   737 E C0370003:Sample [Substance]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]
   737 E C2347026:Sample [Conceptual Entity]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "boiled for 3min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with 22C11."
Processing 00000000.tx.161: Antisense Oligonucleotide Introduction-- COS-7 cells were seeded at a density of 1106 cells per 100-mm dish. 

Phrase: "Antisense Oligonucleotide Introduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1293116:Introduction [Health Care Activity]
   827   C1875307:INTRODUCTION [Manufactured Object]
   734   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "--"

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded at a density of 1106 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C0162339:Cell Density [Quantitative Concept]
   748   C0007634:Cells [Cell]
   748   C0178587:density [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714   C0036563:Seed [Plant]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714 E C1948049:Cell [Spatial Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "per 100-mm dish."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.162: Twenty-four hours later, 3g each of antisense caveolin-1 oligonucleotide (TTTGCCCCCAGACAT; complementary to the 15-base initiation sequence of human caveolin-1) and the HA-APP695 cDNA were co-transfected into COS-7 cells using 30l of LipofectAMINE. 

Phrase: "Twenty-four hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "3g"

Phrase: "each of antisense caveolin-1 oligonucleotide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   790   C1332669:CAVEOLIN 1 [Gene or Genome]
   783   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1457900:Each [Quantitative Concept]

Phrase: "(TTTGCCCCCAGACAT"

Phrase: "; complementary to the 15-base initiation sequence of human caveolin-1"

Phrase: ")"

Phrase: "and"

Phrase: "the HA-APP695 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "co-transfected into COS-7 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C1257858:COS-7 Cells [Cell]
   783   C0376702:COS Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0454802:Cos [Geographic Area]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "30l of LipofectAMINE."
Processing 00000000.tx.163: Twelve hours later, the media were discarded and replaced with 8ml of complete DMEM. 

Phrase: "Twelve hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "discarded"

Phrase: "and"

Phrase: "replaced with 8ml of complete DMEM."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0205197:Complete [Qualitative Concept]
   753   C0559956:Replaced [Functional Concept]
   753   C0725685:COMPLEAT [Food]
   753   C1299987:replaced [Functional Concept]
   719 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.164: Forty-eight hours post-transfection, media were harvested and mixed with 2 RIPA buffer. 

Phrase: "Forty-eight hours post-transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439227:hours [Temporal Concept]
   771 E C0564385:/hour [Quantitative Concept]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "mixed with 2 RIPA buffer."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0034584:RIPA [Laboratory Procedure]
   760   C0205430:Mixed [Functional Concept]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]
Processing 00000000.tx.165: As a control, a sense-caveolin-1 oligonucleotide (ATGTCTGGGGGCAAA) which corresponded to the 15bases of the initiation sequence was used. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "a sense-caveolin-1 oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(ATGTCTGGGGGCAAA"

Phrase: ")"

Phrase: "which"

Phrase: "corresponded to the 15bases of the initiation sequence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0589507:Initiation [Mental Process]
   744   C1158830:Initiation [Genetic Function]
   744   C1519249:Sequence [Functional Concept]
   744   C1704686:Initiation [Functional Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.166: The media and cells were subjected to further analyses.  

Phrase: "The media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to further analyses."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C1517331:Further [Spatial Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737 E C0205108:far [Spatial Concept]
   737   C0681850:Subject [Group]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.167: RESULTS Top Abstract Introduction Procedures Results Discussion References Interaction of APP with Caveolin-1: A Requirement for the Caveolin Scaffolding Domain-- To investigate whether endogenous APP is associated with caveolae membranes, caveolae-enriched membrane domains from COS-7 cells were purified by a detergent-free procedure and were ultracentrifuged in a sucrose density gradient. 

Phrase: "RESULTS Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Interaction of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0872079:interaction protein [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "with Caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "A Requirement for the Caveolin Scaffolding Domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514873:Requirement [Functional Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "endogenous APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "associated with caveolae membranes,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   775   C1167209:caveolar membrane [Cell Component]
   770   C0025255:Membranes [Tissue]
   770   C0230653:Caveolae [Cell Component]
   737 E C0596901:Membrane [Cell Component]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706182:Membrane [Manufactured Object]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "caveolae-enriched membrane domains from COS-7 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "were"

Phrase: "purified by a detergent-free procedure"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C1996904:Free [Qualitative Concept]
   753   C1998793:Purified [Functional Concept]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "ultracentrifuged in a sucrose density gradient."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0178587:density [Quantitative Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.168: Immunoblot analysis of the resulting gradient fractions with APP antibody (22C11) detected the vast majority of APP in fractions 4and 5(Fig. 

Phrase: "Immunoblot analysis of the resulting gradient fractions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "with APP antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(22C11"

Phrase: ")"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the vast majority of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680220:majority [Social Behavior]

Phrase: "in fractions 4and 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 1A, upper panel). 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.170: Similarly, caveolin-1 was confined to the same region of the gradient (fractions 4and 5), indicating that caveolae are contained within these fractions (Fig. 1A, lower panel). 

Phrase: "Similarly,"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "confined to the same region of the gradient"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C0812409:Gradient [Quantitative Concept]

Phrase: "(fractions 4and 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "are"

Phrase: "contained within these fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332256:contained [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   770   C2700400:Contained [Activity]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.171: Densitometric analysis revealed that greater than 90% of the total APP-reactive material was recovered in fractions 4and 5.

Phrase: "Densitometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that greater than 90% of the total APP-reactive material"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0439093:Greater Than [Quantitative Concept]
   736   C0443228:greater [Quantitative Concept]
   736   C1704243:Greater [Quantitative Concept]
   703 E C0549177:Great [Quantitative Concept]

Phrase: "was"

Phrase: "recovered in fractions 4and 5."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0521108:recovered [Qualitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C2004454:recover [Organism Function]
Processing 00000000.tx.172: These results demonstrate that molecules containing the 22C11 epitope are primarily enriched with caveolae microdomains in COS-7 cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the 22C11 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "are"

Phrase: "primarily"

Phrase: "enriched with caveolae microdomains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0230653:Caveolae [Cell Component]
   770   C0359583:enriched [Food]

Phrase: "in COS-7 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.173: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.174: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.175: Endogenous APP/APLP and caveolin-1 are co-localized within caveolae-enriched membrane fractions. 

Phrase: "Endogenous APP/APLP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1412466:APLP [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "co-localized within caveolae-enriched membrane fractions."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0025255:Membrane [Tissue]
   748   C0230653:Caveolae [Cell Component]
   748   C0359583:enriched [Food]
   748   C0392752:Localized [Spatial Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1264633:Fractions [Quantitative Concept]
   748   C1706182:Membrane [Manufactured Object]
   732   C1167209:caveolar membrane [Cell Component]
   714 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.176: COS-7 (A), HEK293 (B), and MDCK cells (C) grown to confluence in 150-mm dishes were used to prepare caveolin-enriched membrane domains, as described previously (38). 

Phrase: "COS-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454802:Cos [Geographic Area]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "HEK293"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MDCK cells (C)"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0598829:MDCK Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "grown to confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "in 150-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "caveolin-enriched membrane domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.177: After two washes with ice-cold phosphate-buffered saline, cells (two confluent 150-mm dishes) were scraped into 2ml of 500mM sodium carbonate, pH 11.0.

Phrase: "After two washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "with ice-cold phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(two confluent 150-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0020498:DISH [Disease or Syndrome]

Phrase: ")"

Phrase: "were"

Phrase: "scraped into 2ml of 500mM sodium carbonate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]
   748   C0007026:Carbonate [Inorganic Chemical]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0184933:scraped [Therapeutic or Preventive Procedure]
   748   C0444082:scraped [Body Substance]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 11.0."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.178: Homogenization was carried out using a loose-fitting Dounce homogenizer, a Polytron tissue grinder, and a sonicator. 

Phrase: "Homogenization"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a loose-fitting Dounce homogenizer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0181200:homogenizer [Medical Device]

Phrase: "a Polytron tissue grinder,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0493160:GRINDER, TISSUE [Medical Device]

Phrase: "and"

Phrase: "a sonicator."
Processing 00000000.tx.179: The homogenate was adjusted to 45% sucrose and placed at the bottom of an ultracentrifuge tube. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "adjusted to 45% sucrose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0456081:Adjusted [Functional Concept]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "placed at the bottom of an ultracentrifuge tube."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0175730:Tube [Medical Device]
   744   C1511276:Bottom [Spatial Concept]
   744   C1547937:Tube NOS [Intellectual Product]
   744   C1552825:bottom [Idea or Concept]
   744   C1561954:tube [Conceptual Entity]
   744   C1704730:TUBE [Medical Device]
   711   C0442504:Place [Spatial Concept]
   711   C1704765:Place [Functional Concept]
   711   C1882509:Place [Activity]
   711   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.180: A 5-35% discontinuous sucrose gradient was formed above (4ml of 5% sucrose, 4ml of 35% sucrose; both in MBS containing 250mM sodium carbonate) and centrifuged at 39,000rpm for 16-20 h. 

Phrase: "A 5-35% discontinuous sucrose gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439182:% gradient [Quantitative Concept]
   804   C0812409:Gradient [Quantitative Concept]

Phrase: "was"

Phrase: "formed above"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0205431:Formed [Functional Concept]
   799 E C0348078:Form [Qualitative Concept]
   799 E C0376315:Form [Manufactured Object]
   799 E C1522492:Form [Functional Concept]

Phrase: "(4ml of 5% sucrose,"

Phrase: "4ml of 35% sucrose"

Phrase: ";"

Phrase: "both in MBS containing 250mM sodium carbonate"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]
   742   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0007026:Carbonate [Inorganic Chemical]
   742   C0036082:Saline [Substance]
   742   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0238767:Both [Spatial Concept]
   742   C0265215:MES [Congenital Abnormality]
   742   C0332256:Containing [Functional Concept]
   742   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1417092:MES [Gene or Genome]
   742   C1706086:Both [Qualitative Concept]
   742   C2700400:Containing [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "centrifuged at 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000rpm for 16-20 h."
Processing 00000000.tx.181: From the top of each gradient, 1-ml gradient fractions were collected to yield a total of 12fractions. 

Phrase: "From the top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "of each gradient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "1-ml gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "a total of 12fractions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.182: Gradient fractions were separated by SDS-PAGE (4-20% linear gradient gel) and transferred to Immobilon-PSQ. 

Phrase: "Gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "separated by SDS-PAGE (4-20% linear gradient gel"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   764   C1538569:PAGE-4 [Gene or Genome]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0086972:Separated [Finding]
   742   C0205132:Linear [Spatial Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1382104:Gel [Substance]
   742   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "transferred to Immobilon-PSQ."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]
Processing 00000000.tx.183: After transfer, the sheets were subjected to immunoblotting with 22C11 (upper panel) and anti-caveolin-1 antibodies (lower panel). 

Phrase: "After transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "the sheets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439643:Sheets [Spatial Concept]
   966 E C2349187:Sheet [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with 22C11"

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "anti-caveolin-1 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.184: Arrows indicate APP/APLP (upper panel) and caveolin-1 (lower panel). 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "APP/APLP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1412466:APLP [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.185: To extend these initial observations, the same fractionation procedure was employed on HEK293 and MDCK cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "these initial observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "the same fractionation procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "employed on HEK293"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0557351:Employed [Finding]
   756 E C0457083:Employ [Functional Concept]

Phrase: "and"

Phrase: "MDCK cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0598829:MDCK Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.186: In HEK293 cells, endogenous 22C11 immunoreactive bands were again highly enriched in fractions 4and 5and precisely coincided with the distribution of caveolin-1 (Fig. 1B). 

Phrase: "In HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "endogenous 22C11 immunoreactive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0175723:Bands [Medical Device]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "again highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205250:Highly [Qualitative Concept]

Phrase: "enriched in fractions 4and 5and precisely"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0359583:enriched [Food]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "coincided with the distribution of caveolin-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   778   C1332669:CAVEOLIN 1 [Gene or Genome]
   748   C0520511:distribution [Idea or Concept]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1704711:Distribution [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.187: In MDCK cells, three major bands were detected by immunoblot analysis with 22C11 (Fig. 1C). 

Phrase: "In MDCK cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0598829:MDCK Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "three major bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "detected by immunoblot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "with 22C11"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.188: Approximately 80% of the total 22C11 immunoreactive material was confined to the caveolin-rich fractions. 

Phrase: "Approximately 80% of the total 22C11 immunoreactive material"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0332232:Approximately [Qualitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0520510:Material [Substance]

Phrase: "was"

Phrase: "confined to the caveolin-rich fractions."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0699759:Rich [Qualitative Concept]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.189: In addition, when the independent fractionation procedure involved homogenization in Triton X-100 containing buffers, essentially identical results were obtained (not shown). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "when"

Phrase: "the independent fractionation procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "homogenization in Triton X-100 containing buffers,"

Phrase: "essentially identical results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.190: Therefore, it is likely that the 22C11 immunoreactive proteins physically associated with specialized caveolin-enriched membrane microdomains in these three distinct cell lines. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the 22C11 immunoreactive proteins physically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with specialized caveolin-enriched membrane microdomains"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0887868:Membrane Microdomains [Cell Component]
   748   C0025255:Membrane [Tissue]
   748   C0205555:specialized [Qualitative Concept]
   748   C0359583:enriched [Food]
   748   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0596901:Membrane [Cell Component]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1704211:Specialized [Conceptual Entity]
   748   C1706182:Membrane [Manufactured Object]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in these three distinct cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.191: The antibody 22C11 recognizes both APP and other molecules closely related to APP, termed APLPs (47). 

Phrase: "The antibody 22C11"

Phrase: "recognizes"

Phrase: "both APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "other molecules closely"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "related to APP,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "termed APLPs"

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.192: To determine if APP itself is confined to caveolae-enriched domains, we next employed a recombinant approach. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "itself"

Phrase: "is"

Phrase: "confined"

Phrase: "to caveolae-enriched domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a recombinant approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.193: COS-7 cells were co-transfected with epitope-tagged forms of APP and caveolin-1 (the HA epitope was inserted into the extracellular domain of APP695 and the myc epitope was placed at the extreme C terminus of caveolin-1). 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with epitope-tagged forms of APP"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   741   C1818826:protein tag [Molecular Function]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003316:Epitope [Immunologic Factor]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1708632:Tagged [Qualitative Concept]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C1522492:Form [Functional Concept]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "the HA epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "was"

Phrase: "inserted into the extracellular domain of APP695"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C1517050:Extracellular Domain [Spatial Concept]
   748   C0441587:Inserted [Health Care Activity]
   748   C0521119:Extracellular [Cell Component]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   714 E C1743766:Insert [Medical Device]
   714 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "the myc epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "was"

Phrase: "placed at the extreme C terminus of caveolin-1"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   764   C1332669:CAVEOLIN 1 [Gene or Genome]
   742   C0007634:Cells [Cell]
   742   C0205403:Extreme [Qualitative Concept]
   742   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C3282337:Cells [Cell]
   708   C0442504:Place [Spatial Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708   C1704765:Place [Functional Concept]
   708   C1882509:Place [Activity]
   708 E C1948049:Cell [Spatial Concept]
   708   C3496241:place [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.194: These transiently transfected cells were then subjected to the same detergent-free fractionation procedure described above. 

Phrase: "These transiently transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to the same detergent-free fractionation procedure"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   744   C0011740:Detergent [Chemical Viewed Functionally]
   744   C0016640:fractionation [Laboratory Procedure]
   744   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   744   C0332296:free [Functional Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C0524811:fractionation [Therapeutic or Preventive Procedure]
   744   C1880497:Free [Qualitative Concept]
   744   C1948041:Procedure [Therapeutic or Preventive Procedure]
   744   C1996904:Free [Qualitative Concept]
   744   C2700391:Procedure [Activity]
   744   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   744   C3274430:PROCEDURE [Health Care Activity]
   744   C3538935:Procedure [Idea or Concept]
   744   C3539779:Procedure [Intellectual Product]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.195: HA-tagged APP695 and myc-tagged caveolin-1 were confined mainly to fraction 4and were undetectable in the remaining 11fractions (Fig. 2A). 

Phrase: "HA-tagged APP695"

Phrase: "and"

Phrase: "myc-tagged caveolin-1"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "confined"

Phrase: "mainly to fraction 4and"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "undetectable in the remaining 11fractions"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.196: These data indicate that the majority of recombinant APP695 and caveolin-1 co-fractionate and are localized within caveolae-enriched membrane domains. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the majority of recombinant APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-fractionate"

Phrase: "and"

Phrase: "are"

Phrase: "localized within caveolae-enriched membrane domains."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0025255:Membrane [Tissue]
   753   C0230653:Caveolae [Cell Component]
   753   C0359583:enriched [Food]
   753   C0392752:Localized [Spatial Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   742   C1167209:caveolar membrane [Cell Component]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.197: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.198: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.199: Recombinant APP and caveolin-1 form a physical complex. 

Phrase: "Recombinant APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a physical complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.200: A, recombinant APP and recombinant caveolin-1 co-fractionate and are targeted to caveolae-enriched membranes. 

Phrase: "A,"

Phrase: "recombinant APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "recombinant caveolin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514798:recombinant [Organism]

Phrase: "co-fractionate"

Phrase: "and"

Phrase: "are"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "to caveolae-enriched membranes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   816   C1167209:caveolar membrane [Cell Component]
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.201: HA-APP and myc-caveolin-1 were transfected into COS-7 cells with LipofectAMINE. 

Phrase: "HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "myc-caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transfected into COS-7 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with LipofectAMINE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]
Processing 00000000.tx.202: 48h post-transfection, cells were harvested and subjected to detergent-free caveolae purification as in Fig. 

Phrase: "48h post-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "subjected to detergent-free caveolae purification"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0230653:Caveolae [Cell Component]
   753   C0243114:purification [Functional Concept]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C1998793:Purification [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.203: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.204: Gradient fractions were separated by SDS-PAGE (4-20% linear gradient gel) and subjected to immunoblotting with IgG directed against the epitope tags, HA (upper panel) and myc (lower panel). 

Phrase: "Gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "separated by SDS-PAGE (4-20% linear gradient gel"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   764   C1538569:PAGE-4 [Gene or Genome]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0086972:Separated [Finding]
   742   C0205132:Linear [Spatial Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1382104:Gel [Substance]
   742   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with IgG"

Phrase: "directed against the epitope tags,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0003316:Epitope [Immunologic Factor]
   760   C1139855:tags [Medical Device]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726   C0439851:Direct [Qualitative Concept]
   726 E C1710492:TAG [Gene or Genome]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "HA (upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "myc (lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.205: B, recombinant APP and caveolin-1 form a stable complex in vivo. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "recombinant APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a stable complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.206: After co-transfection of HA-APP with either vector alone (mock), caveolin-1 (cav-1), caveolin-1 lacking residues 61-100 (61-100), or caveolin-1 (cav-1), cells were incubated with DMEM plus Me2SO containing bis-[-(4-azidosalicylamindo)ethyl] disulfide and were exposed to ultraviolet light. 

Phrase: "After co-transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "with either vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: ")"

Phrase: ","

Phrase: "caveolin-1 (cav-1),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "caveolin-1 lacking residues 61-100"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   827   C1332669:CAVEOLIN 1 [Gene or Genome]
   799   C0332268:Lacking [Qualitative Concept]
   799   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "(61-100"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(cav-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with DMEM plus Me2SO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332287:Plus [Qualitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "bis-[-(4-azidosalicylamindo"

Phrase: ")"

Phrase: "ethyl"

Phrase: "] disulfide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "were"

Phrase: "exposed to ultraviolet light."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0041625:Ultraviolet Light [Natural Phenomenon or Process]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   791 E C0181651:ultraviolet lights [Medical Device]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C1306462:Light [Functional Concept]
   770   C1532472:Ultraviolet [Qualitative Concept]
   770   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.207: Cells were solubilized in buffer A with the help of sonication. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "solubilized in buffer A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "with the"

Phrase: "help of sonication."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018896:Help [Social Behavior]
   790   C0037680:Sonication [Research Activity]
   790   C1552861:help [Idea or Concept]
Processing 00000000.tx.208: After centrifugation, supernatants were collected and subjected to immunoprecipitation with anti-myc antibody and immunoblotted with anti-HA (upper panel) or anti-myc antibodies (middle panel). 

Phrase: "After centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with anti-HA (upper panel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441833:Panel [Idea or Concept]
   753   C1282910:Upper [Spatial Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "or"

Phrase: "anti-myc antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.209: Cell lysates without chemical cross-linking were also subjected to immunoblotting with anti-HA antibodies (lower panel). 

Phrase: "Cell lysates without chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "were"

Phrase: "also"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-HA antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.210: C, recombinant APP and caveolin-1 co-immunoprecipitate (IP). 

Phrase: "C,"

Phrase: "recombinant APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-immunoprecipitate (IP)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.211: After transfection of HA-APP with either caveolin-1 (cav-1) or caveolin-1 lacking residues 61-100 (61-100), cells were subjected to detergent-free caveolae purification as in Fig. 

Phrase: "After transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "with either caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(cav-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "or"

Phrase: "caveolin-1 lacking residues 61-100"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   827   C1332669:CAVEOLIN 1 [Gene or Genome]
   799   C0332268:Lacking [Qualitative Concept]
   799   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "(61-100"

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subjected to detergent-free caveolae purification"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0230653:Caveolae [Cell Component]
   753   C0243114:purification [Functional Concept]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C1998793:Purification [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.212: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.213: Caveolae fractions were diluted with Mes-buffered saline, collected by centrifugation, and solubilized in buffer A lacking Triton X-100. 

Phrase: "Caveolae fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "diluted with Mes-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036082:Saline [Substance]
   760   C0265215:MES [Congenital Abnormality]
   760   C1417092:MES [Gene or Genome]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "collected by centrifugation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "solubilized in buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "A lacking Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]
Processing 00000000.tx.214: After centrifugation at 15,000rpm for 30min, supernatants were collected and subjected to dialysis against buffer A without detergent. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 15,"

Phrase: "000rpm for 30min,"

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to dialysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0011945:Dialysis [Natural Phenomenon or Process]
   790   C0011946:dialysis [Therapeutic or Preventive Procedure]
   790   C0917873:dialysis [Therapeutic or Preventive Procedure]
   790   C1059964:Dialysis [Eukaryote]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "against buffer A"

Phrase: "without detergent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergent [Chemical Viewed Functionally]
Processing 00000000.tx.215: Immunoprecipitation was conducted with (i) anti-HA (HA) or normal rat IgG (NRG) (left panel), (ii) with anti-myc (myc) or normal mouse IgG antibody (NMG) (middle panel) and (iii) with anti-HA or anti-myc (right panel). 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "conducted with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0004927:Conduct [Individual Behavior]

Phrase: "(i) anti-HA (HA)"

Phrase: "or"

Phrase: "normal rat IgG (NRG) (left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441833:Panel [Idea or Concept]
   804   C1999270:Panel [Intellectual Product]
   804   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "(ii"

Phrase: ")"

Phrase: "with anti-myc (myc)"

Phrase: "or"

Phrase: "normal mouse IgG antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2754943:IgG antibody [Cell Component]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(NMG"

Phrase: ")"

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "with anti-HA"

Phrase: "or"

Phrase: "anti-myc (right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.216: The samples were subjected to immunoblotting with anti-myc, HA, or AC-1 antibodies. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc,"

Phrase: "HA,"

Phrase: "or"

Phrase: "AC-1 antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.217: D, purified recombinant APP cytoplasmic domain interacts with purified recombinant caveolin-1. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "recombinant APP cytoplasmic domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C0162808:Protein Domain [Spatial Concept]
   839   C1514562:Protein Domain [Amino Acid Sequence]
   827   C1511625:Cytoplasmic Domain [Cell Component]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "interacts with purified recombinant caveolin-1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   790   C1332669:CAVEOLIN 1 [Gene or Genome]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514798:recombinant [Organism]
   753   C1998793:Purified [Functional Concept]
Processing 00000000.tx.218: Recombinant caveolin-1 was affinity purified from the Sf21 cells overproducing His-tagged caveolin using the Ni-NTA-agarose. 

Phrase: "Recombinant caveolin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514798:recombinant [Organism]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from the Sf21 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C3494246:Sf21 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1998793:Purified [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "overproducing"

Phrase: "His-tagged caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Ni-NTA-agarose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]
Processing 00000000.tx.219: Recombinant GST-APP or GST was purified from E.coli harboring plasmids encoding either GST-APP or GST alone. 

Phrase: "Recombinant GST-APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "GST"

Phrase: "was"

Phrase: "purified from E.coli harboring plasmids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0014834:E coli [Bacterium]
   753   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1998793:Purified [Functional Concept]
   719   C0475311:Harbor [Manufactured Object]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "either GST-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "GST"

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.220: GST-APP or GST alone were pre-bound to glutathione-agarose beads and incubated with caveolin-1-myc-H7. 

Phrase: "GST-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "GST"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "were"

Phrase: "pre-bound to glutathione-agarose beads"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Agarose [Carbohydrate]
   753   C0332152:Pre [Temporal Concept]
   753   C0332297:bound [Spatial Concept]
   753   C0740175:Pre [Qualitative Concept]
   753   C0991566:Beads [Biomedical or Dental Material]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2257086:PRE [Genetic Function]
   753   C2349209:Bound [Conceptual Entity]
   719 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "incubated with caveolin-1-myc-H7."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   790   C1332669:CAVEOLIN 1 [Gene or Genome]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.221: Bound proteins were eluted with buffer containing 10mM reduced glutathione and were subjected to SDS-PAGE (12% acrylamide) and Western blot analysis with anti-caveolin-1 or anti-GST antibodies. 

Phrase: "Bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with buffer containing 10mM reduced glutathione"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0034917:Reduced Glutathione [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332256:Containing [Functional Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "were"

Phrase: "subjected to SDS-PAGE (12% acrylamide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   753   C1704732:Page [Intellectual Product]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Western blot analysis with anti-caveolin-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]

Phrase: "or"

Phrase: "anti-GST antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.222: Under the same binding conditions, the binding capacity of myelin basic protein and FE65 PTB2 domain (484-612 amino acids) was also determined. 

Phrase: "Under the same binding conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the binding capacity of myelin basic protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C1276857:Protein binding capacity [Molecular Function]
   778   C0439155:Binding capacity [Quantitative Concept]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "FE65 PTB2 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(484-612 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "determined."
Processing 00000000.tx.223: Myelin basic protein was detected by anti-myelin basic protein antibody, whereas FE65 was detected by biotin conjugated-calmodulin binding, followed by diaminobenzidine staining. 

Phrase: "Myelin basic protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   913   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026969:Myelin [Tissue]
   827   C0026973:Myelin [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1527178:Basic [Functional Concept]
   755 E C0920750:basicity [Quantitative Concept]

Phrase: "was"

Phrase: "detected by anti-myelin basic protein antibody,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   897   C0369713:Anti-myelin basic protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Myelin basic protein antibody
   814   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   814   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   804   C1276239:Anti-myelin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Myelin antibody
   778   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0026969:Myelin [Tissue]
   748   C0026973:Myelin [Cell Component]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1527178:Basic [Functional Concept]

Phrase: "whereas"

Phrase: "FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "detected by biotin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C2700256:Biotin [Laboratory Procedure]

Phrase: "conjugated-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]

Phrase: "calmodulin binding,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1149164:calmodulin binding [Molecular Function]
   861   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "followed by diaminobenzidine staining."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.224: G-protein-coupled receptors (the endothelin receptor) and growth factor receptors can form physical complexes with caveolin-1 (48, 49). 

Phrase: "G-protein-coupled receptors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682972:G-Protein-Coupled Receptors [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:protein receptors [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1948027:Coupled [Functional Concept]
   779 E C0010222:couple [Family Group]

Phrase: "("

Phrase: "the endothelin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059285:Endothelin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "and"

Phrase: "growth factor receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "physical complexes with caveolin-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.225: In the case of epidermal growth factor receptor, caveolin-1 interacts with the epidermal growth factor receptor kinase domain via the caveolin scaffolding domain. 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of epidermal growth factor receptor,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with the epidermal growth factor receptor kinase domain"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   849   C0034802:Epidermal Growth Factor Receptor Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
           Epidermal Growth Factor Receptor
   818   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   790   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1323367:epidermal growth factor [Molecular Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0014520:Epidermal [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0220844:growth [Physiologic Function]
   742   C0221920:Epidermal [Spatial Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "via the caveolin scaffolding domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.226: As APP is physically and functionally coupled to the heterotrimeric G-protein, Go (29), APP may also interact directly with caveolin-1. 

Phrase: "As APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "physically"

Phrase: "and"

Phrase: "functionally"

Phrase: "coupled to the heterotrimeric G-protein,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0752348:Heterotrimeric G Protein [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1325335:heterotrimeric G-protein [Cell Component]
   790   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   783 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "may"

Phrase: "also"

Phrase: "interact"

Phrase: "directly with caveolin-1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   833   C1332669:CAVEOLIN 1 [Gene or Genome]
   770   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.227: Direct interaction of caveolin-1 with receptors and downstream signaling molecules is thought to facilitate sequestration of multiple signaling molecules within caveolae membranes. 

Phrase: "Direct interaction of caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "downstream signaling molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1519315:Signaling Molecule [Biologically Active Substance]
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "sequestration of multiple signaling molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443301:Sequestration [Functional Concept]

Phrase: "within caveolae membranes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   941   C1167209:caveolar membrane [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.228: To test this hypothesis, we employed a chemical cross-linking approach coupled with immunoprecipitation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "coupled with immunoprecipitation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]
Processing 00000000.tx.229: COS-7 cells were transiently co-transfected with epitope-tagged APP and caveolin-1 as described above and subjected to chemical cross-linking with the membrane-permeant photoreactive agent, 9-bis-[-(4-azidosalicylamindo)ethyl] disulfide. 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "co-transfected with epitope-tagged APP"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750   C1818826:protein tag [Molecular Function]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0003316:Epitope [Immunologic Factor]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1708632:Tagged [Qualitative Concept]
   744   C1709634:Precursor [Idea or Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "subjected to chemical"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0220806:Chemical [Chemical]
   790   C3272558:Chemical [Intellectual Product]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "cross-linking with the membrane-permeant photoreactive agent,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0332220:Cross-linking [Functional Concept]
   754 E C0178576:Cross link [Natural Phenomenon or Process]
   744   C0025255:Membrane [Tissue]
   744   C0450442:Agent [Chemical Viewed Functionally]
   744   C0596901:Membrane [Cell Component]
   744   C1254351:Agent [Pharmacologic Substance]
   744   C1521826:Agent [Intellectual Product]
   744   C1706182:Membrane [Manufactured Object]
   744   C2828360:Cross [Conceptual Entity]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "9-bis-[-(4-azidosalicylamindo"

Phrase: ")"

Phrase: "ethyl"

Phrase: "] disulfide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012771:disulfide [Chemical Viewed Structurally]
Processing 00000000.tx.230: After photolysis the cross-linked cells were solubilized with a buffer containing 1% Triton X-100 and 60mM octylglycoside. 

Phrase: "After photolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031751:photolysis [Molecular Function]

Phrase: "the"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "solubilized with a buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "60mM octylglycoside."
Processing 00000000.tx.231: Samples were then immunoprecipitated with anti-myc IgG to recover epitope-tagged caveolin. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoprecipitated with anti-myc IgG to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "recover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]

Phrase: "epitope-tagged caveolin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.232: After immunoprecipitation, samples were subjected to immunoblot analysis to visualize HA-tagged APP. 

Phrase: "After immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to immunoblot analysis to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "visualize"

Phrase: "HA-tagged APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.233: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.234: 2B, two major bands corresponding to caveolin-1 and caveolin-1 were detected in these immunoprecipitates using the myc antibody for Western blot analysis (Fig. 2B, lane 2). 

Phrase: "2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "two major bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "corresponding to caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   833   C1332669:CAVEOLIN 1 [Gene or Genome]
   770   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "detected in these immunoprecipitates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the myc antibody for Western blot analysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.235: Anti-HA immunoblot analysis revealed that HA-tagged APP was also detected in these immunoprecipitates. 

Phrase: "Anti-HA immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that HA-tagged APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "detected in these immunoprecipitates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.236: In the mock-transfected cells, neither caveolin-1 nor APP immunoreactivity were detected by Western blotting with anti-HA or anti-myc (Fig. 2B, lane 1). 

Phrase: "In the mock-transfected cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "neither caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "nor"

Phrase: "APP immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0597879:immunoreactivity [Molecular Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-HA"

Phrase: "or"

Phrase: "anti-myc (Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450354:2b [Intellectual Product]
   812   C1706096:2B [Research Activity]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.237: The results establish that caveolin-1 forms a physical complex with APP in intact COS-7 cells. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a physical complex with APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1523872:protein complex [Cell Component]
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in intact COS-7 cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C1257858:COS-7 Cells [Cell]
   886   C0682538:intact cell [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.238: Under the same experimental conditions expect using no chemical cross-linking reagent, the physical association of APP and caveolin was not observed, suggesting that treatment with chemical cross-linking reagent is necessary to observe sufficient binding of APP and caveolin in this transient expression system. 

Phrase: "Under the same experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "expect"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "no chemical cross-linking reagent,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0332220:Cross-linking [Functional Concept]
   844 E C0178576:Cross link [Natural Phenomenon or Process]
   812   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   812   C2828360:Cross [Conceptual Entity]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]

Phrase: "the physical association of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that treatment with chemical cross-linking reagent"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "is"

Phrase: "necessary to"

Phrase: "observe"

Phrase: "sufficient binding of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "caveolin in this transient expression system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.239: To investigate further the specificity of this interaction, the same experiment was performed using other forms of caveolin-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the specificity of this interaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "the same experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "other forms of caveolin-1."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.240: We used myc-tagged caveolin-1, the shorter isoform of caveolin-1 that lacks caveolin residues 1-31, and myc-tagged caveolin-1-( 61-100), an internal deletion mutant that lacks the caveolin-1 scaffolding domain. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "myc-tagged caveolin-1,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "the shorter isoform of caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "caveolin residues 1-31,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   875   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   875   C1332669:CAVEOLIN 1 [Gene or Genome]
   812   C0450355:31 [Intellectual Product]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "myc-tagged caveolin-1-"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "( 61-100"

Phrase: ")"

Phrase: ","

Phrase: "an internal deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the caveolin-1 scaffolding domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.241: Immunoprecipitation and Western blotting with anti-myc IgG detected both caveolin-1 and caveolin-1-( 61-100) (Fig. 2B, lanes 3and 4), as expected. 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western blotting with anti-myc IgG"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   773 E C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "both caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "caveolin-1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "( 61-100"

Phrase: ")"

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lanes 3and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "expected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.242: However, immunoblot analysis with anti-HA antibody revealed that APP only co-immunoprecipitated with caveolin-1 but not with caveolin-1-( 61-100). 

Phrase: "However,"

Phrase: "immunoblot analysis with anti-HA antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that APP only"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "co-immunoprecipitated with caveolin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   806   C1332669:CAVEOLIN 1 [Gene or Genome]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "but"

Phrase: "not with caveolin-1-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   833   C1332669:CAVEOLIN 1 [Gene or Genome]
   770   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1518422:Not [Functional Concept]

Phrase: "( 61-100"

Phrase: ")."
Processing 00000000.tx.243: These results indicate that caveolin residues 1-31 are not required for interaction of APP with caveolin-1; 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that caveolin residues 1-31"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   875   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   875   C1332669:CAVEOLIN 1 [Gene or Genome]
   812   C0450355:31 [Intellectual Product]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for interaction of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0872079:interaction protein [Molecular Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1514873:Required [Functional Concept]
   748   C1704675:Interaction [Functional Concept]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "with caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.244: in addition, they implicate caveolin residues 61-100 in this process, demonstrating a crucial role for the caveolin-1 scaffolding domain in the recognition of APP by caveolin-1 in vivo. 

Phrase: "in addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "they"

Phrase: "implicate"

Phrase: "caveolin residues 61-100 in this process,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1184743:Process [Body Part, Organ, or Organ Component]
   748   C1522240:Process [Phenomenon or Process]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "demonstrating"

Phrase: "a crucial role for the caveolin-1 scaffolding domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in the recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "by caveolin-1 in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.245: In another independent approach, we employed detergent-free immunoprecipitation. 

Phrase: "In another independent approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "detergent-free immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.246: COS-7 cells were transiently co-transfected with epitope-tagged forms of APP and caveolin-1 (caveolin-1 and caveolin-1-( 61-100)) as described above. 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "co-transfected with epitope-tagged forms of APP"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   741   C1818826:protein tag [Molecular Function]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0003316:Epitope [Immunologic Factor]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1708632:Tagged [Qualitative Concept]
   739   C1709634:Precursor [Idea or Concept]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C1522492:Form [Functional Concept]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "caveolin-1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "( 61-100"

Phrase: ")"

Phrase: ")"

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.247: After detergent-free cell fractionation, caveolae containing fractions were collected and solubilized with 60mM octylglycoside. 

Phrase: "After detergent-free cell fractionation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007593:Cell Fractionation [Laboratory Procedure]
   812   C0016640:fractionation [Laboratory Procedure]
   812   C0524811:fractionation [Therapeutic or Preventive Procedure]
   812   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "caveolae containing fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "solubilized with 60mM octylglycoside."
Processing 00000000.tx.248: After dialysis to remove detergent, these caveolin-rich membranes were subjected to immunoprecipitation with either anti-myc or anti-HA antibodies. 

Phrase: "After dialysis to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "detergent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergent [Chemical Viewed Functionally]

Phrase: "these caveolin-rich membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with either anti-myc"

Phrase: "or"

Phrase: "anti-HA antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.249: Immunoblot analysis revealed that APP is associated with caveolin-1 but not caveolin-1-( 61-100) (Fig. 2C). 

Phrase: "Immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "associated with caveolin-1"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   833   C1332669:CAVEOLIN 1 [Gene or Genome]
   770   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "not caveolin-1-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1518422:Not [Functional Concept]

Phrase: "( 61-100"

Phrase: ")"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.250: Also, normal mouse IgG did not immunoprecipitate either HA-tagged APP or the myc-tagged forms of caveolin-1, confirming the specific nature of these interactions. 

Phrase: "Also,"

Phrase: "normal mouse IgG"

Phrase: "did"

Phrase: "not immunoprecipitate either HA-tagged APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   835   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   835   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   822   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "the myc-tagged forms of caveolin-1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the specific nature of these interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]
Processing 00000000.tx.251: The results indicate that APP and caveolin form physical complexes and they are consistent with chemical cross-linking studies of intact cells (Fig. 2B). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "physical complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "they"

Phrase: "are"

Phrase: "consistent with chemical"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "studies of intact cells"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.252: Although the experiments described above indicate that APP and caveolin-1 form a physical complex in intact cells, it remains unknown whether this interaction is direct or occurs via another protein that may act as a bridge to link APP with caveolin-1. 

Phrase: "Although"

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "indicate"

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a physical complex in intact cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "it"

Phrase: "remains"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "whether"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "occurs via another protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "that"

Phrase: "may"

Phrase: "act as a bridge to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0456378:Bridge [Medical Device]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "APP with caveolin-1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.253: To address this issue, the interaction between a purified GST fusion protein encoding the short cytoplasmic tail of APP and purified recombinant caveolin-1 containing both myc and His tags (caveolin-1-myc-His7) was investigated. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "the interaction between a purified GST fusion protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interaction protein [Molecular Function]
   744   C1704675:Interaction [Functional Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the short cytoplasmic tail of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1511625:Cytoplasmic Tail [Cell Component]
   767   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0010834:Cytoplasmic [Cell Component]
   744   C0039259:Tail [Body Part, Organ, or Organ Component]
   744   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "purified recombinant caveolin-1 containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332256:Containing [Functional Concept]
   804   C2700400:Containing [Activity]

Phrase: "both myc"

Phrase: "and"

Phrase: "His tags"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1139855:tags [Medical Device]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]

Phrase: "(caveolin-1-myc-His7"

Phrase: ")"

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.254: GST alone or GST-APP cytoplasmic tail immobilized on glutathione-agarose beads were incubated with purified recombinant caveolin-1. 

Phrase: "GST"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "GST-APP cytoplasmic tail"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1511625:Cytoplasmic Tail [Cell Component]
   799   C0010834:Cytoplasmic [Cell Component]
   799   C0039259:Tail [Body Part, Organ, or Organ Component]
   799   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "immobilized on glutathione-agarose beads"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Agarose [Carbohydrate]
   760   C0991566:Beads [Biomedical or Dental Material]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "incubated with purified recombinant caveolin-1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   790   C1332669:CAVEOLIN 1 [Gene or Genome]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1514798:recombinant [Organism]
   753   C1998793:Purified [Functional Concept]
Processing 00000000.tx.255: After binding, the beads were extensively washed with buffers containing high salt and detergents, and the bound proteins were then specifically eluted with buffer containing excess reduced glutathione. 

Phrase: "After binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "extensively"

Phrase: "washed with buffers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "high salt"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0205250:High [Qualitative Concept]
   861   C0206136:Salt [Food,Inorganic Chemical]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]

Phrase: "and"

Phrase: "detergents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergents [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "the bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "then specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "eluted with buffer containing excess reduced glutathione."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0034917:Reduced Glutathione [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332256:Containing [Functional Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1979886:Excess [Qualitative Concept]
   748   C2700400:Containing [Activity]
Processing 00000000.tx.256: These eluates were then subjected to immunoblot analysis with anti-caveolin-1 IgG. 

Phrase: "These eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with anti-caveolin-1 IgG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.257: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.258: 2D shows that caveolin-1 specifically associated with GST-APP cytoplasmic tail but not with GST alone. 

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that caveolin-1 specifically"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with GST-APP cytoplasmic tail"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   789   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1511625:Cytoplasmic Tail [Cell Component]
   767   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0010834:Cytoplasmic [Cell Component]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0039259:Tail [Body Part, Organ, or Organ Component]
   744   C0521449:Cytoplasmic [Body Location or Region]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "not with GST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.259: We also used FE65 APP binding domain as a positive control and myelin basic protein as a negative control for these experiments. 

Phrase: "We also used FE65 APP binding domain as a positive control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   766   C1514535:Protein Binding Domain [Amino Acid Sequence]
   749   C0162808:Protein Domain [Spatial Concept]
   749   C1514562:Protein Domain [Amino Acid Sequence]
   735   C1880389:Domain [Functional Concept]
   735   C1883221:Domain [Conceptual Entity]
   735   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "myelin basic protein as a negative control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   814   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   774   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0026969:Myelin [Tissue]
   748   C0026973:Myelin [Cell Component]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1527178:Basic [Functional Concept]

Phrase: "for these experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.260: Under our conditions, FE65 PTB2 domain (484-612 amino acids) but not myelin basic protein bound GST-APP cytoplasmic tail (Fig. 2D), indicating that the employed experimental conditions were appropriate to evaluate the direct interaction between the APP cytoplasmic region and its associated molecules. 

Phrase: "Under our conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "FE65 PTB2 domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(484-612 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "but"

Phrase: "not myelin basic protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0014063:Myelin Basic Protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   923   C1417057:MYELIN BASIC PROTEIN [Gene or Genome]
   875   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026969:Myelin [Tissue]
   812   C0026973:Myelin [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1527178:Basic [Functional Concept]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "GST-APP cytoplasmic tail"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1511625:Cytoplasmic Tail [Cell Component]
   799   C0010834:Cytoplasmic [Cell Component]
   799   C0039259:Tail [Body Part, Organ, or Organ Component]
   799   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the employed experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "appropriate to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the direct interaction between the APP cytoplasmic region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0872079:interaction protein [Molecular Function]
   739   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "its associated molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.261: Taken together, these results clearly indicate that APP interacts directly with caveolin-1 through a portion of the cytoplasmic tail of APP. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "interacts"

Phrase: "directly with caveolin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   833   C1332669:CAVEOLIN 1 [Gene or Genome]
   770   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1947931:Directly [Qualitative Concept]

Phrase: "through a portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449719:Portion [Spatial Concept]

Phrase: "of the cytoplasmic tail"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Tail [Cell Component]
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0039259:Tail [Body Part, Organ, or Organ Component]
   861   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.262: Cell surface caveolae can be detected by cholera toxin B subunit binding (45, 50). 

Phrase: "Cell surface caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230653:Caveolae [Cell Component]
   734   C0699040:Cell surface [Cell Component]

Phrase: "can"

Phrase: "be"

Phrase: "detected by cholera toxin B subunit binding"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   748   C0008354:Cholera [Disease or Syndrome]
   748   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   748   C0243122:binding [Functional Concept]
   748   C0442726:Detected [Finding]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "(45,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.263: To investigate the possibility that cell surface caveolae contain APP, we immunostained living COS-7 cells with anti-HA and cholera toxin antibodies following incubation of the cells with cholera toxin B subunit after transfection of recombinant HA-APP and myc-caveolin cDNAs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possibility"

Phrase: "that cell surface caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230653:Caveolae [Cell Component]
   734   C0699040:Cell surface [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "we"

Phrase: "immunostained"

Phrase: "living COS-7 cells with anti-HA"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   814   C1257858:COS-7 Cells [Cell]
   774   C0376702:COS Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cholera toxin antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation of the cells"

Phrase: "with cholera toxin B subunit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   812   C0008354:Cholera [Disease or Syndrome]
   812   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of recombinant HA-APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "myc-caveolin cDNAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.264: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.265: 3, HA (green) and cholera toxin B subunit staining (red) are co-localized on the cell surface. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "HA (green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cholera toxin B subunit staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0487602:Staining [Laboratory Procedure]
   804   C1704680:Staining [Finding]
   771   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "are"

Phrase: "co-localized on the cell surface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0699040:Cell surface [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0205148:Surface [Spatial Concept]
   753   C0392752:Localized [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.266: These results support the hypothesis that APP is localized within cell surface caveolae in living cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "localized within cell surface caveolae"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0230653:Caveolae [Cell Component]
   760   C0392752:Localized [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in living cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.267: View larger version (93K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(93K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.268: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.269: Localization of APP and cholera toxin B subunit binding site within a single cell. 

Phrase: "Localization of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597704:protein localisation [Cell Function]
   797   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "cholera toxin B subunit binding site within a single cell."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0005456:Binding Site [Receptor]
   760   C0682969:Binding Site [Amino Acid Sequence]
   739   C0205145:Site [Spatial Concept]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]
Processing 00000000.tx.270: COS-7 cells transfected with HA-APP695 and myc-tagged caveolin-1 were incubated with cholera toxin B subunit and immunostained with anti-HA (A and C) and anti-cholera toxin (B and D) antibodies. 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with HA-APP695"

Phrase: "and"

Phrase: "myc-tagged caveolin-1"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "incubated with cholera toxin B subunit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   753   C0008354:Cholera [Disease or Syndrome]
   753   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "immunostained with anti-HA (A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "C"

Phrase: ")"

Phrase: "and"

Phrase: "anti-cholera toxin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.271: Primary antibodies were detected using differentially tagged fluorescent secondary antibodies (fluorescein isothiocyanate-conjugated for HA and Texas Red-conjugated for cholera toxin B subunit). 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "differentially tagged fluorescent secondary antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   836   C0016318:fluorescent antibody [Laboratory Procedure]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(fluorescein isothiocyanate-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: "conjugated for HA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0522529:Conjugated [Spatial Concept]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "and"

Phrase: "Texas Red-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0076359:Texas red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0039711:Texas [Geographic Area]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "conjugated for cholera toxin B subunit"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   882   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   767   C0085998:Toxin Conjugate [Pharmacologic Substance]
   753   C0008354:Cholera [Disease or Syndrome]
   753   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1711351:Subunit [Quantitative Concept]
   719 E C0301869:Conjugate [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.272: Both epitopes were visualized by laser confocal microscopy. 

Phrase: "Both epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitopes [Immunologic Factor]

Phrase: "were"

Phrase: "visualized by laser confocal microscopy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0242842:Microscopy, Confocal [Laboratory Procedure]
   797   C0600395:Laser Microscopy [Laboratory Procedure]
   760   C0023089:Laser [Manufactured Object]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0234621:Visualized [Functional Concept]
   760   C0458142:Laser [Phenomenon or Process]
   760   C1023865:Laser [Plant]
   760   C1706315:Laser [Medical Device]
Processing 00000000.tx.273: Two single cells immunostained with anti-HA antibody (green), and with anti-cholera toxin B subunit antibody (red) are presented. 

Phrase: "Two single cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "immunostained with anti-HA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and with anti-cholera toxin B subunit antibody"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]
   789   C0301850:Anti-B antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0008354:Cholera [Disease or Syndrome]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   744   C1515981:And [Idea or Concept]
   744   C1711351:Subunit [Quantitative Concept]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "are"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.274: Similar results were observed in at least 100independent cells. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1441672:Observed [Functional Concept]

Phrase: "at least 100independent cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.275: Arrows point at co-localization of APP and cholera toxin B subunit binding site. 

Phrase: "Arrows point at co-localization of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0234196:Point localisation [Organ or Tissue Function]
   742   C1552961:Point [Quantitative Concept]
   742   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "cholera toxin B subunit binding site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0005456:Binding Site [Receptor]
   827   C0682969:Binding Site [Amino Acid Sequence]
   799   C0205145:Site [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C0008357:Cholera Toxin B Subunit [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.276: In summary, we have shown here that (i) both endogenous and recombinant APP co-fractionate with caveolin-1, (ii) APP forms a physical complex with caveolin, (iii) the scaffolding domain of caveolin and the cytoplasmic domain of APP participate in this reciprocal interaction, and (iv) cell surface caveolae contain APP. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "both endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205227:Endogenous [Functional Concept]

Phrase: "and"

Phrase: "recombinant APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "co-fractionate with caveolin-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   806   C1332669:CAVEOLIN 1 [Gene or Genome]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(ii"

Phrase: ")"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a physical complex with caveolin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "the scaffolding domain of caveolin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the cytoplasmic domain of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1511625:Cytoplasmic Domain [Cell Component]
   774   C0162808:Protein Domain [Spatial Concept]
   774   C1514562:Protein Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "participate in this reciprocal interaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704675:Interaction [Functional Concept]
   760   C1882911:Reciprocal [Qualitative Concept]

Phrase: "and ("

Phrase: "iv) cell surface caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0230653:Caveolae [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.277: A C-terminal Degradation Product of APP Is Localized within Caveolae-rich Fractions, and the Generation of This APP Product Is Specifically Dependent upon the Expression of Caveolin-1-- The -secretase-generated degradation product of APP can be detected in COS-7 cells by immunoblotting with C-terminal APP antibodies (51). 

Phrase: "A C-terminal Degradation Product of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "Is"

Phrase: "Localized within Caveolae-rich Fractions,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0230653:Caveolae [Cell Component]
   760   C0392752:Localized [Spatial Concept]
   760   C0699759:Rich [Qualitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "the Generation of This APP Product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "Is"

Phrase: "Specifically Dependent upon the Expression of Caveolin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The -secretase-generated degradation product of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected in COS-7 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0442726:Detected [Finding]
   760   C0454802:Cos [Geographic Area]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with C-terminal APP antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   810   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.278: To determine if -secretase-mediated APP degradation occurred in our experimental system, COS-7 cells were transiently transfected with HA-tagged APP and subjected to detergent-free subcellular fractionation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if -"

Phrase: "secretase-mediated APP degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1327161:amyloid precursor protein degradation [Molecular Function]
   827   C0597297:Protein Degradation [Molecular Function]
   827   C0597304:Protein Degradation [Molecular Function]
   827   C1623036:Protein Degradation [Molecular Function]
   799   C0243125:degradation [Functional Concept]
   799   C0699900:Degradation [Organism Function]

Phrase: "occurred in our experimental system,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0449913:System [Functional Concept]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with HA-tagged APP"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1818826:protein tag [Molecular Function]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1708632:Tagged [Qualitative Concept]
   748   C1709634:Precursor [Idea or Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "subjected to detergent-free subcellular fractionation."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C1656251:subcellular fractionation [Laboratory Procedure]
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0016640:fractionation [Laboratory Procedure]
   753   C0332296:free [Functional Concept]
   753   C0524811:fractionation [Therapeutic or Preventive Procedure]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.279: These fractions were then analyzed by immunoblotting with C-terminal APP antibodies (AC-1). 

Phrase: "These fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with C-terminal APP antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   810   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(AC-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.280: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.281: 4, two bands confined to caveolin-rich fraction 4were detected; 

Phrase: "4,"

Phrase: "two bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "confined to caveolin-rich fraction 4were"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0699759:Rich [Qualitative Concept]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.282: the high molecular weight band represents intact APP695, whereas the low molecular weight band is a short fragment of APP that contains a C-terminal epitope recognized by the AC-1 antibody. 

Phrase: "the high molecular weight band"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "intact APP695,"

Phrase: "whereas"

Phrase: "the low molecular weight band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   708   C0041667:Low weight [Finding]

Phrase: "is"

Phrase: "a short fragment of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a C-terminal epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003316:Epitope [Immunologic Factor]

Phrase: "recognized by the AC-1 antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1412573:AC [Gene or Genome]
   753   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3539770:AC [Gene or Genome]
Processing 00000000.tx.283: As this low molecular weight band was not detected by immunoblotting with an antibody directed against the extracellular domain of APP (22C11) (Fig. 2), these results indicate that this short fragment represents a C-terminally derived APP degradation product. 

Phrase: "As this low molecular weight band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   708   C0041667:Low weight [Finding]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the extracellular domain of APP"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1517050:Extracellular Domain [Spatial Concept]
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0521119:Extracellular [Cell Component]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]
   708   C0439851:Direct [Qualitative Concept]
   708   C1947931:Direct [Qualitative Concept]

Phrase: "(22C11"

Phrase: ")"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "this short fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a C-terminally derived APP degradation product."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1514468:product [Entity]
   791   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.284: To obtain a more precise estimate of the molecular mass of this C-terminal APP fragment, the same sample was subjected to Tris/Tricine SDS-PAGE and immunoblotting with AC-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a more precise estimate of the molecular mass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0750572:Estimate [Quantitative Concept]

Phrase: "of this C-terminal APP fragment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "the same sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "subjected to Tris/Tricine SDS-PAGE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077068:tricine [Organic Chemical]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0814229:TRI [Intellectual Product]
   753   C1704732:Page [Intellectual Product]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "immunoblotting with AC-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.285: A 10-kDa band was detected, supporting the hypothesis that it is derived from APP -secretase processing (51). 

Phrase: "A 10-kDa band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0230715:A band [Cell Component]
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "derived from APP -secretase processing"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   853   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   853   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0033666:protein processing [Molecular Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1441547:Derived [Qualitative Concept]
   748   C1709634:Precursor [Idea or Concept]
   748   C1709694:Processing [Activity]
   748   C3245521:derived [Idea or Concept]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.286: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.287: 4.  

Phrase: "4."
Processing 00000000.tx.288: A C-terminal fragment of APP is the product of -secretase cleavage and is concentrated within caveolae-enriched membrane fractions. 

Phrase: "A C-terminal fragment of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "the product of -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "is"

Phrase: "concentrated within caveolae-enriched membrane fractions."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0025255:Membrane [Tissue]
   753   C0230653:Caveolae [Cell Component]
   753   C0359583:enriched [Food]
   753   C0596901:Membrane [Cell Component]
   753   C1264633:Fractions [Quantitative Concept]
   753   C1706182:Membrane [Manufactured Object]
   753   C1880165:Concentrated [Biomedical or Dental Material]
   742   C1167209:caveolar membrane [Cell Component]
   719 E C1554103:Fraction [Idea or Concept]
   719 E C1880310:Concentrate [Manufactured Object]
   719 E C2003864:Concentrate [Substance]
Processing 00000000.tx.289: A, a well defined C-terminal fragment of APP is concentrated within caveolae-enriched membranes fractions. 

Phrase: "A,"

Phrase: "a well defined C-terminal fragment of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "concentrated within caveolae-enriched membranes fractions."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   753   C0025255:Membranes [Tissue]
   753   C0230653:Caveolae [Cell Component]
   753   C0359583:enriched [Food]
   753   C1264633:Fractions [Quantitative Concept]
   753   C1880165:Concentrated [Biomedical or Dental Material]
   725   C1167209:caveolar membrane [Cell Component]
   719 E C0596901:Membrane [Cell Component]
   719 E C1554103:Fraction [Idea or Concept]
   719 E C1706182:Membrane [Manufactured Object]
   719 E C1880310:Concentrate [Manufactured Object]
   719 E C2003864:Concentrate [Substance]
Processing 00000000.tx.290: HA-APP was transfected into COS-7 cells with LipofectAMINE. 

Phrase: "HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "transfected into COS-7 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with LipofectAMINE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]
Processing 00000000.tx.291: 48h post-transfection, cells were harvested and subjected to detergent-free caveolae purification as in Fig. 

Phrase: "48h post-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "subjected to detergent-free caveolae purification"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0230653:Caveolae [Cell Component]
   753   C0243114:purification [Functional Concept]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C1998793:Purification [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.292: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.293: Gradient fractions were collected, separated by SDS-PAGE (4-20% linear gradient gel), and subjected to immunoblotting with AC-1 antibody which is directed against the C terminus of APP. 

Phrase: "Gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "separated by SDS-PAGE (4-20% linear gradient gel"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   764   C1538569:PAGE-4 [Gene or Genome]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0086972:Separated [Finding]
   742   C0205132:Linear [Spatial Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1382104:Gel [Substance]
   742   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with AC-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "directed against the C terminus of APP."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C3282337:Cells [Cell]
   708   C0439851:Direct [Qualitative Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708   C1947931:Direct [Qualitative Concept]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.294: Inset, lysates from the transfected cells were also subjected to Tris/Tricine SDS-PAGE (10-20% linear gradient gel) and to immunoblotting with AC-1. 

Phrase: "Inset,"

Phrase: "lysates from the transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "also"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to Tris/Tricine SDS-PAGE (10-20% linear gradient gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0017243:Gel [Biomedical or Dental Material]
   791   C1382104:Gel [Substance]

Phrase: ")"

Phrase: "and to immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1515981:And [Idea or Concept]

Phrase: "with AC-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]
Processing 00000000.tx.295: B, the C-terminal fragment is an -secretase-cleaved product of APP. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the C-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "an -secretase-cleaved product of APP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.296: COS-7 cells transfected with HA-APP were subject to immunoprecipitation with various C-terminal APP antibodies (369,CT-15, and AC-1) followed by immunoblotting with anti-A antibodies (4G8 which is directed against residues 18-40 of A peptide and 6E10 which is directed against residues 1-17). 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "were subject to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "with various C-terminal APP antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   801   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   762 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(369,"

Phrase: "CT-15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "AC-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: ")"

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-A antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(4G8"

Phrase: "which"

Phrase: "is"

Phrase: "directed against residues 18-40 of A peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0439509:/40 [Temporal Concept]
   711   C0439851:Direct [Qualitative Concept]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
   711   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "6E10"

Phrase: "which"

Phrase: "is"

Phrase: "directed against residues 1-17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0439851:Direct [Qualitative Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
   726   C1947931:Direct [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.297: C, a soluble form of the extracellular domain of APP (APPs) is shed into the culture media. 

Phrase: "C,"

Phrase: "a soluble form of the extracellular domain of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C1522492:Form [Functional Concept]

Phrase: "(APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: "is"

Phrase: "shed into the culture media."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.298: The culture media of cells transfected with HA-APP were collected and subjected to immunoprecipitation with anti-A antibodies (4G8 and 6E10) followed by immunoblotting with 22C11. 

Phrase: "The culture media of cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   827   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   797   C0007585:cells culture [Laboratory Procedure]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-A antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(4G8"

Phrase: "and"

Phrase: "6E10"

Phrase: ")"

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 22C11."
Processing 00000000.tx.299: D, APP and its C-terminal fragment are concentrated in caveolae membrane fractions. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "its C-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "concentrated in caveolae membrane fractions."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   765   C1167209:caveolar membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0230653:Caveolae [Cell Component]
   760   C0596901:Membrane [Cell Component]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]
Processing 00000000.tx.300: The Optiprep method was employed to confirm further the observation that both APP and its C-terminal fragment are in caveolae. 

Phrase: "The Optiprep method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "both APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "its C-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "are in caveolae."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.301: Plasma membrane and caveolae membrane fractions were obtained from COS-7 cells transfected with HA-APP by the method developed by Smart et al. 

Phrase: "Plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "caveolae membrane fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "obtained from COS-7 cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C1301820:Obtained [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1706701:Obtain [Activity]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "developed by Smart et al."
Processing 00000000.tx.302: (41), and 4g each of protein was loaded, separated by SDS-PAGE (4-20% linear gradient gel), and subjected to immunoblotting with AC-1 antibody (upper panel) and caveolin antibody (middle panel). 

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "4g"

Phrase: "each of protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1457900:Each [Quantitative Concept]

Phrase: "was"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: ","

Phrase: "separated by SDS-PAGE (4-20% linear gradient gel"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   764   C1538569:PAGE-4 [Gene or Genome]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0086972:Separated [Finding]
   742   C0205132:Linear [Spatial Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1382104:Gel [Substance]
   742   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with AC-1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "caveolin antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.303: The protein concentration profile of fractionated samples is also presented (lower panel). 

Phrase: "The protein concentration profile of fractionated samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "also"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.304: To substantiate further these observations, we subjected the samples to immunoprecipitation with three independent antibodies directed against the C-terminal region of APP (termed 369,CT15, and AC-1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "substantiate"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "these observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "we"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "the samples to immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "with three independent antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the C-terminal region of APP"
Meta Candidates (Total=24; Excluded=3; Pruned=0; Remaining=21)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0018956:cells precursor [Cell]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1514562:Protein Region [Amino Acid Sequence]
   741   C1268228:Cell region [Cell Component]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0007634:Cells [Cell]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0017446:Region [Geographic Area]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205088:Terminal [Temporal Concept]
   739   C0205147:Region [Spatial Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C3282337:Cells [Cell]
   706   C0439851:Direct [Qualitative Concept]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706   C1947931:Direct [Qualitative Concept]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "369,"

Phrase: "CT15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412189:CT15 [Gene or Genome]

Phrase: "and"

Phrase: "AC-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.305: These immunoprecipitates were then immunoblotted with antibodies directed against the A amyloid region of APP (termed 4G8 and 6E10). 

Phrase: "These immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoblotted with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756   C0020985:Immunoblot [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "A amyloid region of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1514562:Protein Region [Amino Acid Sequence]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "(termed 4G8"

Phrase: "and"

Phrase: "6E10"

Phrase: ")."
Processing 00000000.tx.306: 4G8 recognizes residues 18-24 of the amyloid peptide, whereas 6E10 recognizes residues 1-17 of the amyloid peptide. 

Phrase: "4G8"

Phrase: "recognizes"

Phrase: "residues 18-24 of the amyloid peptide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "whereas"

Phrase: "6E10"

Phrase: "recognizes"

Phrase: "residues 1-17 of the amyloid peptide."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.307: As the -secretase cleavage site is located at residue 17or 18 of the amyloid peptide, these antibodies should allow us to the precisely determine the origin of this C-terminal low molecular weight product of APP. 

Phrase: "As the -secretase cleavage site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located at residue 17or 18 of the amyloid peptide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709915:Residue [Conceptual Entity]
   742   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "these antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "should"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to the precisely"

Phrase: "determine"

Phrase: "the origin of this C-terminal low molecular weight product"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   747   C0021288:Low birth weight [Patient or Disabled Group]
   747   C0024032:Low Birth Weight [Finding]
   739   C0079946:origin [Classification]
   739   C0439659:Origin [Temporal Concept]
   739   C1550512:origin [Intellectual Product]
   730   C0086345:Molecular Genetic [Biomedical Occupation or Discipline]
   716   C0005612:Birth Weight [Organism Attribute]

Phrase: "of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.308: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.309: 4B, the short APP fragment that was immunoprecipitated with antibodies directed against the C terminus of APP is immunoreactive with the 4G8 antibody but not with 6E10. 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "the short APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "immunoprecipitated with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "directed against the C terminus of APP"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C3282337:Cells [Cell]
   708   C0439851:Direct [Qualitative Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708   C1947931:Direct [Qualitative Concept]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "immunoreactive with the 4G8 antibody"

Phrase: "but"

Phrase: "not with 6E10."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.310: These data indicate that the short C-terminal APP fragment contains both the C terminus of APP and the 4G8 epitope, but it does not contain the 6E10 epitope. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the short C-terminal APP fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   795   C0332255:fragment [Functional Concept]
   795   C1708096:Fragment [Qualitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "both the C terminus of APP"

Phrase: "and"

Phrase: "the 4G8 epitope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "but"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the 6E10 epitope."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]
Processing 00000000.tx.311: These studies provide additional evidence that this 10-kDa fragment represents an -secretase processed product of APP (APPct). 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "this 10-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "product of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "(APPct"

Phrase: ")."
Processing 00000000.tx.312: These results also establish that both intact APP and APPct co-fractionate with caveolin-1 and are concentrated within caveolae-enriched fractions. 

Phrase: "These results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that"

Phrase: "both intact APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APPct"

Phrase: "co-fractionate with caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   806   C1332669:CAVEOLIN 1 [Gene or Genome]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "are"

Phrase: "concentrated within caveolae-enriched fractions."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0230653:Caveolae [Cell Component]
   760   C0359583:enriched [Food]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]
Processing 00000000.tx.313: As -secretase promotes secretion of the APP extracellular domain (APPs), we investigated the possibility that APPs are present in the media containing our transfected cells. 

Phrase: "As -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "secretion of the APP extracellular domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1159339:Protein Secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "(APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the possibility"

Phrase: "that APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "are"

Phrase: "present in the media"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "our transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.314: The media from cells transfected with HA-APP were collected and subjected to immunoprecipitation with anti-A peptide antibodies followed by immunoblotting with 22C11. 

Phrase: "The media from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-A peptide antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 22C11."
Processing 00000000.tx.315: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.316: 4C, a band corresponding to APPs was detected by immunoprecipitation with 6E10 but not with 4G8. 

Phrase: "4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "a band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230715:A band [Cell Component]
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "corresponding to APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C3538722:APP [Laboratory Procedure]

Phrase: "was"

Phrase: "detected by immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with 6E10"

Phrase: "but"

Phrase: "not with 4G8."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.317: Detection of a soluble fragment of the extracellular domain of APP that contains residues 1-17 of the A amyloid peptide (the epitope of 6E10) provides additional support for -secretase cleavage of APP in COS-7 cells. 

Phrase: "Detection of a soluble fragment of the extracellular domain of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "residues 1-17 of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "A amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "the epitope of 6E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003316:Epitope [Immunologic Factor]

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "additional support for -secretase cleavage of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0183683:Support [Medical Device]
   742   C1521721:Support [Conceptual Entity]

Phrase: "in COS-7 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.318: Taken together, these findings demonstrate that APP is correctly processed at its -secretase cleavage site in COS-7 cells. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "correctly"

Phrase: "processed at its -secretase cleavage site"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0010813:cleavage [Cell Function]
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205145:Site [Spatial Concept]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C1515974:Site [Body Location or Region]
   753   C1522240:Processed [Phenomenon or Process]
   753   C2825164:Site [Spatial Concept]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "in COS-7 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.319: As an alternative approach, we employed a method developed by Smart et al. 

Phrase: "As an alternative approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "developed by Smart et al."
Processing 00000000.tx.320: (41) to purify caveolae (Optiprep approach) to substantiate further our observation that intact full-length APP and its -secretase-cleaved C-terminal fragment are localized in caveolae. 

Phrase: "(41"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "(Optiprep approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "substantiate"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that intact full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "its -secretase-cleaved C-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "localized in caveolae."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.321: We first transiently transfected HA-APP and myc-caveolin-1 into COS-7 cells and then purified caveolae by the Optiprep method. 

Phrase: "We first transiently transfected HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "myc-caveolin-1 into COS-7 cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   814   C1257858:COS-7 Cells [Cell]
   800   C1257857:COS-1 Cells [Cell]
   778   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   778   C1332669:CAVEOLIN 1 [Gene or Genome]
   774   C0376702:COS Cells [Cell]
           COS-1
   748   C0007634:Cells [Cell]
   748   C0454802:Cos [Geographic Area]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "then purified caveolae by the Optiprep method."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0230653:Caveolae [Cell Component]
Processing 00000000.tx.322: In this approach, the bulk of protein which was recovered in fractions 7-13, termed "plasma membrane fractions," was successfully separated from the "caveolae membrane fraction" (fractions 1-6) (Fig. 4D, lower panel), consistent with the method originally described by Smart et al. 

Phrase: "In this approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "the bulk of protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012173:Bulk [Food]
   770   C1337615:Bulk [Biomedical or Dental Material]

Phrase: "which"

Phrase: "was"

Phrase: "recovered in fractions 7-13,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0521108:recovered [Qualitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "termed ""plasma membrane fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: """"

Phrase: "was"

Phrase: "successfully"

Phrase: "separated from the ""caveolae membrane fraction"""
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0025255:Membrane [Tissue]
   753   C0086972:Separated [Finding]
   753   C0230653:Caveolae [Cell Component]
   753   C0443299:separated [Spatial Concept]
   753   C0596901:Membrane [Cell Component]
   753   C0687118:Separated [Functional Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1706182:Membrane [Manufactured Object]
   748   C1167209:caveolar membrane [Cell Component]

Phrase: "(fractions 1-6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "(Fig. 4D,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "consistent with the method originally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "described by Smart et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.323: (41). 

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.324: By using this approach, full-length APP and its processed product were dramatically enriched within the caveolae membrane fraction (Fig. 4D, upper panel). 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "its processed product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "dramatically"

Phrase: "enriched within the caveolae membrane fraction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0025255:Membrane [Tissue]
   753   C0230653:Caveolae [Cell Component]
   753   C0359583:enriched [Food]
   753   C0596901:Membrane [Cell Component]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1706182:Membrane [Manufactured Object]
   748   C1167209:caveolar membrane [Cell Component]

Phrase: "(Fig. 4D, upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.325: As reported previously, the plasma membrane fraction did not contain caveolin, which was specifically recovered in the caveolae membrane fraction (Fig. 4D, middle panel). 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously,"

Phrase: "the plasma membrane fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "caveolin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "was"

Phrase: "specifically"

Phrase: "recovered in the caveolae membrane fraction"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0025255:Membrane [Tissue]
   753   C0230653:Caveolae [Cell Component]
   753   C0521108:recovered [Qualitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1706182:Membrane [Manufactured Object]
   748   C1167209:caveolar membrane [Cell Component]
   719 E C2004454:recover [Organism Function]

Phrase: "(Fig. 4D, middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.326: Importantly, the full-length APP and its processed product were not detected in these plasma membrane fractions (Fig. 4D, upper panel). 

Phrase: "Importantly,"

Phrase: "the full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "its processed product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in these plasma membrane fractions"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0007603:Plasma membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0442726:Detected [Finding]
   753   C0596901:Membrane [Cell Component]
   753   C1264633:Fractions [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 4D, upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.327: These data clearly support the hypothesis that not only full-length APP but also its short product processed by -secretase are present within caveolae microdomains. 

Phrase: "These data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "not only full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: "but"

Phrase: "also"

Phrase: "its short product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "processed by -secretase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "present within caveolae microdomains."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.328: These observations prompted us to investigate if caveolae play any role in the -secretase processing of APP. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "if"

Phrase: "caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "any role in the -secretase processing of APP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.329: One possibility is that the relative amount of caveolin expression could modulate whether APP undergoes -secretase processing. 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the relative amount of caveolin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "could"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "whether"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "undergoes -"

Phrase: "secretase processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]
Processing 00000000.tx.330: To test this hypothesis, we (i) co-transfected COS-7 cells with HA-tagged APP and myc-tagged caveolin-1 and (ii) assessed -secretase activity by measuring the amounts of APPct in cell lysates and of APPs in the culture media. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we (i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "co-transfected"

Phrase: "COS-7 cells with HA-tagged APP"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C1257858:COS-7 Cells [Cell]
   762   C0018956:cells precursor [Cell]
   762   C0376702:COS Cells [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "myc-tagged caveolin-1"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "assessed -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "secretase activity by measuring"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "the amounts of APPct in cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "and of APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   756   C3538722:APP [Laboratory Procedure]

Phrase: "in the culture media."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0162867:Media [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1254021:Media [Tissue]
   861   C2242979:Culture [Laboratory Procedure]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.331: In addition, we performed detergent-free subcellular fractionation on these samples. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "detergent-free subcellular fractionation on these samples."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1656251:subcellular fractionation [Laboratory Procedure]
   748   C0016640:fractionation [Laboratory Procedure]
   748   C0524811:fractionation [Therapeutic or Preventive Procedure]
   748   C3161031:Fractionation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.332: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.333: 5A, two major bands corresponding to intact APP and APPct that were confined to fractions 4and 5were detected by immunoblot analysis with C-terminal APP antibodies. 

Phrase: "5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "two major bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "corresponding to intact APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205266:Intact [Qualitative Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1554187:Intact [Idea or Concept]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APPct"

Phrase: "that"

Phrase: "were"

Phrase: "confined to fractions 4and 5were"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "detected by immunoblot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "with C-terminal APP antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   810   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.334: The ratio APPct to intact APP was increased significantly by co-expression with caveolin-1 (as compared with HA-APP expressed alone). 

Phrase: "The ratio APPct to intact APP"

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly by co-expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "as"

Phrase: "compared with HA-APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1707455:Compared [Activity]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "expressed"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ")."
Processing 00000000.tx.335: Densitometric analysis revealed that the ratio increased from 1:1 to 5:1. 

Phrase: "Densitometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "increased from 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: ":"

Phrase: "1 to 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0450316:1/5 [Quantitative Concept]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.336: In contrast, overexpression of the caveolin mutant which lacks the APP binding domain (caveolin-1-( 61-100)) did not increase APPct (Fig. 5A), indicating that caveolin binding to APP promotes APP degradation. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "overexpression of the caveolin mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "which"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the APP binding domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C1514535:Protein Binding Domain [Amino Acid Sequence]
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(caveolin-1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "( 61-100"

Phrase: ")"

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APPct"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that caveolin binding to APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0033618:Protein Binding [Molecular Function]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "APP degradation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.337: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.338: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.339: Overexpression of caveolin-1 promotes -secretase processing of APP. 

Phrase: "Overexpression of caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "promotes -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "secretase processing of APP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]
Processing 00000000.tx.340: A, production of the C-terminal fragment of APP is greatly enhanced by overexpression of caveolin (cav-1) but not by overexpression of caveolin-1 lacking residues 61-100 (cav-161-100). 

Phrase: "A,"

Phrase: "production of the C-terminal fragment of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "greatly"

Phrase: "enhanced by overexpression of caveolin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514559:Overexpression [Genetic Function]
   760   C2349975:Enhanced [Activity]

Phrase: "(cav-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "but"

Phrase: "not by overexpression of caveolin-1 lacking residues 61-100"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   760   C1332669:CAVEOLIN 1 [Gene or Genome]
   739   C0332268:Lacking [Qualitative Concept]
   739   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1514559:Overexpression [Genetic Function]
   739   C1518422:Not [Functional Concept]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(cav-161-100"

Phrase: ")."
Processing 00000000.tx.341: COS-7 cells were transfected with HA-APP and myc-caveolin-1 or myc-caveolin lacking residues 61-100. 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "myc-caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "myc-caveolin lacking residues 61-100."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   799   C0332268:Lacking [Qualitative Concept]
   799   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.342: 48h post-transfection, cells were harvested and subjected to detergent-free caveolae fractionation. 

Phrase: "48h post-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "subjected to detergent-free caveolae fractionation."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0016640:fractionation [Laboratory Procedure]
   753   C0230653:Caveolae [Cell Component]
   753   C0332296:free [Functional Concept]
   753   C0524811:fractionation [Therapeutic or Preventive Procedure]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.343: Gradient fractions were collected, separated by SDS-PAGE (4-20% linear gradient gel), and subjected to immunoblotting with AC-1 and anti-myc antibodies. 

Phrase: "Gradient fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "separated by SDS-PAGE (4-20% linear gradient gel"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   764   C1538569:PAGE-4 [Gene or Genome]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0086972:Separated [Finding]
   742   C0205132:Linear [Spatial Concept]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0443299:separated [Spatial Concept]
   742   C0687118:Separated [Functional Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1382104:Gel [Substance]
   742   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with AC-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.344: The equivalent expression of recombinant caveolin-1 and mutant caveolin-1 was confirmed by immunoblotting with the anti-myc antibody (data not shown). 

Phrase: "The equivalent expression of recombinant caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mutant caveolin-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "confirmed by immunoblotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "with the anti-myc antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.345: B, media from cells co-transfected with HA-APP and myc-caveolin-1 were subjected to immunoprecipitation with anti-A-(1-28) antibody (anti-A) (lanes 1and 2) or normal rabbit immunoglobulin (NRG) (lane 3) and analyzed by immunoblotting with 22C11. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "media from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "co-transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "myc-caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "(lanes 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "normal rabbit immunoglobulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1621846:immunoglobulin [Molecular Function]

Phrase: "(NRG) (lane 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C0205307:Normal [Qualitative Concept]
   804   C0439166:% normal [Quantitative Concept]
   804   C1708639:Lane [Spatial Concept]
   804   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with 22C11."
Processing 00000000.tx.346: Prior to immunoprecipitation, the anti-A-(1-28) antibody was pre-absorbed with an A-(1-16) synthetic peptide and was then used for immunoprecipitation (lane 2). 

Phrase: "Prior to immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "the anti-A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "pre-absorbed with an A-(1-16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0332152:Pre [Temporal Concept]
   748   C0740175:Pre [Qualitative Concept]
   748   C2257086:PRE [Genetic Function]

Phrase: ")"

Phrase: "synthetic peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "and"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "used for immunoprecipitation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.347: C, media from cells transfected with or without HA-APP (+APP or APP) together with either mock (cav-1), caveolin (cav-1), or caveolin which lacks residues 61-100 (61-100) were subjected to immunoprecipitation (IP) with an anti-A-(1-28) antibody or 1153and immunoblotted with 22C11 (lower panel). 

Phrase: "C,"

Phrase: "media from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "transfected with"

Phrase: "or without HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "(+APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "together with either mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0562577:mock [Finding]

Phrase: "(cav-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(cav-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "caveolin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "residues 61-100"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(61-100"

Phrase: ")"

Phrase: "were"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "(IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ")"

Phrase: "with an anti-A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "1153and"

Phrase: "immunoblotted with 22C11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.348: Cell lysates (100g) were also subjected to immunoblotting with 22C11 (upper panel) or anti-myc antibodies (middle panel). 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(100g"

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with 22C11"

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "anti-myc antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.349: D, APP degradation occurs on the cell surface. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "occurs on the cell surface."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1709305:Occur [Activity]
   760   C1948049:Cell [Spatial Concept]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.350: Left panels, cells transfected with HA-APP alone or in combination with myc-tagged caveolin-1 were surface-labeled with the cell-impermeant probe sulfo-NHS biotin. 

Phrase: "Left panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with myc-tagged caveolin-1"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "surface-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205148:Surface [Spatial Concept]

Phrase: "labeled with the cell-impermeant probe sulfo-NHS biotin."
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   790   C0084682:sulfo-NHS-biotin [Organic Chemical]
   764   C0053654:NHS-biotin [Organic Chemical]
   764   C1143577:sulfo-NHS [Organic Chemical]
   742   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   742   C0007634:Cell [Cell]
   742   C0182400:Probe [Medical Device]
   742   C0796085:NHS [Congenital Abnormality,Disease or Syndrome]
   742   C1269647:Cell [Cell]
   742   C1417725:NHS [Gene or Genome]
   742   C1704653:Cell [Medical Device]
   742   C1704681:Probe [Gene or Genome]
   742   C1708632:Labeled [Qualitative Concept]
   742   C1948049:Cell [Spatial Concept]
   742   C2347609:Probe [Chemical Viewed Functionally]
   742   C2700256:Biotin [Laboratory Procedure]
   742   C3536729:Probe [Manufactured Object]
   708 E C0181496:Label [Manufactured Object]
   708 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.351: After incubation for 0(0h) or 4h (4h), the media were collected and subjected to precipitation with Neutravidin beads. 

Phrase: "After incubation"

Phrase: "for 0"

Phrase: "(0h"

Phrase: ")"

Phrase: "or"

Phrase: "4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: "(4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to precipitation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with Neutravidin beads."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]
Processing 00000000.tx.352: Precipitated proteins were to immunoblotted with 22C11. 

Phrase: "Precipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "immunoblotted with 22C11."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.353: Right panel, cells transfected with HA-APP alone or in combination with myc-tagged caveolin-1 were subjected to immunoprecipitation with CT-15, followed by immunoblotting with 22C11. 

Phrase: "Right panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with myc-tagged caveolin-1"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with CT-15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 22C11."
Processing 00000000.tx.354: The culture medium was then collected from these cells, immunoprecipitated with an anti-A-(1-28) antibody, and analyzed by Western blotting with 22C11. 

Phrase: "The culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "collected from these cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "immunoprecipitated with an anti-A-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with 22C11."
Processing 00000000.tx.355: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.356: 5B, APPs were detected in the media, and this immunoreactivity was abolished by preincubating the anti-A antibody with a synthetic peptide containing A residues 1-16. 

Phrase: "5B,"

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "were"

Phrase: "detected in the media,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0442726:Detected [Finding]
   770   C1254021:Media [Tissue]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "this immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "abolished by preincubating"

Phrase: "the anti-A antibody with a synthetic peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "A residues 1-16."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.357: In contrast, non-immune rabbit IgG did not immunoprecipitate a band corresponding to APPs. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "non-immune rabbit IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034493:Rabbit [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "a band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230715:A band [Cell Component]
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "corresponding to APPs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C3538722:APP [Laboratory Procedure]
Processing 00000000.tx.358: These results clearly indicate the APPs in the media are an end product of -secretase-processed APP. 

Phrase: "These results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "the APPs in the media"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C3538722:APP [Laboratory Procedure]

Phrase: "are"

Phrase: "an end product of -secretase-processed APP."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   835   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   835   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   822   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   820   C0033666:process protein [Molecular Function]
   812   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.359: The amount of APPs secreted into the media from cells transiently transfected with HA-APP and myc-tagged forms of caveolin-1 was compared (Fig. 5C). 

Phrase: "The amount of APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "secreted into the media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1327616:Secreted [Cell Function]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "from cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "myc-tagged forms of caveolin-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.360: Co-transfection of caveolin-1 with APP significantly increased the amount of APPs secreted into the media detected by 22C11 immunoblotting. 

Phrase: "Co-transfection of caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with APP significantly"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "secreted into the media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1327616:Secreted [Cell Function]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "detected by 22C11 immunoblotting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.361: In contrast, co-transfection with an internal deletion mutant of caveolin lacking the APP binding domain (caveolin-1-( 61-100)) failed to increase the amount of APP secreted into the media. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "co-transfection with an internal deletion mutant of caveolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the APP binding domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C1514535:Protein Binding Domain [Amino Acid Sequence]
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(caveolin-1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "( 61-100"

Phrase: ")"

Phrase: ")"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "secreted into the media."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1327616:Secreted [Cell Function]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.362: Immunoblots with 22C11 and myc antibodies showed similar expression levels of HA-APP and caveolin among the different transfectants. 

Phrase: "Immunoblots with 22C11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "and"

Phrase: "myc antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar expression levels of HA-APP"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1171362:expression protein [Genetic Function]
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "caveolin among the different transfectants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.363: These results establish that caveolin-1 overexpression promotes -secretase processing of APP and that the caveolin scaffolding domain is required for this effect. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that caveolin-1 overexpression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514559:Overexpression [Genetic Function]
   734   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332669:CAVEOLIN 1 [Gene or Genome]

Phrase: "promotes -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "secretase processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "that"

Phrase: "the caveolin scaffolding domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for this effect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1280500:Effect [Qualitative Concept]
   770   C1514873:Required [Functional Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.364: As caveolae represent a subcompartment of the plasma membrane, -secretase processing should be observed on the cell surface. 

Phrase: "As caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a subcompartment of the plasma membrane, -"

Phrase: "secretase processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "should"

Phrase: "be"

Phrase: "observed on the cell surface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.365: To investigate this possibility, we measured the amount of -secretase cleavage product of APP that was shed from the cell surface by exploiting the membrane-impermeant probe, sulfo-NHS-biotin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the amount of -secretase cleavage product of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0597304:Protein Cleavage [Molecular Function]
   739   C0010813:cleavage [Cell Function]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C1330957:cleavage [Cell Function]
   739   C1514468:product [Entity]
   739   C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "shed from the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "by exploiting"

Phrase: "the membrane-impermeant probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]

Phrase: "sulfo-NHS-biotin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0084682:sulfo-NHS-biotin [Organic Chemical]
   901   C0053654:NHS-biotin [Organic Chemical]
   827   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C2700256:Biotin [Laboratory Procedure]
   734   C1143577:sulfo-NHS [Organic Chemical]
Processing 00000000.tx.366: COS-7 cells were co-transfected with HA-APP and myc-tagged caveolin-1, subjected to cell surface biotinylation, and placed in fresh media for 4h. 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "myc-tagged caveolin-1,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   861   C1332669:CAVEOLIN 1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "subjected to cell surface biotinylation,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0525026:Biotinylation [Laboratory Procedure]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "placed in fresh media"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0443224:Fresh [Qualitative Concept]
   770   C1254021:Media [Tissue]
   770   C2827486:Fresh [Body Substance]
   737 E C0439536:Medium [Quantitative Concept]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737 E C1705217:Medium [Substance]
   737   C1882509:Place [Activity]
   737 E C3244283:medium [Intellectual Product]
   737   C3496241:place [Disease or Syndrome]

Phrase: "for 4h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292426:4H [Temporal Concept]
Processing 00000000.tx.367: The media were then collected, and cell surface biotinylated molecules were specifically recovered by incubating the media with Neutravidin beads. 

Phrase: "The media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "cell surface biotinylated molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "specifically"

Phrase: "recovered by incubating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0521108:recovered [Qualitative Concept]
   790   C1439852:incubating [Laboratory Procedure]
   756 E C2004454:recover [Organism Function]

Phrase: "the media with Neutravidin beads."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.368: After extensively washing the beads with buffer containing high salt and detergents, these samples were immunoblotted with 22C11. 

Phrase: "After"

Phrase: "extensively"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the beads with buffer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0991566:Beads [Biomedical or Dental Material]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "high salt"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0205250:High [Qualitative Concept]
   861   C0206136:Salt [Food,Inorganic Chemical]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]

Phrase: "and"

Phrase: "detergents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergents [Chemical Viewed Functionally]

Phrase: "these samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immunoblotted with 22C11."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.369: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.370: 5D (right panel), biotinylated APPs were only detected in the medium of cells co-transfected with APP and caveolin-1; 

Phrase: "5D"

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "biotinylated APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "detected in the medium of cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.371: in contrast, no biotinylated APPs were detected in the medium of cells transfected with APP alone (middle panel). 

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no biotinylated APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: "were"

Phrase: "detected in the medium of cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.372: Immunoblotting of these cell lysates confirmed that APP expression was similar in the presence or absence of caveolin transfection (left panel). 

Phrase: "Immunoblotting of these cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that APP expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "similar in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "absence of caveolin transfection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.373: These data indicate that APPs are created on the cell surface, and its production is dependent on caveolin expression, further supporting the hypothesis that caveolae organelles and the caveolin-1 protein play a pivotal role in -secretase-mediated APP degradation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "are"

Phrase: "created on the cell surface,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1706214:Created [Activity]
   760   C1948049:Cell [Spatial Concept]
   726 E C3244320:create [Functional Concept]

Phrase: "and"

Phrase: "its production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "dependent on caveolin expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that caveolae organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "and"

Phrase: "the caveolin-1 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332669:CAVEOLIN 1 [Gene or Genome]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a pivotal role in -secretase-mediated APP degradation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   849   C1327161:amyloid precursor protein degradation [Molecular Function]
   807   C0597297:Protein Degradation [Molecular Function]
   807   C0597304:Protein Degradation [Molecular Function]
   807   C1623036:Protein Degradation [Molecular Function]
   791   C0243125:degradation [Functional Concept]
   791   C0699900:Degradation [Organism Function]
Processing 00000000.tx.374: If caveolin-1 overexpression greatly promoted -secretase-mediated degradation of APP, loss of endogenous caveolin-1 expression should block the basal production of APPs. 

Phrase: "If"

Phrase: "caveolin-1 overexpression greatly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514559:Overexpression [Genetic Function]

Phrase: "promoted -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "secretase-mediated degradation of APP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1327161:amyloid precursor protein degradation [Molecular Function]
   774   C0597297:Protein Degradation [Molecular Function]
   774   C0597304:Protein Degradation [Molecular Function]
   774   C1623036:Protein Degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "loss of endogenous caveolin-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "should"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the basal production of APPs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.375: To examine if the expression of endogenous caveolin-1 is strictly required for this processing event, we introduced caveolin-1 antisense oligonucleotides to deplete the cells of endogenous caveolin-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "if"

Phrase: "the expression of endogenous caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "strictly"

Phrase: "required for this processing event,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0441471:Event [Event]
   760   C1514873:Required [Functional Concept]
   760   C1709694:Processing [Activity]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
   726 E C1522240:Process [Phenomenon or Process]

Phrase: "we"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "caveolin-1 antisense oligonucleotides to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "the cells of endogenous caveolin-1."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0007634:THE CELL [Cell]
           Cells
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.376: The caveolin-1 antisense oligonucleotide included the first 15bases of the 5'-coding sequence of the caveolin-1 gene. 

Phrase: "The caveolin-1 antisense oligonucleotide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the first 15bases of the 5'-coding sequence"

Phrase: "of the caveolin-1 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1707074:Caveolin-1 Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332669:CAVEOLIN 1 [Gene or Genome]
Processing 00000000.tx.377: This antisense oligonucleotide and the corresponding sense nucleotide were introduced into COS-7 cells by transient transfection in combination with HA-tagged APP. 

Phrase: "This antisense oligonucleotide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the corresponding sense nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "introduced into COS-7 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1292748:introduce [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with HA-tagged APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.378: The media were collected, and the amount of APPs produced was detected by immunoprecipitation with the anti-A-(1-28) antibody followed by Western blotting with 22C11. 

Phrase: "The media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the amount of APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "produced"

Phrase: "was"

Phrase: "detected by immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with the anti-A-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1-28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by Western blotting"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0332283:Followed by [Temporal Concept]
           followed
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with 22C11."
Processing 00000000.tx.379: Expression of endogenous caveolin-1 was virtually undetectable after transfection with the antisense oligonucleotide indicating that the synthesis of endogenous caveolin-1 was efficiently abrogated; 

Phrase: "Expression of endogenous caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "virtually undetectable after transfection"

Phrase: "with the antisense oligonucleotide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "indicating"

Phrase: "that"

Phrase: "the synthesis of endogenous caveolin-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "efficiently"

Phrase: "abrogated"

Phrase: ";"
Processing 00000000.tx.380: in contrast, the sense oligonucleotide had no effect on the expression of endogenous caveolin-1 (Fig. 6B). 

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the sense oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "no effect on the expression of endogenous caveolin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.381: Co-transfection with the antisense oligonucleotide decreased the amount of APPs produced and secreted to the media by more than 80% as compared with cells transfected with HA-APP alone (Fig. 6A). 

Phrase: "Co-transfection with the antisense oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the amount of APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "produced"

Phrase: "and"

Phrase: "secreted to the media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1327616:Secreted [Cell Function]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "by more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 80%"

Phrase: "as"

Phrase: "compared with cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1707455:Compared [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with HA-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.382: Accordingly, the amount of APPct produced was dramatically inhibited by co-transfection of HA-APP with the caveolin-1 antisense oligonucleotide, without affecting the production of intact APP (Fig. 6B). 

Phrase: "Accordingly,"

Phrase: "the amount of APPct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "produced"

Phrase: "was"

Phrase: "dramatically"

Phrase: "inhibited by co-transfection of HA-APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   742   C0311403:Inhibited [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "with the caveolin-1 antisense oligonucleotide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "without affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the production of intact APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.383: Importantly, co-transfection with the sense oligonucleotide had little or no effect on the production of APPs or APPct (Fig. 6, A and B). 

Phrase: "Importantly,"

Phrase: "co-transfection with the sense oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "had"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no effect on the production of APPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "APPct"

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.384: View larger version (22K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.385: 6.  

Phrase: "6."
Processing 00000000.tx.386: Ablation of caveolin-1 expression leads to inhibition of -secretase processing of APP. 

Phrase: "Ablation of caveolin-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0547070:Ablation [Therapeutic or Preventive Procedure]
   760   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "leads to inhibition of -secretase processing of APP."
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   799   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   799   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033666:protein processing [Molecular Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0181586:leads [Medical Device]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   739   C1522538:Lead [Functional Concept]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C1709694:Processing [Activity]
   739   C2348269:Lead [Element, Ion, or Isotope]
   739   C3275067:LEAD [Therapeutic or Preventive Procedure]
   739   C3463820:Inhibition [Activity]
Processing 00000000.tx.387: A, transfection with caveolin-1-derived antisense oligonucleotides decreases the amount of APPs that are shed into the media. 

Phrase: "A,"

Phrase: "transfection with caveolin-1-derived antisense oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the amount of APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "shed into the media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.388: COS-7 cells were transfected with 3g each of antisense caveolin-1 oligonucleotide and HA-APP695 cDNA using LipofectAMINE. 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 3g"

Phrase: "each of antisense caveolin-1 oligonucleotide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   790   C1332669:CAVEOLIN 1 [Gene or Genome]
   783   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1457900:Each [Quantitative Concept]

Phrase: "and"

Phrase: "HA-APP695 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LipofectAMINE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]
Processing 00000000.tx.389: Twelve hours later, the media were discarded and replaced with complete DMEM. 

Phrase: "Twelve hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "discarded"

Phrase: "and"

Phrase: "replaced with complete DMEM."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205197:Complete [Qualitative Concept]
   770   C0559956:Replaced [Functional Concept]
   770   C0725685:COMPLEAT [Food]
   770   C1299987:replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.390: 48h post-transfection, the medium was harvested, mixed with 2 RIPA buffer, and subjected to immunoprecipitation with an anti-A polyclonal antibody or 1153.

Phrase: "48h post-transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442464:48H [Temporal Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "mixed with 2 RIPA buffer,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0034584:RIPA [Laboratory Procedure]
   760   C0205430:Mixed [Functional Concept]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with an anti-A polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "1153."
Processing 00000000.tx.391: Each of the final samples was subjected to immunoblot analysis with 22C11, and positive bands were visualized with ECL-Plus. 

Phrase: "Each of the final samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205088:Final [Temporal Concept]
   760   C1457900:Each [Quantitative Concept]
   760   C1546485:Final [Idea or Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with 22C11,"

Phrase: "and"

Phrase: "positive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized with ECL-Plus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0234621:Visualized [Functional Concept]
   770   C0332287:Plus [Qualitative Concept]
   770   C1332684:ECL [Gene or Genome]
Processing 00000000.tx.392: Lane 1, no oligonucleotide transfection; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "no oligonucleotide transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: ";"
Processing 00000000.tx.393: lane 2, sense oligonucleotide transfection; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "sense oligonucleotide transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: ";"
Processing 00000000.tx.394: lane 3, antisense oligonucleotide transfection. 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "antisense oligonucleotide transfection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   734   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.395: B, transfection with caveolin-1-derived antisense oligonucleotides decreases the amount of C-terminal APP fragment within cell lysates. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "transfection with caveolin-1-derived antisense oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the amount of C-terminal APP fragment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "within cell lysates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.396: COS-7 cells were transfected with the following: lane 1, no oligonucleotides; 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the following"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0332283:follow [Temporal Concept]
   737   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "no oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.397: lane 2, a caveolin-1 sense oligonucleotide; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "a caveolin-1 sense oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.398: and lane 3, a caveolin-1 antisense oligonucleotide. 

Phrase: "and"

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "a caveolin-1 antisense oligonucleotide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079925:antisense oligonucleotide [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.399: Cell lysates were prepared and subjected to immunoblot analysis with anti-APP C-terminal antibody (AC-1) (left panel) or anti-caveolin monoclonal antibody (2234) (right panel).  

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with anti-APP C-terminal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   845   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(AC-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: ")"

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "anti-caveolin monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "(2234"

Phrase: ")"

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.400: DISCUSSION Top Abstract Introduction Procedures Results Discussion References We have presented several independent lines of evidence that APP localizes within caveolae membranes and interacts directly with caveolin-1, a principal structural component of caveolae. 

Phrase: "DISCUSSION Top Abstract Introduction Procedures Results Discussion"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "several independent lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "localizes within caveolae membranes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   775   C1167209:caveolar membrane [Cell Component]
   770   C0025255:Membranes [Tissue]
   770   C0230653:Caveolae [Cell Component]
   770   C0392752:localize [Spatial Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "interacts"

Phrase: "directly with caveolin-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   833   C1332669:CAVEOLIN 1 [Gene or Genome]
   770   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1947931:Directly [Qualitative Concept]

Phrase: "a principal structural component of caveolae."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1882460:Principal Component [Quantitative Concept]
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.401: More specifically, we have shown that (i) APP and caveolin-1 co-fractionate when cells are subjected to two independent detergent-free subcellular fractionation protocols previously used to purify caveolae from cultured cells; 

Phrase: "More specifically,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "(i) APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "co-fractionate"

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to two independent detergent-free subcellular fractionation protocols previously"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   791   C0442711:Protocols [Intellectual Product]
   758 E C1507394:Protocol [Intellectual Product]
   758 E C1522729:Protocol [Intellectual Product]
   758 E C2348563:Protocol [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "caveolae from cultured cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0230653:Caveolae [Cell Component]

Phrase: ";"
Processing 00000000.tx.402: (ii) APP and caveolin-1 can form a physical complex in intact cells as shown by chemical cross-linking and co-immunoprecipitation experiments; 

Phrase: "(ii"

Phrase: ")"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a physical complex in intact cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "as"

Phrase: "shown by chemical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220806:Chemical [Chemical]
   790   C3272558:Chemical [Intellectual Product]
   756   C1547282:Show [Intellectual Product]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "co-immunoprecipitation experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.403: (iii) association of APP with caveolin-1 occurs via a direct interaction between the C-terminal cytoplasmic domain of APP and the caveolin-1 scaffolding domain; 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "association of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with caveolin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "occurs via a direct interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439851:Direct [Qualitative Concept]
   760   C1704675:Interaction [Functional Concept]
   760   C1709305:Occur [Activity]
   760   C1947931:Direct [Qualitative Concept]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "between the C-terminal cytoplasmic domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1511625:Cytoplasmic Domain [Cell Component]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "the caveolin-1 scaffolding domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.404: (iv) cell surface caveolae contain APP; 

Phrase: "(iv) cell surface caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0230653:Caveolae [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.405: (v) the characteristic C-terminal fragment that results from APP processing by -secretase was also localized within caveolae; 

Phrase: "(v)"

Phrase: "the characteristic C-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that results from APP processing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "by -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "also"

Phrase: "localized within caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C0392752:Localized [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.406: (vi) -secretase processing was significantly promoted by recombinant overexpression of caveolin-1 in intact cells, resulting in increased secretion of the soluble extracellular domain of APP; 

Phrase: "(vi) -secretase processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "significantly"

Phrase: "promoted by recombinant overexpression of caveolin-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   778   C1332669:CAVEOLIN 1 [Gene or Genome]
   748   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1514559:Overexpression [Genetic Function]
   748   C1514798:recombinant [Organism]
   714   C0033414:Promote [Activity]

Phrase: "in intact cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "resulting in increased secretion of the soluble extracellular domain of APP"
Meta Candidates (Total=29; Excluded=3; Pruned=0; Remaining=26)
   766   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   766   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   750   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0332294:Resulting in [Functional Concept]
   750   C1517050:Extracellular Domain [Spatial Concept]
   749   C0162808:Protein Domain [Spatial Concept]
   749   C1159339:Protein Secretion [Cell Function]
   749   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   749   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   749   C1514562:Protein Domain [Amino Acid Sequence]
   735   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0011560:Amyloid [Pathologic Function]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0036536:secretion [Biologic Function]
   735   C0036537:Secretion [Body Substance]
   735   C0205217:Increased [Quantitative Concept]
   735   C0442805:Increased [Functional Concept]
   735   C0521119:Extracellular [Cell Component]
   735   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0678226:resulting [Functional Concept]
   735   C1709634:Precursor [Idea or Concept]
   735   C1749467:soluble [Cell Component]
   735   C1880389:Domain [Functional Concept]
   735   C1883221:Domain [Conceptual Entity]
   735   C1948047:Soluble [Qualitative Concept]
   735   C3541951:Domain [Intellectual Product]
   702 E C1274040:Result [Functional Concept]
   702 E C1546471:Result [Idea or Concept]
   702 E C2825142:Result [Finding]

Phrase: ";"
Processing 00000000.tx.407: and (vii) depletion of endogenous caveolin-1 using antisense oligonucleotides prevented this cleavage event. 

Phrase: "and ("

Phrase: "vii"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445385:VII [Intellectual Product]

Phrase: ")"

Phrase: "depletion of endogenous caveolin-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333668:Depletion [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisense oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "this cleavage event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]
Processing 00000000.tx.408: It is therefore likely that a physical interaction between APP and caveolin-1 functionally sequesters APP within caveolae membranes and thereby compartmentalizes the -secretase-mediated proteolysis of APP. 

Phrase: "It"

Phrase: "is"

Phrase: "therefore likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "a physical interaction between APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1167622:Physical Interaction [Molecular Function]
   774   C0872079:interaction protein [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "caveolin-1 functionally"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "sequesters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "APP within caveolae membranes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "compartmentalizes"

Phrase: "the -secretase-mediated proteolysis of APP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597304:Proteolysis [Molecular Function]
Processing 00000000.tx.409: The caveolin-1 region that interacts with APP includes the caveolin scaffolding domain, a short stretch of 20amino acids that directly participate in the recognition of multiple classes of signaling molecules. 

Phrase: "The caveolin-1 region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
   734   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332669:CAVEOLIN 1 [Gene or Genome]

Phrase: "that"

Phrase: "interacts with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the caveolin scaffolding domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "a short stretch of 20amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "that directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "participate in the recognition of multiple classes of signaling molecules."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   743   C1519315:Signaling Molecule [Biologically Active Substance]
   739   C0037083:Signaling [Cell Function]
   739   C0439064:Multiple [Quantitative Concept]
   739   C0456387:Class [Intellectual Product]
   739   C0524637:Recognition [Mental Process]
   739   C0567416:molecules [Substance]
   739   C1705943:Class [Classification]
   739   C3537152:signaling [Biologic Function]
   716   C0599844:molecular recognition [Molecular Function]
   706 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.410: Recent evidence suggests that the caveolin scaffolding domain functions as a modular protein domain that interacts with peptide and protein ligands that contain a specific caveolin binding motif (28). 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the caveolin scaffolding domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "functions as a modular protein domain"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0162808:Protein Domain [Spatial Concept]
   790   C1514562:Protein Domain [Amino Acid Sequence]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "interacts with peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "protein ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a specific caveolin binding motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.411: APP contains a predicted caveolin binding motif within its C-terminal cytoplasmic tail. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a predicted caveolin binding motif within its C-terminal cytoplasmic tail."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.412: It is likely that this sequence is recognized by the caveolin scaffolding domain and functions to sequester APP within caveolae microdomains. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "this sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "recognized by the caveolin scaffolding domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0337143:scaffolding [Manufactured Object]
   753   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "functions to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0031843:function [Physiologic Function]
   833   C0542341:Function [Functional Concept]
   833   C0700205:FUNCTION [Classification]
   833   C1705273:Function [Intellectual Product]

Phrase: "sequester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "APP within caveolae microdomains."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.413: Cholesterol and sphingolipids are highly concentrated with caveolae domains. 

Phrase: "Cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "sphingolipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037900:Sphingolipids [Lipid]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "concentrated with caveolae domains."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0230653:Caveolae [Cell Component]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1880310:Concentrate [Manufactured Object]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737 E C2003864:Concentrate [Substance]
   737   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.414: Recent findings indicate that transport of newly synthesized cholesterol from the endoplasmic reticulum to the plasma membrane is mediated via caveolin proteins (52, 53). 

Phrase: "Recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that transport of newly synthesized cholesterol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1159709:cholesterol transport [Cell Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "from the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "to the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "mediated via caveolin proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0887901:Caveolin Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0379710:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(52,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.415: In addition, caveolin-1 directly binds cholesterol, and cholesterol is required for the insertion of recombinant caveolin-1 into model lipid membranes (54, 55). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "caveolin-1 directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   901   C1332669:CAVEOLIN 1 [Gene or Genome]
   827   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1947931:Directly [Qualitative Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "cholesterol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "is"

Phrase: "required for the insertion of recombinant caveolin-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
   770   C1332669:CAVEOLIN 1 [Gene or Genome]
   744   C0021107:Insertion [Therapeutic or Preventive Procedure]
   744   C0441587:Insertion [Health Care Activity]
   744   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1512796:Insertion [Genetic Function]
   744   C1514798:recombinant [Organism]
   744   C1514873:Required [Functional Concept]
   744   C1883719:Insertion [Functional Concept]

Phrase: "into model lipid membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.416: There are several links between cholesterol metabolism and the pathogenesis of Alzheimer's disease. 

Phrase: "There"

Phrase: "are"

Phrase: "several links between cholesterol metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the pathogenesis of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.417: Cholesterol affects APP processing by interfering with the activity of -secretase (56). 

Phrase: "Cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP processing by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0033666:protein processing [Molecular Function]
   760   C1709694:Processing [Activity]

Phrase: "interfering with the activity of -secretase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0521102:interfering [Qualitative Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.418: An isoform of a major cholesterol carrier protein, apoE, is a genetic risk factor for Alzheimer's disease (57). 

Phrase: "An isoform of a major cholesterol carrier protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform

Phrase: "apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "a genetic risk factor for Alzheimer's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0814299:factor genetic risk [Qualitative Concept]
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.419: Thus, these links to cholesterol metabolism may simply reflect the caveolar localization of APP. 

Phrase: "Thus,"

Phrase: "these links to cholesterol metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "may"

Phrase: "simply"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the caveolar localization of APP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597704:protein localisation [Cell Function]
   774   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.420: The processing of APP has been intensively studied since the APP molecule was first identified. 

Phrase: "The processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "intensively"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "since"

Phrase: "the APP molecule"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0567416:Molecule [Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   741 E C1521991:Molecular [Qualitative Concept]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.421: Normal processing of APP occurs at the so-called -site by -secretase, which generates a non-amyloidogenic extracellular domain of APP (APPs) (3, 58). 

Phrase: "Normal processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "occurs at the so-called -site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C2825164:Site [Spatial Concept]
   719   C0679006:Call [Mental Process]
   719   C1947967:Call [Functional Concept]

Phrase: "by -secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "generates"

Phrase: "a non-amyloidogenic extracellular domain of APP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1517050:Extracellular Domain [Spatial Concept]
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0521119:Extracellular [Cell Component]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "(APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.422: This processing event makes the extracellular domain of APP containing a Kunitz-type protease inhibitor available in the extracellular space. 

Phrase: "This processing event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the extracellular domain of APP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1517050:Extracellular Domain [Spatial Concept]
   774   C0162808:Protein Domain [Spatial Concept]
   774   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1514562:Protein Domain [Amino Acid Sequence]
   748   C0521119:Extracellular [Cell Component]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a Kunitz-type protease inhibitor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   861   C3536890:Protease Inhibitor [Pharmacologic Substance]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Protease [Enzyme]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "available in the extracellular space."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]
Processing 00000000.tx.423: This protease inhibitor activity is thought to prevent thrombin from injuring neurons (59, 60). 

Phrase: "This protease inhibitor activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1152582:protease inhibitor activity [Molecular Function]
   913   C1150095:protease activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "thrombin from injuring neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(59,"

Phrase: "60"

Phrase: ")."
Processing 00000000.tx.424: In addition, -secretase is a target for the development of potential agents for the treatment of Alzheimer's disease, as -secretase may cleave and solubilize A amyloid peptide, a major insoluble component of the senile plaque. 

Phrase: "In addition, -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a target for the development of potential agents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1521840:Target [Functional Concept]
   744   C2986546:TARGET [Diagnostic Procedure]

Phrase: "for the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "as -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "cleave"

Phrase: "and"

Phrase: "solubilize"

Phrase: "A amyloid peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a major insoluble component of the senile plaque."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.425: Recently, it has been reported that APPs activate microglial cells and thereby enhance the local release of neurotoxic agents (61). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "microglial cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0206116:Microglial cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the local release of neurotoxic agents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.426: Therefore, APPs possess a broad range of biological effects. 

Phrase: "Therefore,"

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a broad range of biological effects."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]
Processing 00000000.tx.427: As our current evidence suggests that APP is processed at its -site within caveolae membranes, this may help in the identification and cloning of the protein or proteins that possess -secretase activity. 

Phrase: "As our current evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "processed at its -site"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C1522240:Processed [Phenomenon or Process]
   770   C2825164:Site [Spatial Concept]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "within caveolae membranes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   941   C1167209:caveolar membrane [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "this"

Phrase: "may"

Phrase: "help in the identification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018896:Help [Social Behavior]
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]
   770   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "cloning of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009015:Cloning [Research Activity]

Phrase: "or"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "possess -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.428: Several previous reports support the view that -secretase-mediated cleavage of APP occurs on the cell surface (62-65). 

Phrase: "Several previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0684224:Reports [Intellectual Product]
   827   C0700287:reports [Health Care Activity]
   793 E C3273238:Report [Intellectual Product]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that -secretase-mediated cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597304:Protein Cleavage [Molecular Function]
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "occurs on the cell surface"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1709305:Occur [Activity]
   760   C1948049:Cell [Spatial Concept]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "(62-65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.429: These observations fit well with our current findings that APP is processed at its -site within caveolae, as caveolae are specialized microdomains of plasma membrane. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "well with our current findings"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0205170:Well [Qualitative Concept]
   760   C0521116:Current [Temporal Concept]
   760   C1705970:Current [Natural Phenomenon or Process]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3146287:Well [Manufactured Object]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "processed at its -site"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C1522240:Processed [Phenomenon or Process]
   770   C2825164:Site [Spatial Concept]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "within caveolae,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "as"

Phrase: "caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "are"

Phrase: "specialized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205555:specialized [Qualitative Concept]
  1000   C1704211:Specialized [Conceptual Entity]

Phrase: "microdomains of plasma membrane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C0887868:Membrane Microdomains [Cell Component]
Processing 00000000.tx.430: APP requires membrane anchoring for its cleavage by -secretase suggesting that the protease itself is a membrane-anchored protein (64). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "requires"

Phrase: "membrane anchoring for its cleavage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1293132:Anchoring [Therapeutic or Preventive Procedure]
   760   C1624581:anchoring [Molecular Function]

Phrase: "by -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "itself"

Phrase: "is"

Phrase: "a membrane-anchored protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.431: Interestingly, caveolae have been reported to contain a protease activity (66). 

Phrase: "Interestingly,"

Phrase: "caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a protease activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150095:protease activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(66"

Phrase: ")."
Processing 00000000.tx.432: The cleavage mechanism for APP may be similar to that of other proteolytic activities known to cleave a number of single membrane-spanning precursors (tumor necrosis factor and notch) at the cell surface to release their ectodomains to the media (67). 

Phrase: "The cleavage mechanism for APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "similar to that of other proteolytic activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "a number of single membrane-spanning precursors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "(tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: ")"

Phrase: "at the cell surface to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0699040:Cell surface [Cell Component]
   827   C0205148:Surface [Spatial Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "their ectodomains to the media"

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.433: -Secretase cleavage can also occur intracellularly (68-70). 

Phrase: "-Secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "can"

Phrase: "also"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "intracellularly"

Phrase: "(68-70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.434: Therefore, a second mechanism should exist that involves an intracellular compartment that may be independent of plasma membrane caveolae. 

Phrase: "Therefore,"

Phrase: "a second mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "should"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "that"

Phrase: "involves"

Phrase: "an intracellular compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "that"

Phrase: "may"

Phrase: "be independent of plasma membrane caveolae."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0007603:Plasma membrane [Cell Component]
   790   C0332291:Independent of [Functional Concept]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0085862:Independent [Idea or Concept]
   753   C0230653:Caveolae [Cell Component]
   753   C0596901:Membrane [Cell Component]
   753   C1299583:Independent [Finding]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]
   753   C2987476:Be [Conceptual Entity]
   742   C1167209:caveolar membrane [Cell Component]
Processing 00000000.tx.435: Alternatively, this phenomenon may be explained by the presence of intracellular forms of caveolae, i.e. plasmalemmal vesicles. 

Phrase: "Alternatively,"

Phrase: "this phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the presence of intracellular forms of caveolae,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C0230653:Caveolae [Cell Component]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   708 E C1522492:Form [Functional Concept]

Phrase: "i.e. plasmalemmal vesicles."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0598070:plasmalemmal vesicle [Cell Component]
   812   C0333262:VESICLES [Acquired Abnormality]
   779 E C1622418:vesicle [Cell Component]
   741   C0007603:Plasmalemma [Cell Component]
   729 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.436: In our experiments, we could not detect a cell surface cleavage product of APP in cells that were singly transfected with APP (Fig. 5D); 

Phrase: "In our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a cell surface cleavage product of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0597304:Protein Cleavage [Molecular Function]
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "singly"

Phrase: "transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 5D"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.437: in contrast, in cells co-transfected with APP and caveolin-1, APPs were produced at the cell surface. 

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "caveolin-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "were"

Phrase: "produced at the cell surface."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.438: Overall cleavage of APP by -secretase may be modulated by the cycle of caveolae internalization and recycling (APP could cycle between cell surface and intracellular populations of caveolae). 

Phrase: "Overall cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "by -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "modulated by the cycle of caveolae internalization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0230653:Caveolae [Cell Component]
   748   C0443264:Modulated [Spatial Concept]
   748   C0871786:internalization [Mental Process]
   748   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "recycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "could"

Phrase: "cycle between cell surface"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0007586:Cell Cycle [Cell Function]
   819   C1155839:Cell Cycle [Cell Function]
   770   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "intracellular populations of caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: ")."
Processing 00000000.tx.439: The -secretase cleavage occurs not only at Leu17 but also at Val18 in the amyloid peptide (3), suggesting the existence of multiple -secretases. 

Phrase: "The -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "not only at Leu17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also at Val18"

Phrase: "in the amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of multiple -secretases."
Processing 00000000.tx.440: Thus, caveolae and an undefined intracellular compartment may possess different -secretases that cleave APP at distinct -sites. 

Phrase: "Thus,"

Phrase: "caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "and"

Phrase: "an undefined intracellular compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "may"

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "different -secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "cleave"

Phrase: "APP at distinct -sites."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.441: Protein kinase C activation promotes the -secretase-mediated processing of APP (71), by an unknown molecular mechanism. 

Phrase: "Protein kinase C activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   844   C1326120:cell activation [Cell Function]
   812   C1879547:Activation [Activity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the -secretase-mediated processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0033666:protein processing [Molecular Function]
   744   C1709694:Processing [Activity]

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "by an unknown molecular mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.442: Since this PKC is a well established component of caveolae (72) and PKC activators inhibit caveolae internalization (potocytosis) (73), it is possible that PKC activation prolongs the amount of time APP spends in cell surface caveolae and therefore in close contact with -secretase activity. 

Phrase: "Since"

Phrase: "this PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "is"

Phrase: "a well established component of caveolae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(72"

Phrase: ")"

Phrase: "and"

Phrase: "PKC activators"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "caveolae internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: "(potocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598721:potocytosis [Cell Function]

Phrase: ")"

Phrase: "(73"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that PKC activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3546691:PKC activation [Molecular Function]
   861   C1879547:Activation [Activity]

Phrase: "prolongs"

Phrase: "the amount of time APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "spends"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680968:spend [Quantitative Concept]

Phrase: "in cell surface caveolae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0230653:Caveolae [Cell Component]

Phrase: "and"

Phrase: "therefore in close contact"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332158:contact [Functional Concept]
   770   C0337611:Contact [Population Group]
   770   C0587267:Close [Functional Concept]
   770   C1705415:Contact [Idea or Concept]

Phrase: "with -secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.443: APP is known to transit through clathrin-coated pits and vesicles on its way to endosomes and lysosomes (74). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transit through clathrin-coated pits"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0598180:COATED PITS [Cell Component]
   790   C1166872:clathrin coat [Cell Component]
   773 E C1167211:coated pit [Cell Component]
   760   C0008905:Clathrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1301827:transit [Functional Concept]
   760   C1522408:Coated [Qualitative Concept]
   726   C0175697:PIT [Congenital Abnormality,Disease or Syndrome]
   726 E C0453946:Coat [Manufactured Object]
   726   C2697656:PIT [Gene or Genome]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
   704 E C0332467:Indented [Spatial Concept]

Phrase: "and"

Phrase: "vesicles on its way"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: "to endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(74"

Phrase: ")."
Processing 00000000.tx.444: Recent findings suggest a number of signaling receptors that are cleared from the cell surface via clathrin-coated pits are first present within caveolae microdomains (15, 21, 75). 

Phrase: "Recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a number of signaling receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "cleared from the cell surface"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   781   C0229473:Clear cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0521097:cleared [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C2963144:Clear [Qualitative Concept]

Phrase: "via clathrin-coated pits"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   901   C0598180:COATED PITS [Cell Component]
   884   C1166872:clathrin coat [Cell Component]
   867 E C1167211:coated pit [Cell Component]
   827   C0008905:Clathrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522408:Coated [Qualitative Concept]
   793   C0175697:PIT [Congenital Abnormality,Disease or Syndrome]
   793 E C0453946:Coat [Manufactured Object]
   793   C2697656:PIT [Gene or Genome]
   793 E C2987482:Coat [Body Part, Organ, or Organ Component]
   771 E C0332467:Indented [Spatial Concept]
   743 E C0205323:Pitting [Functional Concept]
   743 E C1882401:PITTED [Event]

Phrase: "are"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "present within caveolae microdomains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0230653:Caveolae [Cell Component]
   770   C0449450:Present [Idea or Concept]

Phrase: "(15,"

Phrase: "21,"

Phrase: "75"

Phrase: ")."
Processing 00000000.tx.445: In fact, internalized caveolae microdomains and clathrin-coated vesicles may be targeted to a common endosomal pool (77). 

Phrase: "In fact,"

Phrase: "internalized caveolae microdomains"

Phrase: "and"

Phrase: "clathrin-coated vesicles"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0887885:Clathrin-Coated Vesicles [Cell Component]
   901   C0242915:Coated Vesicles [Cell Component]
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]
   717   C1166872:clathrin coat [Cell Component]

Phrase: "may"

Phrase: "be"

Phrase: "targeted to a common endosomal pool"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0205214:Common [Quantitative Concept]
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C1521840:Targeted [Functional Concept]
   753   C1522138:Common [Functional Concept]
   753   C2349200:Pool [Functional Concept]
   753   C3245511:common [Intellectual Product]
   719 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "(77"

Phrase: ")."
Processing 00000000.tx.446: This scenario would provide two distinct mechanisms for clearing signaling receptors from the cell surface. 

Phrase: "This scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "would"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "two distinct mechanisms for clearing signaling receptors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "from the cell surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.447: In fact, APPct was reported to be enriched in lysosomes (62). 

Phrase: "In fact,"

Phrase: "APPct"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "enriched in lysosomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0024369:Lysosomes [Cell Component]
   790   C0359583:enriched [Food]
   756 E C2984253:Lysosome [Functional Concept]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.448: It therefore is likely that APP is first present within caveolae where -secretase processing takes place, whereas the remaining intact APP may be cleared from the cell surface via clathrin-coated pits and targeted to endosomes and lysosomes for proteolytic processing. 

Phrase: "It therefore"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "present within caveolae where -secretase processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0150312:Present [Quantitative Concept]
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0230653:Caveolae [Cell Component]
   753   C0449450:Present [Idea or Concept]
   753   C1709694:Processing [Activity]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "whereas"

Phrase: "the remaining intact APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "cleared from the cell surface"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0699040:Cell surface [Cell Component]
   781   C0229473:Clear cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0521097:cleared [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C2963144:Clear [Qualitative Concept]

Phrase: "via clathrin-coated pits"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   901   C0598180:COATED PITS [Cell Component]
   884   C1166872:clathrin coat [Cell Component]
   867 E C1167211:coated pit [Cell Component]
   827   C0008905:Clathrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522408:Coated [Qualitative Concept]
   793   C0175697:PIT [Congenital Abnormality,Disease or Syndrome]
   793 E C0453946:Coat [Manufactured Object]
   793   C2697656:PIT [Gene or Genome]
   793 E C2987482:Coat [Body Part, Organ, or Organ Component]
   771 E C0332467:Indented [Spatial Concept]
   743 E C0205323:Pitting [Functional Concept]
   743 E C1882401:PITTED [Event]

Phrase: "and"

Phrase: "targeted to endosomes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "lysosomes for proteolytic processing."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0024369:Lysosomes [Cell Component]
   737 E C2984253:Lysosome [Functional Concept]
Processing 00000000.tx.449: Caveolae-like membrane domains exist in neuronal cells and have been characterized by a number of independent laboratories (13, 75, 78). 

Phrase: "Caveolae-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230653:Caveolae [Cell Component]

Phrase: "like membrane domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "exist in neuronal cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C2987476:Exist [Conceptual Entity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "characterized by a number of independent laboratories"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   774   C0332291:Independent of [Functional Concept]
   748   C0022877:Laboratories [Manufactured Object,Organization]
   748   C0085862:Independent [Idea or Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1299583:Independent [Finding]
   748   C1619828:Laboratories [Intellectual Product]
   748   C1880022:Characterized [Activity]
   714 E C3244292:laboratory [Functional Concept]

Phrase: "(13,"

Phrase: "75,"

Phrase: "78"

Phrase: ")."
Processing 00000000.tx.450: In addition, Allinquant and co-workers (13) provided preliminary evidence that axonal APP is concentrated within caveolae-like structures in neurons. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Allinquant"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(13"

Phrase: ")"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "preliminary evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that axonal APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "concentrated within caveolae-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0230653:Caveolae [Cell Component]
   790   C1880165:Concentrated [Biomedical or Dental Material]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.451: Thus, it is likely that a neuron-specific form of caveolin may exist that promotes caveolae formation in neuronal cells and interacts with neuronally expressed APP. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "a neuron-specific form of caveolin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "may"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "caveolae formation in neuronal cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2753910:caveola formation [Cell Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "interacts with neuronally expressed APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.452: In Alzheimer's disease, caveolae dysfunction may cause reduced activity of -secretase and accumulation of toxic A amyloid peptide.  

Phrase: "In Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "caveolae dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "reduced activity of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "accumulation of toxic"

Phrase: "A amyloid peptide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.453: ACKNOWLEDGEMENTS We thank Y.Sakaki for the gift of APP cDNAs and Sangram S.

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Y.Sakaki for the gift of APP cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1207167:sakaki [Plant]

Phrase: "and"

Phrase: "Sangram S."
Processing 00000000.tx.454: Sisodia, Samuel E.Gandy, Richard W.Scott, Kazuaki Yoshikawa for generously donating APP antibodies.  

Phrase: "Sisodia,"

Phrase: "Samuel E.Gandy,"

Phrase: "Richard W.Scott,"

Phrase: "Kazuaki Yoshikawa for generously"

Phrase: "donating"

Phrase: "APP antibodies."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   844   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.455: FOOTNOTES * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.456: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.457: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.458: This work was supported in part by United States Public Health Service Grant MH56036 (to T.O.).  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by United States Public Health Service Grant MH56036"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   747   C0041734:United States Public Health Service [Health Care Related Organization]

Phrase: "("

Phrase: "to T.O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.459: Fellow of Japan Society for the Promotion of Science for Research Abroad. 

Phrase: "Fellow of Japan Society"

Phrase: "for the Promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "for Research Abroad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
Processing 00000000.tx.460: Supported by National Institutes of Health FIRST Award GM-50443 (to M.P.L.), a grant from the G.Harold and Leila Y.

Phrase: "Supported by National Institutes of Health FIRST Award GM-50443"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   760   C1517195:FIRST Award [Governmental or Regulatory Activity]
   739   C0004446:Award [Manufactured Object]
   739   C0018684:Health [Idea or Concept]
   739   C0021622:Institutes [Organization]
   739   C0205435:First [Quantitative Concept]
   739   C0546866:GM [Antibiotic,Carbohydrate]
   739   C1279901:First [Qualitative Concept]
   739   C1521721:Supported [Conceptual Entity]
   739   C3245503:national [Intellectual Product]
   706 E C0183683:Support [Medical Device]
   706 E C1272753:Institute [Idea or Concept]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "P.L."

Phrase: ")"

Phrase: ","

Phrase: "a grant from the G.Harold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018173:Grant [Quantitative Concept]
   753   C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "Leila Y."
Processing 00000000.tx.461: Mathers Charitable Foundation (to M.P.L.), and Scholarship in the Medical Sciences from the Charles E.

Phrase: "Mathers Charitable Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "P.L."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Scholarship in the Medical Sciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036365:scholarship [Idea or Concept]

Phrase: "from the Charles E."
Processing 00000000.tx.462: Culpeper Foundation (to M.P.L.). 

Phrase: "Culpeper Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "P.L."

Phrase: ")."
Processing 00000000.tx.463: ** To whom correspondence should be addressed: NC30, Cleveland Clinic Foundation, 9500Euclid Ave., Cleveland, OH 44195.Tel.: 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "NC30,"

Phrase: "Cleveland Clinic Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "9500Euclid Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44195.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.464: 216-444-3592; 

Phrase: "216-444-3592"

Phrase: ";"
Processing 00000000.tx.465: Fax: 216-444-7927; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "216-444-7927"

Phrase: ";"
Processing 00000000.tx.466: E-mail: okamott{at}cesmtp.ccf.org . 1 The abbreviations used are: APP, amyloid precursor protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "okamott{at}cesmtp.ccf.org . 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0009081:CCF [Congenital Abnormality]
   799   C0018802:ccf [Disease or Syndrome]
   799   C1522486:ORG [Professional or Occupational Group]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.467: GST, glutathione S-transferase; 

Phrase: "GST,"

Phrase: "glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.468: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.469: RT, room temperature; 

Phrase: "RT,"

Phrase: "room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.470: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.471: DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.472: HA, hemagglutinin; 

Phrase: "HA,"

Phrase: "hemagglutinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.473: Mes, 4-morpholineethanesulfonic acid; 

Phrase: "Mes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265215:MES [Congenital Abnormality]
  1000   C1417092:MES [Gene or Genome]

Phrase: "4-morpholineethanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.474: MBS, Mes-buffered saline; 

Phrase: "MBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036082:Saline [Substance]

Phrase: "Mes-buffered saline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036082:Saline [Substance]

Phrase: ";"
Processing 00000000.tx.475: MDCK, Madin-Darby canine kidney cells; 

Phrase: "MDCK,"

Phrase: "Madin-Darby canine kidney cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C0598829:Madin Darby Canine Kidney Cells [Cell]
   823   C0553257:kidney cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0012984:Canine, NOS [Mammal]
   804   C0022646:Kidney [Body Part, Organ, or Organ Component]
   804   C0227665:kidney [Body Part, Organ, or Organ Component]
   804   C1278978:Kidney [Body Part, Organ, or Organ Component]
   804   C1280551:Canine [Mammal]
   804   C1514845:KIDNEY [Tissue]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   711 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.476: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.477: TBS, Tris-buffered saline; 

Phrase: "TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.478: NTA, nitrilotriacetic acid; 

Phrase: "NTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028132:NTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "nitrilotriacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028132:Nitrilotriacetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.479: CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.  

Phrase: "CHAPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   966 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "["

Phrase: "(3-cholamidopropyl"

Phrase: ")"

Phrase: "dimethylammonio"

Phrase: "]-1-propanesulfonic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.480: REFERENCES Top Abstract Introduction Procedures Results Discussion References Selkoe, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Procedures Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.481: J. 

Phrase: "J."
Processing 00000000.tx.482: (1989) Cell 58, 611-612[Medline] [OrderarticleviaInfotrieve] Kang, J., Lemaire, H. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 58,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "611-612"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kang,"

Phrase: "J.,"

Phrase: "Lemaire,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.483: G., Unterbeck, A., Salbaum, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "Salbaum,"

Phrase: "J."
Processing 00000000.tx.484: M., Masters, C. 

Phrase: "M."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.485: L., Grzeschik, K. 

Phrase: "L., Grzeschik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.486: H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Muller-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.487: (1987) Nature 325, 733-736[CrossRef][Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 325,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "733-736"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.488: J. 

Phrase: "J."
Processing 00000000.tx.489: (1994) Annu. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.490: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.491: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.492: 10, 373-403[CrossRef] Sisodia, S. 

Phrase: "10,"

Phrase: "373-403"

Phrase: "[CrossRef"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.493: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.494: H., Beyreuther, K., Unterbeck, A., and Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.495: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.496: (1990) Science 248, 492-495[Medline] [OrderarticleviaInfotrieve] van Duijn, C. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "492-495"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] van Duijn,"

Phrase: "C."
Processing 00000000.tx.497: M., Hendriks, L., Cruts, M., Hardy, J. 

Phrase: "M."

Phrase: ","

Phrase: "Hendriks,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.498: A., Hofman, A., and Van Broeckhoven, C. 

Phrase: "A.,"

Phrase: "Hofman,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.499: (1991) Lancet 337, 978[Medline] [OrderarticleviaInfotrieve] Nishimoto, I., Okamoto, T., Matsuura, Y., Okamoto, T., Murayama, Y., and Ogata, E. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Lancet 337,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "978"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nishimoto,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsuura,"

Phrase: "Y.,"

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murayama,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Ogata,"

Phrase: "E."
Processing 00000000.tx.500: (1993) Nature 362, 75-79[CrossRef][Medline] [OrderarticleviaInfotrieve] Fiore, F., Zambrano, N., Minopoli, G., Donini, V., Duilio, A., and Russo, T. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 362,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "75-79"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fiore,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Donini,"

Phrase: "V.,"

Phrase: "Duilio,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.501: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.502: Biol. 

Phrase: "Biol."
Processing 00000000.tx.503: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.504: 270, 30853-30856[Abstract/Free FullText] Borg, J. 

Phrase: "270,"

Phrase: "30853-30856"

Phrase: "[Abstract/Free FullText"

Phrase: "] Borg,"

Phrase: "J."
Processing 00000000.tx.505: P., Oo, I. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Oo,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.506: J., Levy, E., and Margolis, B. 

Phrase: "J.,"

Phrase: "Levy,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Margolis,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.507: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.508: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.509: Biol 16, 6229-6241[Abstract] Guenette, S. 

Phrase: "Biol 16,"

Phrase: "6229-6241"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.510: Y., Chen, J., Jondro, P. 

Phrase: "Y.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.511: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.512: E. 

Phrase: "E."
Processing 00000000.tx.513: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.514: Natl. 

Phrase: "Natl."
Processing 00000000.tx.515: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.516: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.517: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.518: 93, 10832-10837[Abstract/Free FullText] Chow, N., Korenberg, J.R., Chen, X.-N., and Neve, R.L. 

Phrase: "93,"

Phrase: "10832-10837"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Korenberg,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.-"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Neve,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.519: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.520: Biol. 

Phrase: "Biol."
Processing 00000000.tx.521: Chem 271, 11339-11346[Abstract/Free FullText] Yamatsuji, T., Matsui, T., Okamoto, T., Komatsuzaki, K., Takeda, S., Fukumoto, H., Iwatsubo, T., Suzuki, N., Asami-Odaka, A., Ireland, S., Kinane, T. 

Phrase: "Chem 271,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "11339-11346"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamatsuji,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsui,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Komatsuzaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "S."

Phrase: ","

Phrase: "Fukumoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Asami-Odaka,"

Phrase: "A.,"

Phrase: "Ireland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022067:Ireland [Geographic Area]

Phrase: "S."

Phrase: ","

Phrase: "Kinane,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.522: B., Giambarella, U., and Nishimoto, I. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Giambarella,"

Phrase: "U.,"

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.523: (1996) Science 272, 1349-1352[Abstract] Ikezu, T., Okamoto, T., Komatsuzaki, K., Matsui, T., Martyn, J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Science 272,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1349-1352"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ikezu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Komatsuzaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsui,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Martyn,"

Phrase: "J."
Processing 00000000.tx.524: A.J., and Nishimoto, I. 

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.525: (1996) EMBO J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.526: 15, 2468-2475[Abstract] Bouillot, C., Prochiantz, A., Rougon, G., and Allinquant, B. 

Phrase: "15,"

Phrase: "2468-2475"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bouillot,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Prochiantz,"

Phrase: "A.,"

Phrase: "Rougon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Allinquant,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.527: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.528: Biol. 

Phrase: "Biol."
Processing 00000000.tx.529: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.530: 271, 7640-7644[Abstract/Free FullText] Mineo, C., James, G. 

Phrase: "271,"

Phrase: "7640-7644"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mineo,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "James,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.531: L., Smart, E. 

Phrase: "L., Smart,"

Phrase: "E."
Processing 00000000.tx.532: J., and Anderson, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Anderson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.533: G.W. 

Phrase: "G.W."
Processing 00000000.tx.534: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.535: Biol. 

Phrase: "Biol."
Processing 00000000.tx.536: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.537: 271, 11930-11935[Abstract/Free FullText] Liu, P., Ying, Y., Ko, Y.-G., and Anderson, R. 

Phrase: "271,"

Phrase: "11930-11935"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ying,"

Phrase: "Y.,"

Phrase: "Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "Y.-G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Anderson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.538: G.W. 

Phrase: "G.W."
Processing 00000000.tx.539: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.540: Biol. 

Phrase: "Biol."
Processing 00000000.tx.541: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.542: 271, 10299-10303[Abstract/Free FullText] Lisanti, M. 

Phrase: "271,"

Phrase: "10299-10303"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: P., Scherer, P., Tang, Z.-L., and Sargiacomo, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Scherer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tang,"

Phrase: "Z.-"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sargiacomo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.544: (1994) Trends Cell Biol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol."
Processing 00000000.tx.545: 4, 231-235[CrossRef] Glenney, J. 

Phrase: "4,"

Phrase: "231-235"

Phrase: "[CrossRef"

Phrase: "] Glenney,"

Phrase: "J."
Processing 00000000.tx.546: R., and Soppet, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Soppet,"

Phrase: "D."
Processing 00000000.tx.547: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.548: Natl. 

Phrase: "Natl."
Processing 00000000.tx.549: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.550: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.551: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.552: 89, 10517-10521[Abstract] Scherer, P. 

Phrase: "89,"

Phrase: "10517-10521"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Scherer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.553: E., Tang, Z., Chun, M., Sargiacomo, M., Lodish, H. 

Phrase: "E.,"

Phrase: "Tang,"

Phrase: "Z.,"

Phrase: "Chun,"

Phrase: "M."

Phrase: ","

Phrase: "Sargiacomo,"

Phrase: "M."

Phrase: ","

Phrase: "Lodish,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.554: F., and Lisanti, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.556: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.557: Biol. 

Phrase: "Biol."
Processing 00000000.tx.558: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.559: 270, 16395-16401[Abstract/Free FullText] Tang, Z., Scherer, P. 

Phrase: "270,"

Phrase: "16395-16401"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tang,"

Phrase: "Z.,"

Phrase: "Scherer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.560: E., Okamoto, T., Song, K., Chu, C., Kohtz, D. 

Phrase: "E.,"

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chu,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Kohtz,"

Phrase: "D."
Processing 00000000.tx.561: S., Nishimoto, I., Lodish, H. 

Phrase: "S."

Phrase: ","

Phrase: "Nishimoto,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lodish,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.562: F., and Lisanti, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.563: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.564: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.565: Biol. 

Phrase: "Biol."
Processing 00000000.tx.566: Chem 271, 2255-2261[Abstract/Free FullText] Sargiacomo, M., Scherer, P. 

Phrase: "Chem 271,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "2255-2261"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sargiacomo,"

Phrase: "M."

Phrase: ","

Phrase: "Scherer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.567: E., Tang, Z., Kubler, E., Song, K. 

Phrase: "E.,"

Phrase: "Tang,"

Phrase: "Z.,"

Phrase: "Kubler,"

Phrase: "E.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.568: S., Sanders, M. 

Phrase: "S."

Phrase: ","

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.569: C., and Lisanti, M. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.570: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.571: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.572: Natl. 

Phrase: "Natl."
Processing 00000000.tx.573: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.574: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.575: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.576: 92, 9407-9411[Abstract] Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. 

Phrase: "92,"

Phrase: "9407-9411"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: ","

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chun,"

Phrase: "M."

Phrase: ","

Phrase: "Sargiacomo,"

Phrase: "M."

Phrase: ","

Phrase: "Casanova,"

Phrase: "J."
Processing 00000000.tx.577: E., Hansen, S. 

Phrase: "E.,"

Phrase: "Hansen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.578: H., Nishimoto, I., and Lisanti, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nishimoto,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.579: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.580: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.581: Biol. 

Phrase: "Biol."
Processing 00000000.tx.582: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.583: 270, 15693-15701[Abstract/Free FullText] Chun, M., Liyanage, U. 

Phrase: "270,"

Phrase: "15693-15701"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chun,"

Phrase: "M."

Phrase: ","

Phrase: "Liyanage,"

Phrase: "U."
Processing 00000000.tx.584: K., Lisanti, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: P., and Lodish, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lodish,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.586: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.587: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.588: Natl. 

Phrase: "Natl."
Processing 00000000.tx.589: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.590: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.591: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.592: 91, 11728-11732[Abstract/Free FullText] Feron, O., Smith, T. 

Phrase: "91,"

Phrase: "11728-11732"

Phrase: "[Abstract/Free FullText"

Phrase: "] Feron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515381:Feron [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.593: W., Michel, T., and Kelly, R. 

Phrase: "W., Michel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kelly,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.594: A. 

Phrase: "A."
Processing 00000000.tx.595: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.596: Biol. 

Phrase: "Biol."
Processing 00000000.tx.597: Chem 272, 17744-17748[Abstract/Free FullText] de Weerd, W. 

Phrase: "Chem 272,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "17744-17748"

Phrase: "[Abstract/Free FullText"

Phrase: "] de Weerd,"

Phrase: "W."
Processing 00000000.tx.598: F., and Leeb-Lundberg, L. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Leeb-Lundberg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.599: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.600: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.601: Biol. 

Phrase: "Biol."
Processing 00000000.tx.602: Chem 272, 17858-17866[Abstract/Free FullText] Raposo, G., Dunia, I., Marvelo, S., Andre, C., Guillet, J. 

Phrase: "Chem 272,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "17858-17866"

Phrase: "[Abstract/Free FullText"

Phrase: "] Raposo,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dunia,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Marvelo,"

Phrase: "S."

Phrase: ","

Phrase: "Andre,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Guillet,"

Phrase: "J."
Processing 00000000.tx.603: G., Strosberg, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Strosberg,"

Phrase: "A."
Processing 00000000.tx.604: D., Benedeth, E. 

Phrase: "D."

Phrase: ","

Phrase: "Benedeth,"

Phrase: "E."
Processing 00000000.tx.605: L., and Hoebeke, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hoebeke,"

Phrase: "J."
Processing 00000000.tx.606: (1987) Biol. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.607: Cell 60, 117-124[Medline] [OrderarticleviaInfotrieve] Raposo, G., Dunia, I., Delavier-Klutchko, C., Kaveri, S., Stroberg, A. 

Phrase: "Cell 60,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "117-124"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Raposo,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dunia,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Delavier-Klutchko,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Kaveri,"

Phrase: "S."

Phrase: ","

Phrase: "Stroberg,"

Phrase: "A."
Processing 00000000.tx.608: D., and Benedeth, E. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Benedeth,"

Phrase: "E."
Processing 00000000.tx.609: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.610: (1989) Eur. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.611: J.

Phrase: "J."
Processing 00000000.tx.612: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.613: 50, 340-352[Medline] [OrderarticleviaInfotrieve] Okamoto, T., Schlegel, A., Scherer, P. 

Phrase: "50,"

Phrase: "340-352"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schlegel,"

Phrase: "A.,"

Phrase: "Scherer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.614: E., and Lisanti, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.615: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.616: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.617: Biol. 

Phrase: "Biol."
Processing 00000000.tx.618: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.619: 273, 5419-5422[Free FullText] Couet, J., Li, S., Okamoto, T., Ikezu, T., and Lisanti, M. 

Phrase: "273,"

Phrase: "5419-5422"

Phrase: "[Free FullText"

Phrase: "] Couet,"

Phrase: "J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: ","

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ikezu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.620: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.621: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.622: Biol. 

Phrase: "Biol."
Processing 00000000.tx.623: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.624: 272, 6525-6533[Abstract/Free FullText] Okamoto, T., Takeda, S., Murayama, Y., Ogata, E., and Nishimoto, I. 

Phrase: "272,"

Phrase: "6525-6533"

Phrase: "[Abstract/Free FullText"

Phrase: "] Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takeda,"

Phrase: "S."

Phrase: ","

Phrase: "Murayama,"

Phrase: "Y.,"

Phrase: "Ogata,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.625: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.626: Biol. 

Phrase: "Biol."
Processing 00000000.tx.627: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.628: 270, 4205-4208[Abstract/Free FullText] Song, K. 

Phrase: "270,"

Phrase: "4205-4208"

Phrase: "[Abstract/Free FullText"

Phrase: "] Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.629: S., Tang, Z., Li, S., and Lisanti, M. 

Phrase: "S."

Phrase: ","

Phrase: "Tang,"

Phrase: "Z.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.630: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.631: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.632: Biol. 

Phrase: "Biol."
Processing 00000000.tx.633: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.634: 272, 4398-4403[Abstract/Free FullText] Kim, K. 

Phrase: "272,"

Phrase: "4398-4403"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.635: S., Wen, G. 

Phrase: "S."

Phrase: ","

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.636: Y., Bancher, C. 

Phrase: "Y.,"

Phrase: "Bancher,"

Phrase: "C."
Processing 00000000.tx.637: M., Chen, J., Sapeenza, V. 

Phrase: "M."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "Sapeenza,"

Phrase: "V."
Processing 00000000.tx.638: J., Hong, H., and Wisniewski, H. 

Phrase: "J.,"

Phrase: "Hong,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.639: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.640: (1990) Neurosci. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.641: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.642: Commun. 

Phrase: "Commun."
Processing 00000000.tx.643: 7, 118-122 Reaume, A. 

Phrase: "7,"

Phrase: "118-122 Reaume,"

Phrase: "A."
Processing 00000000.tx.644: G., Howland, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Howland,"

Phrase: "D."
Processing 00000000.tx.645: S., Trusko, S. 

Phrase: "S."

Phrase: ","

Phrase: "Trusko,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.646: P., Savage, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Savage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331893:Savage [Health Care Related Organization]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.647: J., Lang, D. 

Phrase: "J.,"

Phrase: "Lang,"

Phrase: "D."
Processing 00000000.tx.648: M., Greenberg, B. 

Phrase: "M."

Phrase: ","

Phrase: "Greenberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.649: D., Siman, R., and Scott, R. 

Phrase: "D."

Phrase: ","

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Scott,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.650: W. 

Phrase: "W."
Processing 00000000.tx.651: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.652: Biol. 

Phrase: "Biol."
Processing 00000000.tx.653: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.654: 271, 23380-23388[Abstract/Free FullText] Buxbaum, J. 

Phrase: "271,"

Phrase: "23380-23388"

Phrase: "[Abstract/Free FullText"

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.655: D., Gandy, S. 

Phrase: "D."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.656: E., Cicchetti, P., Ehrlich, M. 

Phrase: "E.,"

Phrase: "Cicchetti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ehrlich,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.657: E., Czernk, A. 

Phrase: "E.,"

Phrase: "Czernk,"

Phrase: "A."
Processing 00000000.tx.658: J., Fracasso, R. 

Phrase: "J.,"

Phrase: "Fracasso,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.659: P., Ramabhadran, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ramabhadran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.660: V., Unterbeck, A. 

Phrase: "V., Unterbeck,"

Phrase: "A."
Processing 00000000.tx.661: J., and Greengard, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.662: (1990) Proc. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.663: Natl. 

Phrase: "Natl."
Processing 00000000.tx.664: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.665: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.666: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.667: 87, 6003-6006[Abstract] Hayashi, Y., Kashiwagi, K., and Yoshikawa, K. 

Phrase: "87,"

Phrase: "6003-6006"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hayashi,"

Phrase: "Y.,"

Phrase: "Kashiwagi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yoshikawa,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.668: (1992) Biochem. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.669: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.670: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.671: Commun. 

Phrase: "Commun."
Processing 00000000.tx.672: 187, 1249-1255[Medline] [OrderarticleviaInfotrieve] Sisodia, S. 

Phrase: "187,"

Phrase: "1249-1255"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.673: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.674: H., Hoffman, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hoffman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.675: N., Perry, G., and Price, D. 

Phrase: "N., Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.676: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.677: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.678: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.679: 13, 3136-3142[Abstract] Ikezu, T., Okamoto, T., Murayama, Y., Okamoto, T., Homma, Y., Ogata, E., and Nishimoto, I. 

Phrase: "13,"

Phrase: "3136-3142"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ikezu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murayama,"

Phrase: "Y.,"

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Homma,"

Phrase: "Y.,"

Phrase: "Ogata,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.680: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.681: Biol. 

Phrase: "Biol."
Processing 00000000.tx.682: Chem 269, 31955-31961[Abstract/Free FullText] Yamatsuji, T., Okamoto, T., Takeda, S., Murayama, Y., Tanaka, N., and Nishimoto, I. 

Phrase: "Chem 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "31955-31961"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamatsuji,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takeda,"

Phrase: "S."

Phrase: ","

Phrase: "Murayama,"

Phrase: "Y.,"

Phrase: "Tanaka,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.683: (1996) EMBO J 15, 498-509[Abstract] Song, K. 

Phrase: "(1996"

Phrase: ")"

Phrase: "EMBO J 15,"

Phrase: "498-509"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.684: S., Li, S., Okamoto, T., Quilliam, L., Sargiacomo, M., and Lisanti, M. 

Phrase: "S."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: ","

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Quilliam,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sargiacomo,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.686: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.687: Biol. 

Phrase: "Biol."
Processing 00000000.tx.688: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.689: 271, 9690-9697[Abstract/Free FullText] Tang, Z., Okamoto, T., Boontrakulpoontawee, P., Katada, T., Otsuka, A. 

Phrase: "271,"

Phrase: "9690-9697"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tang,"

Phrase: "Z.,"

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Boontrakulpoontawee,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Katada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Otsuka,"

Phrase: "A."
Processing 00000000.tx.690: J., and Lisanti, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.691: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.692: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.693: Biol. 

Phrase: "Biol."
Processing 00000000.tx.694: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.695: 272, 2437-2445[Abstract/Free FullText] Schnitzer, J., McIntosh, D., Dvorak, A. 

Phrase: "272,"

Phrase: "2437-2445"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schnitzer,"

Phrase: "J.,"

Phrase: "McIntosh,"

Phrase: "D."

Phrase: ","

Phrase: "Dvorak,"

Phrase: "A."
Processing 00000000.tx.696: M., Liu, J., and Oh, P. 

Phrase: "M."

Phrase: ","

Phrase: "Liu,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Oh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.697: (1995) Science 269, 1435-1439[Medline] [OrderarticleviaInfotrieve] Smart, E. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1435-1439"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Smart,"

Phrase: "E."
Processing 00000000.tx.698: J., Y., Ying, C., Mineo, and Anderson, R. 

Phrase: "J.,"

Phrase: "Y.,"

Phrase: "Ying,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Mineo,"

Phrase: "and"

Phrase: "Anderson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.699: G.W. 

Phrase: "G.W."
Processing 00000000.tx.700: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.701: Natl. 

Phrase: "Natl."
Processing 00000000.tx.702: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.703: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.704: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.705: 92, 10104-10108[Abstract] Frangioni, J. 

Phrase: "92,"

Phrase: "10104-10108"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Frangioni,"

Phrase: "J."
Processing 00000000.tx.706: V., and Neel, B. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Neel,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.707: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.708: (1993) Anal. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.709: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.710: 210, 179-187[CrossRef][Medline] [OrderarticleviaInfotrieve] Ermekova, K. 

Phrase: "210,"

Phrase: "179-187"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ermekova,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.711: S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., and Sudol, M. 

Phrase: "S."

Phrase: ","

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Linn,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gertler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Russo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Sudol,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.712: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.713: Biol. 

Phrase: "Biol."
Processing 00000000.tx.714: Chem 272, 32869-32877[Abstract/Free FullText] Sharma, R. 

Phrase: "Chem 272,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "32869-32877"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sharma,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.715: K., Taylor, W. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Taylor,"

Phrase: "W."
Processing 00000000.tx.716: A., and Wang, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wang,"

Phrase: "J."
Processing 00000000.tx.717: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.718: (1983) Methods Enzymol. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.719: 102, 210-219[Medline] [OrderarticleviaInfotrieve] Parton, R. 

Phrase: "102,"

Phrase: "210-219"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Parton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.720: G., Joggerst, B., and Simons, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Joggerst,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.721: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.722: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.723: 127, 1199-1215[Abstract] Lisanti, M. 

Phrase: "127,"

Phrase: "1199-1215"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.724: P., Sargiacomo, M., Graeve, L., Saltiel, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sargiacomo,"

Phrase: "M."

Phrase: ","

Phrase: "Graeve,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Saltiel,"

Phrase: "A."
Processing 00000000.tx.725: R., and Rodriguez-Boulan, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rodriguez-Boulan,"

Phrase: "E."
Processing 00000000.tx.726: (1988) Proc. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.727: Natl. 

Phrase: "Natl."
Processing 00000000.tx.728: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.729: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.730: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.731: 85, 9557-9561[Abstract] Slunt, H. 

Phrase: "85,"

Phrase: "9557-9561"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.732: H., Thinakaran, G., Von Koch, C., Lo, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Von Koch,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Lo,"

Phrase: "A."
Processing 00000000.tx.733: C., Tanzi, R. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.734: E., and Sisodia, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.735: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.736: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.737: Biol. 

Phrase: "Biol."
Processing 00000000.tx.738: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.739: 269, 2637-2644[Abstract/Free FullText] Chun, M., Liyanage, U., Lisanti, M. 

Phrase: "269,"

Phrase: "2637-2644"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chun,"

Phrase: "M."

Phrase: ","

Phrase: "Liyanage,"

Phrase: "U.,"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.740: P., and Lodish, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lodish,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.741: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.742: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.743: Natl. 

Phrase: "Natl."
Processing 00000000.tx.744: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.745: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.746: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.747: 91, 11728-11732[Abstract/Free FullText] Couet, J., Sargiacomo, M., and Lisanti, M. 

Phrase: "91,"

Phrase: "11728-11732"

Phrase: "[Abstract/Free FullText"

Phrase: "] Couet,"

Phrase: "J.,"

Phrase: "Sargiacomo,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.748: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.749: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.750: Biol. 

Phrase: "Biol."
Processing 00000000.tx.751: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.752: 272, 30429-30438[Abstract/Free FullText] Parton, R. 

Phrase: "272,"

Phrase: "30429-30438"

Phrase: "[Abstract/Free FullText"

Phrase: "] Parton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.753: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.754: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.755: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.756: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.757: 42, 155-166[Abstract/Free FullText] Wang, R., Meschia, J. 

Phrase: "42,"

Phrase: "155-166"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Meschia,"

Phrase: "J."
Processing 00000000.tx.758: F., Cotter, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cotter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.759: J., and Sisodia, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.760: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.761: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.762: Biol. 

Phrase: "Biol."
Processing 00000000.tx.763: Chem 266, 16960-16964[Abstract/Free FullText] Fielding, C., Bist, A., and Fielding, P. 

Phrase: "Chem 266,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "16960-16964"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fielding,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0331809:Fielding [Health Care Related Organization]
   966 E C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966 E C1521738:Field [Conceptual Entity]
   966 E C2346620:Field [Conceptual Entity]
   966 E C2349184:Field [Conceptual Entity]
   966 E C3539073:FIELD [Spatial Concept]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Bist,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Fielding,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0331809:Fielding [Health Care Related Organization]
   966 E C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966 E C1521738:Field [Conceptual Entity]
   966 E C2346620:Field [Conceptual Entity]
   966 E C2349184:Field [Conceptual Entity]
   966 E C3539073:FIELD [Spatial Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.764: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.765: Natl. 

Phrase: "Natl."
Processing 00000000.tx.766: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.767: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.768: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.769: 94, 3753-3758[Abstract/Free FullText] Smart, E., Ying, Y., Donzell, W., and Anderson, R. 

Phrase: "94,"

Phrase: "3753-3758"

Phrase: "[Abstract/Free FullText"

Phrase: "] Smart,"

Phrase: "E.,"

Phrase: "Ying,"

Phrase: "Y.,"

Phrase: "Donzell,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Anderson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.770: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.771: Biol. 

Phrase: "Biol."
Processing 00000000.tx.772: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.773: 271, 29427-29435[Abstract/Free FullText] Murata, M., Peranen, J., Schreiner, R., Weiland, F., Kurzchalia, T., and Simons, K. 

Phrase: "271,"

Phrase: "29427-29435"

Phrase: "[Abstract/Free FullText"

Phrase: "] Murata,"

Phrase: "M."

Phrase: ","

Phrase: "Peranen,"

Phrase: "J.,"

Phrase: "Schreiner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Weiland,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kurzchalia,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.774: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.775: Natl. 

Phrase: "Natl."
Processing 00000000.tx.776: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.777: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.778: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.779: 92, 10339-10343[Abstract] Li, S., Song, K. 

Phrase: "92,"

Phrase: "10339-10343"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.780: S., and Lisanti, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.781: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.782: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.783: Biol. 

Phrase: "Biol."
Processing 00000000.tx.784: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.785: 271, 568-573[Abstract/Free FullText] Bodovitz, S., and Klein, W. 

Phrase: "271,"

Phrase: "568-573"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bodovitz,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Klein,"

Phrase: "W."
Processing 00000000.tx.786: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.787: Biol. 

Phrase: "Biol."
Processing 00000000.tx.788: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.789: 271, 4436-4440[Abstract/Free FullText] Czech, C., Forstl, H., Hentschel, F., Monning, U., Besthorn, C., Geiger-Kabisch, C., Sattel, H., Masters, C., and Beyreuther, K. 

Phrase: "271,"

Phrase: "4436-4440"

Phrase: "[Abstract/Free FullText"

Phrase: "] Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Forstl,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hentschel,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Monning,"

Phrase: "U.,"

Phrase: "Besthorn,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Geiger-Kabisch,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Sattel,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.790: (1994) Eur. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.791: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.792: Psychiatry Clin. 

Phrase: "Psychiatry"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.793: Neurosci 243, 291-292[Medline] [OrderarticleviaInfotrieve] Sisodia, S. 

Phrase: "Neurosci 243,"

Phrase: "291-292"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.794: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.795: H., Beyreuther, K., Unterbeck, A., and Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Unterbeck,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.796: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.797: (1990) Science 248, 492-495[Medline] [OrderarticleviaInfotrieve] Van Nostrand, W. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 248,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "492-495"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Van Nostrand,"

Phrase: "W."
Processing 00000000.tx.798: E., Wagner, S. 

Phrase: "E.,"

Phrase: "Wagner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.799: L., Suzuki, M., Choi, B. 

Phrase: "L., Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0998924:suzuki [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Choi,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.800: H., Farrow, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Farrow,"

Phrase: "J."
Processing 00000000.tx.801: S., Geddes, J. 

Phrase: "S."

Phrase: ","

Phrase: "Geddes,"

Phrase: "J."
Processing 00000000.tx.802: W., Cotman, C. 

Phrase: "W., Cotman,"

Phrase: "C."
Processing 00000000.tx.803: W., and Cunningham, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Cunningham,"

Phrase: "D."
Processing 00000000.tx.804: D. 

Phrase: "D."
Processing 00000000.tx.805: (1989) Nature 341, 546-549[CrossRef][Medline] [OrderarticleviaInfotrieve] Oltersdorf, T., Fritz, L. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nature 341,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "546-549"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fritz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414819:FRITZ [Gene or Genome]
  1000   C2681211:fritz [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.806: C., Schenk, D. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.807: B., Lieberburg, I., Johnson-Wood, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.808: L., Beattie, E. 

Phrase: "L., Beattie,"

Phrase: "E."
Processing 00000000.tx.809: C., Ward, P. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.810: J., Blacher, R. 

Phrase: "J.,"

Phrase: "Blacher,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.811: W., Dovey, H. 

Phrase: "W., Dovey,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.812: F., and Sinha, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Sinha,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.813: (1989) Nature 341, 144-147[CrossRef][Medline] [OrderarticleviaInfotrieve] Barger, S. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nature 341,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "144-147"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.814: W., and Harmon, A. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Harmon,"

Phrase: "A."
Processing 00000000.tx.815: D. 

Phrase: "D."
Processing 00000000.tx.816: (1997) Nature 388, 878-881[CrossRef][Medline] [OrderarticleviaInfotrieve] Haass, C., Koo, E. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "878-881"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.817: H., Mellon, A., Hung, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mellon,"

Phrase: "A.,"

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.818: Y., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.819: J. 

Phrase: "J."
Processing 00000000.tx.820: (1992) Nature 357, 500-503[CrossRef][Medline] [OrderarticleviaInfotrieve] Koo, E. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 357,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "500-503"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koo,"

Phrase: "E."
Processing 00000000.tx.821: H., Park, L., and Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.822: J. 

Phrase: "J."
Processing 00000000.tx.823: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.824: Natl. 

Phrase: "Natl."
Processing 00000000.tx.825: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.826: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.827: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.828: 90, 4748-4752[Abstract] Sisodia, S. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "4748-4752"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.829: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.830: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.831: Natl. 

Phrase: "Natl."
Processing 00000000.tx.832: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.833: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.834: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.835: 89, 6075-6079[Abstract] Arribas, J., Lopez-Casillas, F., and Massague, J. 

Phrase: "89,"

Phrase: "6075-6079"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Arribas,"

Phrase: "J.,"

Phrase: "Lopez-Casillas,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Massague,"

Phrase: "J."
Processing 00000000.tx.836: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.837: Biol. 

Phrase: "Biol."
Processing 00000000.tx.838: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.839: 272, 17160-17165[Abstract/Free FullText] Sevinsky, J. 

Phrase: "272,"

Phrase: "17160-17165"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sevinsky,"

Phrase: "J."
Processing 00000000.tx.840: R., Rao, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.841: V., and Ruf, W. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Ruf,"

Phrase: "W."
Processing 00000000.tx.842: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.843: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.844: 133, 293-304[Abstract] Blobel, C. 

Phrase: "133,"

Phrase: "293-304"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blobel,"

Phrase: "C."
Processing 00000000.tx.845: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.846: (1997) Cell 90, 589-592[CrossRef][Medline] [OrderarticleviaInfotrieve] De Strooper, B., Umans, L., Van Leuven, F., and Van Den Berghe, H. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 90,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "589-592"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Umans,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van Den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.847: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.848: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.849: 121, 295-304[Abstract] Sambamurti, K., Refolo, L. 

Phrase: "121,"

Phrase: "295-304"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Refolo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.850: M., Shioi, J., Pappolla, M. 

Phrase: "M."

Phrase: ","

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "Pappolla,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.851: A., and Robakis, N. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.852: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.853: (1992) Ann. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.854: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.855: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.856: 674, 118-128[Medline] [OrderarticleviaInfotrieve] Haass, C., Koo, E. 

Phrase: "674,"

Phrase: "118-128"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.857: H., Capell, A., Teplow, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.858: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.859: J. 

Phrase: "J."
Processing 00000000.tx.860: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.861: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.862: 128, 537-547[Abstract] Jacobsen, J. 

Phrase: "128,"

Phrase: "537-547"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jacobsen,"

Phrase: "J."
Processing 00000000.tx.863: S., Spruyt, M. 

Phrase: "S."

Phrase: ","

Phrase: "Spruyt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.864: A., Brown, A. 

Phrase: "A.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "A."
Processing 00000000.tx.865: M., Sahasrabudhe, S. 

Phrase: "M."

Phrase: ","

Phrase: "Sahasrabudhe,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.866: R., Blume, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blume,"

Phrase: "A."
Processing 00000000.tx.867: J., Vitek, M. 

Phrase: "J.,"

Phrase: "Vitek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553145:Vitek [Laboratory Procedure]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.868: P., Muenkel, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Muenkel,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.869: A., and Sonnenberg-Reines, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Sonnenberg-Reines,"

Phrase: "J."
Processing 00000000.tx.870: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.871: Biol. 

Phrase: "Biol."
Processing 00000000.tx.872: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.873: 269, 8376-8382[Abstract/Free FullText] Lisanti, M. 

Phrase: "269,"

Phrase: "8376-8382"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.874: P., Scherer, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Scherer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.875: E., Vidugiriene, J., Tang, Z.-L., Hermanoski-Vosatka, A., Tu, Y.-H., Cook, R. 

Phrase: "E.,"

Phrase: "Vidugiriene,"

Phrase: "J.,"

Phrase: "Tang,"

Phrase: "Z.-L., Hermanoski-Vosatka,"

Phrase: "A.,"

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "Y.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.876: F., and Sargiacomo, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Sargiacomo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.877: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.878: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.879: 126, 111-126[Abstract] Smart, E. 

Phrase: "126,"

Phrase: "111-126"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Smart,"

Phrase: "E."
Processing 00000000.tx.880: J., Foster, D. 

Phrase: "J.,"

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."
Processing 00000000.tx.881: C., Ying, Y. 

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Ying,"

Phrase: "Y."
Processing 00000000.tx.882: S., Kamen, B. 

Phrase: "S."

Phrase: ","

Phrase: "Kamen,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.883: A., and Anderson, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Anderson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.884: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.885: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.886: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.887: 124, 307-313[Abstract] Nordstedt, C., Caporaso, G. 

Phrase: "124,"

Phrase: "307-313"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Caporaso,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.888: L., Thyberg, J., Gandy, S. 

Phrase: "L., Thyberg,"

Phrase: "J.,"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.889: E., and Greengard, P. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.890: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.891: Biol. 

Phrase: "Biol."
Processing 00000000.tx.892: Chem 268, 608-612[Abstract/Free FullText] Wu, C., Butz, S., Ying, Y., and Anderson, R. 

Phrase: "Chem 268,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "608-612"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Butz,"

Phrase: "S."

Phrase: ","

Phrase: "Ying,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Anderson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.893: G.W. 

Phrase: "G.W."
Processing 00000000.tx.894: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.895: Biol. 

Phrase: "Biol."
Processing 00000000.tx.896: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.897: 272, 3554-3559[Abstract/Free FullText] Li, S., Song, K. 

Phrase: "272,"

Phrase: "3554-3559"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.898: S., Koh, S. 

Phrase: "S."

Phrase: ","

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.899: S., Kikuchi, A., and Lisanti, M.P. 

Phrase: "S."

Phrase: ","

Phrase: "Kikuchi,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Lisanti,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.900: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.901: Biol. 

Phrase: "Biol."
Processing 00000000.tx.902: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.903: 271, 28647-28654[Abstract/Free FullText] Simons, K., and Ikonen, E. 

Phrase: "271,"

Phrase: "28647-28654"

Phrase: "[Abstract/Free FullText"

Phrase: "] Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ikonen,"

Phrase: "E."
Processing 00000000.tx.904: (1997) Nature 387, 569-572[CrossRef][Medline] [OrderarticleviaInfotrieve] Bickel, P. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 387,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "569-572"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bickel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.905: E., Scherer, P. 

Phrase: "E.,"

Phrase: "Scherer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.906: E., Schnitzer, J. 

Phrase: "E.,"

Phrase: "Schnitzer,"

Phrase: "J."
Processing 00000000.tx.907: E., Oh, P., Lisanti, M. 

Phrase: "E.,"

Phrase: "Oh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lisanti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.908: P., and Lodish, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lodish,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.909: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.910: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.911: Biol. 

Phrase: "Biol."
Processing 00000000.tx.912: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.913: 272, 13793-13802[Abstract/Free FullText] Copyright  1998 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "272,"

Phrase: "13793-13802"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  1998 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

